2972
     RDKit          3D

 10 10  0  0  0  0  0  0  0  0999 V2000
   -1.3620   -1.9920    0.0052 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7029    0.4496    0.0062 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3507    0.5250    0.0079 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6794   -0.7221   -0.0046 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6764   -0.7974    0.0048 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5955    1.6889   -0.0074 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5167   -1.9789   -0.0145 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8134    0.6114    0.0136 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4763    0.4673    0.0008 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7381    1.7482   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  2  9  2  0
  3  4  1  0
  3  6  1  0
  3  8  1  0
  4  5  2  0
  4  7  1  0
  5  9  1  0
  6 10  2  0
  9 10  1  0
M  END
>  <InChIKey>  (1) 
TZXKOCQBRNJULO-UHFFFAOYSA-N

>  <PubChem_CID>  (1) 
2972

>  <BOM_1A2>  (1) 


>  <BOM_2A6>  (1) 
<8,3;Dealkylation;R1>
<8,H;Dealkylation;R1>

>  <BOM_2B6>  (1) 


>  <BOM_2C8>  (1) 


>  <BOM_2C9>  (1) 


>  <BOM_2C19>  (1) 


>  <BOM_2D6>  (1) 


>  <BOM_2E1>  (1) 


>  <BOM_3A4>  (1) 
<8,3;Dealkylation;R1>
<8,H;Dealkylation;R1>

>  <References>  (1) 
Zheng, Xiaojiao, et al. "Metabolic activation of deferiprone mediated by CYP2A6." Xenobiotica 51.11 (2021): 1282-1291.

>  <FLAG_COMMENTS>  (1) 


>  <Name>  (1) 
Deferiprone

>  <ID>  (1) 
2972

$$$$
28125517
     RDKit          3D

 16 17  0  0  1  0  0  0  0  0999 V2000
   -2.6201    0.9320   -0.2804 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1533   -0.0033   -1.3256 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5487    1.4597    1.7479 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9541   -0.5776    0.7002 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5118   -0.2760   -1.0597 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.6461   -1.1515   -0.5683 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1387   -0.8894   -0.8239 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3937    0.6739    0.8238 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0677   -0.0111   -0.6989 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5276   -1.1806   -0.1066 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8287    1.1508   -0.6647 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7685   -1.1885    0.5304 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0697    1.1427   -0.0278 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5395   -0.0269    0.5697 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2707   -2.4391    1.1692 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8940    2.3849    0.0149 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1  8  1  0
  2  7  1  0
  2  9  1  0
  3  8  2  0
  4  6  1  0
  4  8  1  0
  5  6  1  0
  5  7  1  1
  9 10  2  0
  9 11  1  0
 10 12  1  0
 11 13  2  0
 12 14  2  0
 12 15  1  0
 13 14  1  0
 13 16  1  0
M  END
>  <InChIKey>  (2) 
IMWZZHHPURKASS-NSHDSACASA-N

>  <PubChem_CID>  (2) 
28125517

>  <BOM_1A2>  (2) 


>  <BOM_2A6>  (2) 
<16,H;Hydroxylation;R1>
<15,H;Hydroxylation;R1>

>  <BOM_2B6>  (2) 


>  <BOM_2C8>  (2) 


>  <BOM_2C9>  (2) 


>  <BOM_2C19>  (2) 
<16,H;Hydroxylation;R1>
<15,H;Hydroxylation;R1>

>  <BOM_2D6>  (2) 


>  <BOM_2E1>  (2) 
<16,H;Hydroxylation;R1>
<15,H;Hydroxylation;R1>

>  <BOM_3A4>  (2) 


>  <References>  (2) 
Liu, He, et al. "Metabolic activation and cytotoxicity of metaxalone mediated by cytochrome P450 enzymes and sulfotransferases." Chemico-Biological Interactions 382 (2023): 110628.

>  <FLAG_COMMENTS>  (2) 


>  <Name>  (2) 
Metaxalone

>  <ID>  (2) 
28125517

$$$$
54697325
     RDKit          2D

 40 43  0  0  0  0  0  0  0  0999 V2000
   -1.0716    1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7861    0.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7861   -0.1760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0716   -0.5885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3572   -0.1760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3572    0.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5006    1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2151    0.6489    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9295    1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6440    0.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3585    1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3585    0.2364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4304   -0.1479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3572    1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3572   -0.5885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0716   -0.1760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0716    0.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7861    1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7861   -0.5885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5007   -0.1760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5007    0.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2151    1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2151   -0.5885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9296   -0.1760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9296    0.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6441    1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6441    1.8864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3584    0.6489    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6441   -0.5885    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2151    1.8864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7985   -1.1719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6235   -1.1719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3860   -1.8864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5007    1.4739    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7861    1.8864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3572    1.8864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0716    1.8864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0716   -1.4135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3572   -1.8260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7861   -1.8260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  1  6  1  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
 14  6  1  0
  6  5  2  0
  5 15  1  0
 16 15  1  6
 14 17  1  0
 18 17  2  0
 17 16  1  0
 16 19  1  0
 20 19  1  6
 18 21  1  0
 22 21  1  0
 21 20  1  0
 20 23  1  0
 23 24  1  0
 24 25  2  0
 22 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 24 29  1  0
 22 30  2  0
 23 31  1  1
 31 32  1  0
 31 33  1  0
 21 34  1  1
 18 35  1  0
 14 36  2  0
  1 37  1  0
 38  4  1  0
 38 39  1  0
 38 40  1  0
M  END
>  <InChIKey>  (3) 
JEECQCWWSTZDCK-IQZGDKDPSA-N

>  <PubChem_CID>  (3) 
54697325

>  <BOM_1A2>  (3) 


>  <BOM_2A6>  (3) 


>  <BOM_2B6>  (3) 


>  <BOM_2C8>  (3) 


>  <BOM_2C9>  (3) 


>  <BOM_2C19>  (3) 


>  <BOM_2D6>  (3) 


>  <BOM_2E1>  (3) 


>  <BOM_3A4>  (3) 


>  <References>  (3) 
"NUZYRA (Omadacycline) Tablets, for Oral Use: Prescribing Information." U.S. Food and Drug Administration, 27 May 2021, www.accessdata.fda.gov/drugsatfda_docs/label/2021/209816s011,209817s010lbl.pdf. Accessed 9 Feb. 2024.

>  <FLAG_COMMENTS>  (3) 
In vitro studies using human liver microsomes and hepatocytes demonstrated that omadacycline is not metabolized. 

>  <Name>  (3) 
Omadacycline

>  <ID>  (3) 
54697325

$$$$
667431
     RDKit          3D

 22 24  0  0  1  0  0  0  0  0999 V2000
   -2.2251    2.0194    0.2264 S   0  0  0  0  0  6  0  0  0  0  0  0
    0.3642    0.5991    1.1882 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9564    2.2442    1.6337 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9554    3.0034   -0.5490 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5821    0.2542   -0.4292 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4205    0.8600   -0.8540 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7623    1.6397   -0.5726 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9397    0.2243   -0.4599 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.4104   -1.1384   -0.9555 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.4567   -0.0224    0.9624 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6417   -2.1200    0.1997 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7287    1.1585   -0.5287 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9338   -0.8883   -1.2736 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7241   -1.2607    1.4497 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3644    0.9882    0.0237 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0838    0.4792    0.1091 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9287   -0.4589    1.1153 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8955    0.2387   -0.9861 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4279   -1.9341   -0.0733 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6059   -1.6749    1.0232 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5728   -0.9773   -1.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1525   -3.2339   -0.1717 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  2  0
  1  4  2  0
  1  7  1  0
  1 16  1  0
  2 15  2  0
  5  6  1  0
  5 12  1  0
  5 13  1  0
  6 15  1  0
  7 15  1  0
  8  9  1  0
  8 10  1  1
  8 12  1  0
  9 11  1  1
  9 13  1  0
 10 14  1  0
 11 14  1  0
 16 17  2  0
 16 18  1  0
 17 20  1  0
 18 21  2  0
 19 20  2  0
 19 21  1  0
 19 22  1  0
M  END
>  <InChIKey>  (4) 
BOVGTQGAOIONJV-BETUJISGSA-N

>  <PubChem_CID>  (4) 
667431

>  <BOM_1A2>  (4) 


>  <BOM_2A6>  (4) 


>  <BOM_2B6>  (4) 


>  <BOM_2C8>  (4) 
<14,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>
<11,H;Hydroxylation;R2>

>  <BOM_2C9>  (4) 
<14,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>
<11,H;Hydroxylation;R2>
<22,H;Hydroxylation;R3>

>  <BOM_2C19>  (4) 
<14,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>
<11,H;Hydroxylation;R2>
<22,H;Hydroxylation;R3>

>  <BOM_2D6>  (4) 


>  <BOM_2E1>  (4) 


>  <BOM_3A4>  (4) 


>  <References>  (4) 
Elliot DJ, Suharjono, Lewis BC, Gillam EM, Birkett DJ, Gross AS, Miners JO: Identification of the human cytochromes P450 catalysing the rate-limiting pathways of gliclazide elimination. Br J Clin Pharmacol. 2007 Oct;64(4):450-7. Epub 2007 May 22. 
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. 
Oida T, Yoshida K, Kagemoto A, Sekine Y, Higashijima T: The metabolism of gliclazide in man. Xenobiotica. 1985 Jan;15(1):87-96.
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.

>  <FLAG_COMMENTS>  (4) 


>  <Name>  (4) 
Gliclazide

>  <ID>  (4) 
667431

$$$$
10220503
     RDKit          2D

 18 20  0  0  1  0  0  0  0  0999 V2000
    6.9103   -3.4878    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.6830    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    1.6830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0981   -0.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981    0.1830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5981    0.1830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0981   -1.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9641   -2.1830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2320   -2.1830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9103   -1.8783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9641   -3.1830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4939   -2.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2320   -3.1830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0981   -3.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    2.1830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    3.1830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    3.6830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  1 13  1  0
  2 16  2  0
  3  8  1  0
  3 16  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  1
  5  6  1  0
  5  8  1  6
  7  9  1  0
  7 10  2  0
  9 11  1  0
  9 12  2  0
 10 14  1  0
 11 13  1  0
 12 15  1  0
 14 15  2  0
 16 17  1  0
 17 18  1  0
M  END
>  <InChIKey>  (5) 
PTOIAAWZLUQTIO-GXFFZTMASA-N

>  <PubChem_CID>  (5) 
10220503

>  <BOM_1A2>  (5) 
<13,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <BOM_2A6>  (5) 


>  <BOM_2B6>  (5) 


>  <BOM_2C8>  (5) 


>  <BOM_2C9>  (5) 
<13,H;Hydroxylation;R1>

>  <BOM_2C19>  (5) 
<13,H;Hydroxylation;R1>

>  <BOM_2D6>  (5) 
<13,H;Hydroxylation;R1>

>  <BOM_2E1>  (5) 


>  <BOM_3A4>  (5) 
<11,H;Hydroxylation;R2>

>  <References>  (5) 
Ogilvie, Brian W., et al. "Clinical assessment of drugdrug interactions of tasimelteon, a novel dual melatonin receptor agonist." The Journal of Clinical Pharmacology 55.9 (2015): 1004-1011.

>  <FLAG_COMMENTS>  (5) 


>  <Name>  (5) 
Tasimelteon

>  <ID>  (5) 
10220503

$$$$
44400012
     RDKit          3D

 13 12  0  0  1  0  0  0  0  0999 V2000
    0.3155    1.6963   -0.1168 P   0  0  0  0  0  5  0  0  0  0  0  0
    0.9649   -1.4698   -0.2386 P   0  0  1  0  0  5  0  0  0  0  0  0
    0.6826    0.0622    1.8028 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9111    1.9173    0.0252 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1114    1.5590   -1.7135 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5002   -0.9612   -0.0306 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5305    2.7412    0.5479 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6494   -1.5201   -1.7161 O   0  0  0  0  0  1  0  0  0  0  0  0
    0.7216   -2.6566    0.6669 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6903   -0.6459   -0.0552 N   0  0  0  0  0  4  0  0  0  0  0  0
    0.0655   -0.0029    0.5073 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.4210   -0.3027    0.7842 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2804   -0.4167   -0.4637 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  1  5  1  0
  1  7  2  0
  1 11  1  0
  2  6  1  6
  2  8  1  0
  2  9  2  0
  2 11  1  0
 11  3  1  1
 10 13  1  0
 11 12  1  0
 12 13  1  0
M  CHG  2   8  -1  10   1
M  END
>  <InChIKey>  (6) 
WRUUGTRCQOWXEG-UHFFFAOYSA-N

>  <PubChem_CID>  (6) 
44400012

>  <BOM_1A2>  (6) 


>  <BOM_2A6>  (6) 


>  <BOM_2B6>  (6) 


>  <BOM_2C8>  (6) 


>  <BOM_2C9>  (6) 


>  <BOM_2C19>  (6) 


>  <BOM_2D6>  (6) 


>  <BOM_2E1>  (6) 


>  <BOM_3A4>  (6) 


>  <References>  (6) 
"Aredia (Pamidronate Disodium for Injection) for Intravenous Infusion: Prescribing Information." U.S. Food and Drug Administration, 22 Sept. 1998, www.accessdata.fda.gov/drugsatfda_docs/label/1998/20927lbl.pdf. Accessed 9 Feb. 2024.

>  <FLAG_COMMENTS>  (6) 
Pamidronate is not metabolized and is exclusively eliminated by renal excretion.

>  <Name>  (6) 
Pamidronic acid

>  <ID>  (6) 
44400012

$$$$
23653540
     RDKit          3D

 21 23  0  0  1  0  0  0  0  0999 V2000
    2.2106   -0.5497    1.1083 S   0  0  0  0  0  6  0  0  0  0  0  0
    3.0070   -1.7139    0.7652 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1704   -0.0808    2.4804 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2575    2.9919   -0.4002 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9908   -1.5521   -1.9213 O   0  0  0  0  0  1  0  0  0  0  0  0
    0.0127   -1.0589   -2.9598 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4294    0.9716   -0.7191 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8668   -0.2140    0.9706 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3493    0.7827    0.1924 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5817    0.3879   -0.0651 N   0  0  0  0  0  4  0  0  0  0  0  0
    0.4833   -0.8188    0.5017 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.6842    0.7925    0.0183 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.4676   -0.1024   -0.8646 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5391    2.2538    0.4707 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2023    2.2438   -0.2927 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5091   -0.1538    1.4748 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1651   -2.3172    0.4389 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8645   -0.9929   -2.0295 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7854   -1.2131    1.1937 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9117   -0.8172    0.5134 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4805    1.1605   -0.8762 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  2  0
  1 11  1  0
  1 12  1  0
  4 15  2  0
  5 18  1  0
  6 18  2  0
  7 12  1  0
  7 13  1  0
  7 15  1  0
  8  9  1  0
  8 16  1  0
  8 19  1  0
  9 10  2  0
 10 20  1  0
 10 21  1  0
 11 13  1  0
 11 16  1  0
 11 17  1  6
 12 14  1  1
 13 18  1  6
 14 15  1  0
 19 20  2  0
M  CHG  2   5  -1  10   1
M  END
>  <InChIKey>  (7) 
HFZITXBUTWITPT-YWVKMMECSA-N

>  <PubChem_CID>  (7) 
23653540

>  <BOM_1A2>  (7) 


>  <BOM_2A6>  (7) 


>  <BOM_2B6>  (7) 


>  <BOM_2C8>  (7) 


>  <BOM_2C9>  (7) 


>  <BOM_2C19>  (7) 


>  <BOM_2D6>  (7) 


>  <BOM_2E1>  (7) 


>  <BOM_3A4>  (7) 


>  <References>  (7) 
"EXBLIFEP (Cefepime and Enmetazobactam) for Injection, for Intravenous Use: Prescribing Information." U.S. Food and Drug Administration, 22 Feb. 2024, www.accessdata.fda.gov/drugsatfda_docs/label/2024/216165s000lbl.pdf. Accessed 12 Apr. 2024.

>  <FLAG_COMMENTS>  (7) 
Enmetazobactam is minimally metabolized.

>  <Name>  (7) 
Enmetazobactam

>  <ID>  (7) 
23653540

$$$$
11511120
     RDKit          3D

 33 36  0  0  0  0  0  0  0  0999 V2000
    5.9098   -3.3062   -2.2272 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.5766   -5.1815    0.0447 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3775   -0.2078    0.9376 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8637    4.5830   -0.7004 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2366   -1.4334    0.4361 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5516    2.0155    0.2023 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9296   -0.3623    0.7308 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7607    3.4664   -0.6025 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4907    1.2762    0.0884 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9447   -2.5471   -1.6577 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4419   -2.3724   -1.8438 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2870   -2.6743   -0.1775 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9037   -1.2299   -0.9808 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6904   -1.5225    0.6327 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6750   -0.3581    1.2533 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1811   -0.2995    1.1347 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5189    0.7935    0.7297 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0282    0.7878    0.6428 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2007    2.3890   -0.0036 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1368    1.8247    0.0456 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7934    1.4629    0.2474 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1066    3.6591   -0.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4792    3.1098   -0.4059 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1972    0.9522    0.2746 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4450    4.0112   -0.6463 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6017   -1.5821    0.5528 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6967    2.5306   -0.3442 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3383   -1.8170   -0.6121 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5390   -2.5702    1.5398 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2527    5.4251    0.3824 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0060   -3.0290   -0.7884 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2064   -3.7823    1.3633 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9400   -4.0116    0.1993 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 31  1  0
  2 33  1  0
  3 18  2  0
  4 22  1  0
  4 30  1  0
  5 13  1  0
  5 14  1  0
  5 15  1  0
  6 18  1  0
  6 19  1  0
  7 24  1  0
  7 26  1  0
  8 23  2  0
  8 27  1  0
  9 24  1  0
  9 27  2  0
 10 11  1  0
 10 12  1  0
 11 13  1  0
 12 14  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 21  2  0
 19 22  1  0
 20 21  1  0
 20 23  1  0
 20 24  2  0
 22 25  2  0
 23 25  1  0
 26 28  2  0
 26 29  1  0
 28 31  1  0
 29 32  2  0
 31 33  2  0
 32 33  1  0
M  END
>  <InChIKey>  (8) 
LVXJQMNHJWSHET-AATRIKPKSA-N

>  <PubChem_CID>  (8) 
11511120

>  <BOM_1A2>  (8) 


>  <BOM_2A6>  (8) 


>  <BOM_2B6>  (8) 


>  <BOM_2C8>  (8) 


>  <BOM_2C9>  (8) 
<30,4;Dealkylation;R1>
<30,H;Dealkylation;R1>

>  <BOM_2C19>  (8) 


>  <BOM_2D6>  (8) 
<30,4;Dealkylation;R1>
<30,H;Dealkylation;R1>

>  <BOM_2E1>  (8) 


>  <BOM_3A4>  (8) 


>  <References>  (8) 
Chen, Xia, et al. "Phase 1 study to investigate the pharmacokinetic properties of dacomitinib in healthy adult Chinese subjects genotyped for CYP2D6." Xenobiotica 48.5 (2018): 459-466.
Sepúlveda, Juan Manuel, et al. "Dacomitinib: an investigational drug for the treatment of glioblastoma." Expert Opinion on Investigational Drugs 27.10 (2018): 823-829.

>  <FLAG_COMMENTS>  (8) 


>  <Name>  (8) 
Dacomitinib

>  <ID>  (8) 
11511120

$$$$
11519070
     RDKit          3D

 32 36  0  0  0  0  0  0  0  0999 V2000
    3.6881    0.0012   -2.0558 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4049   -0.2330   -0.1517 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7663   -0.7693   -0.7796 N   0  0  2  0  0  4  0  0  0  0  0  0
    1.7740   -0.2546   -0.7135 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0142    0.8256   -1.5054 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1853   -0.3034    0.7087 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5052   -1.6137   -1.3858 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4843    0.5254   -1.5496 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3133   -0.6043    0.6752 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0085   -1.9233   -1.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2717    0.0488   -0.6746 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2569   -1.0712   -0.8185 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9958   -1.0493    0.1229 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6481    1.4429   -0.1461 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0140    0.0599   -0.1509 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3036   -2.2232   -0.5175 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6475    2.2486    0.3369 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3002   -0.8047    1.4383 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9677    1.8185   -0.1819 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9599   -3.2189    0.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9892    3.5133    0.8159 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9567   -1.8004    2.1617 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3093    3.0831    0.2973 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1555    0.7989    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2864   -3.0074    1.5456 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3202    3.9304    0.7960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6106    0.4342    0.4425 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3954    0.8264   -0.6363 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1612   -0.2932    1.4919 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7481    0.4872   -0.6659 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5139   -0.6324    1.4621 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3073   -0.2421    0.3832 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  2 15  1  0
  2 24  1  0
  3  8  1  0
  3  9  1  0
  3 10  1  0
  3 12  1  1
  4  5  1  0
  4  6  1  0
  4  7  1  0
  4 11  1  1
  5  8  1  0
  6  9  1  0
  7 10  1  0
 11 13  1  0
 11 14  1  0
 12 15  1  0
 13 16  2  0
 13 18  1  0
 14 17  2  0
 14 19  1  0
 16 20  1  0
 17 21  1  0
 18 22  2  0
 19 23  2  0
 20 25  2  0
 21 26  2  0
 22 25  1  0
 23 26  1  0
 24 27  1  0
 27 28  2  0
 27 29  1  0
 28 30  1  0
 29 31  2  0
 30 32  2  0
 31 32  1  0
M  CHG  1   3   1
M  END
>  <InChIKey>  (9) 
FVTWTVQXNAJTQP-UHFFFAOYSA-N

>  <PubChem_CID>  (9) 
11519070

>  <BOM_1A2>  (9) 


>  <BOM_2A6>  (9) 


>  <BOM_2B6>  (9) 


>  <BOM_2C8>  (9) 


>  <BOM_2C9>  (9) 


>  <BOM_2C19>  (9) 


>  <BOM_2D6>  (9) 
<2,24;Dealkylation;R1>
<24,H;Dealkylation;R1>
<32,H;Hydroxylation;R2>

>  <BOM_2E1>  (9) 


>  <BOM_3A4>  (9) 


>  <References>  (9) 
"INCRUSE ELLIPTA (Umeclidinium Inhalation Powder), for Oral Use." U.S. Food and Drug Administration, 13 Dec. 2023, www.accessdata.fda.gov/drugsatfda_docs/label/2023/205382s013lbl.pdf. Accessed 8 Mar. 2024.
Gao H, Li J, Chen X, Sun Z, Cui G, Cheng M, Ding L: Pharmacokinetics, metabolite profiling, safety, and tolerability of inhalation aerosol of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, in healthy Chinese subjects. Front Pharmacol. 2022 Dec 15;13:1064364. doi: 10.3389/fphar.2022.1064364. eCollection 2022. 
CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS REVIEW: Umeclidinium Bromide 

>  <FLAG_COMMENTS>  (9) 


>  <Name>  (9) 
Umeclidinium

>  <ID>  (9) 
11519070

$$$$
56959
     RDKit          3D

 31 33  0  0  1  0  0  0  0  0999 V2000
   -5.4972    2.5115   -1.1596 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8161   -0.0367   -0.2796 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6118    2.2189   -0.5905 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8289   -1.5111   -1.5539 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9315    1.9966   -0.2847 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8472    2.4012    0.4040 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5354    0.3562    0.8366 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8541    1.3891   -1.0756 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4728    3.2489    0.3288 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3887    1.1496   -0.2115 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2306    3.0091    1.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1154    2.2261   -1.1102 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0301    2.1703    1.2308 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3914    2.3266   -0.2710 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.6542    1.0866    0.5808 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1479    1.6100    0.3683 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5402   -0.4896    0.3094 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4223   -1.2516    0.2141 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8614   -0.0472    0.2448 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2093   -1.7665   -0.1449 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8517   -0.8814   -0.2739 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1997   -2.6006   -0.6635 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4266   -1.9887   -0.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2472    1.3151    0.7234 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8031   -2.2694   -0.0883 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0261   -1.7512    1.3681 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5208   -2.1581   -0.7281 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0347   -3.2253    0.0861 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6340   -2.9877    1.8811 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6385   -3.7247    1.2401 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8204   -2.3261   -2.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
 14  1  1  6
  2 15  1  0
  2 18  1  0
  3 16  2  0
  4 23  1  0
  4 31  1  0
  5  8  1  0
  5  9  1  0
  5 12  1  0
  6 10  1  0
  6 11  1  0
  6 13  1  0
  7 16  1  0
  7 17  1  0
  8 10  1  0
  9 11  1  0
 12 14  1  0
 13 16  1  0
 14 15  1  0
 17 19  2  0
 17 20  1  0
 18 23  2  0
 18 26  1  0
 19 21  1  0
 19 24  1  0
 20 22  2  0
 20 25  1  0
 21 27  2  0
 22 27  1  0
 23 28  1  0
 26 29  2  0
 28 30  2  0
 29 30  1  0
M  END
>  <InChIKey>  (10) 
XKLMZUWKNUAPSZ-UHFFFAOYSA-N

>  <PubChem_CID>  (10) 
56959

>  <BOM_1A2>  (10) 


>  <BOM_2A6>  (10) 


>  <BOM_2B6>  (10) 


>  <BOM_2C8>  (10) 


>  <BOM_2C9>  (10) 


>  <BOM_2C19>  (10) 


>  <BOM_2D6>  (10) 
<31,4;Dealkylation;R1>
<31,H;Dealkylation;R1>
<12,5;Dealkylation;R2>
<12,H;Dealkylation;R2>
<15,2;Dealkylation;R3>
<15,H;Dealkylation;R3>
<16,7;Hydrolysis;R4>
<16,7;Hydrolysis;R4>
<25,H;Hydroxylation;R5>
<24,H;Hydroxylation;R5>
<22,H;Hydroxylation;R6>
<21,H;Hydroxylation;R6>
<13,6;Dealkylation;R7>
<13,H;Dealkylation;R7>

>  <BOM_2E1>  (10) 


>  <BOM_3A4>  (10) 
<31,4;Dealkylation;R1>
<31,H;Dealkylation;R1>
<12,5;Dealkylation;R2>
<12,H;Dealkylation;R2>
<15,2;Dealkylation;R3>
<15,H;Dealkylation;R3>
<16,7;Hydrolysis;R4>
<16,7;Hydrolysis;R4>
<25,H;Hydroxylation;R5>
<24,H;Hydroxylation;R5>
<22,H;Hydroxylation;R6>
<21,H;Hydroxylation;R6>
<13,6;Dealkylation;R7>
<13,H;Dealkylation;R7>

>  <References>  (10) 
"RANEXA (Ranolazine Extended-Release Tablets), for Oral Use." U.S. Food and Drug Administration, 29 Oct. 2019, www.accessdata.fda.gov/drugsatfda_docs/label/2019/021526s035lbl.pdf. Accessed 8 Mar. 2024.
Chaitman BR: Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation. 2006 May 23;113(20):2462-72. doi: 10.1161/CIRCULATIONAHA.105.597500. 
Chaitman BR: Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation. 2006 May 23;113(20):2462-72. doi: 10.1161/CIRCULATIONAHA.105.597500.

>  <FLAG_COMMENTS>  (10) 


>  <Name>  (10) 
Ranolazine

>  <ID>  (10) 
56959

$$$$
621174
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -3.4815   -2.7731   -0.1032 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5907   -0.0824   -0.4851 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5947   -0.5753   -0.0738 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2031   -0.9152   -0.2361 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6425   -0.3140   -1.5247 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3792   -0.4507    0.9652 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8577   -0.5825   -1.6563 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1121   -0.7161    0.7514 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0276   -0.3017   -0.6491 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8130    0.3314    0.5001 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9580    0.8354    0.0414 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6344   -1.5518   -0.0203 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0459   -0.9837    0.1081 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2982    0.1319    0.3314 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9911    1.3788    1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2382    1.5114   -1.1087 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1183   -2.0730    0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8998   -0.9943    0.8726 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0379    1.0776   -0.3625 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3375    2.7254    1.4011 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5844    2.8581   -0.9984 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5087   -1.4791    0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6340    3.4651    0.2565 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2735   -1.1792    0.7165 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4117    0.8926   -0.5187 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0293   -0.2358    0.0207 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  2  0
  2  7  1  0
  2  8  1  0
  2  9  1  0
  3  4  1  0
  3 11  1  0
  3 12  1  0
  4  5  1  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  9 10  1  0
 10 14  1  0
 11 15  2  0
 11 16  1  0
 12 13  1  0
 13 17  1  0
 14 18  2  0
 14 19  1  0
 15 20  1  0
 16 21  2  0
 17 22  1  0
 18 24  1  0
 19 25  2  0
 20 23  2  0
 21 23  1  0
 24 26  2  0
 25 26  1  0
M  END
>  <InChIKey>  (11) 
QQOMYEQLWQJRKK-UHFFFAOYSA-N

>  <PubChem_CID>  (11) 
621174

>  <BOM_1A2>  (11) 


>  <BOM_2A6>  (11) 


>  <BOM_2B6>  (11) 


>  <BOM_2C8>  (11) 


>  <BOM_2C9>  (11) 


>  <BOM_2C19>  (11) 


>  <BOM_2D6>  (11) 
<2,9;Dealkylation;R1>
<9,H;Dealkylation;R1>
<22,H;Hydroxylation;R4>
<26,H;Hydroxylation;R5>

>  <BOM_2E1>  (11) 


>  <BOM_3A4>  (11) 
<2,9;Dealkylation;R1>
<9,H;Dealkylation;R1>
<17,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<22,H;Hydroxylation;R4>

>  <References>  (11) 
Kanamori T, Iwata YT, Segawa H, Yamamuro T, Kuwayama K, Tsujikawa K, Inoue H: Metabolism of Butyrylfentanyl in Fresh Human Hepatocytes: Chemical Synthesis of Authentic Metabolite Standards for Definitive Identification. Biol Pharm Bull. 2019;42(4):623-630. doi: 10.1248/bpb.b18-00765.

>  <FLAG_COMMENTS>  (11) 


>  <Name>  (11) 
Butyrfentanyl

>  <ID>  (11) 
621174

$$$$
3191
     RDKit          3D

 35 38  0  0  0  0  0  0  0  0999 V2000
    2.7844    0.0703   -0.3517 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6124    0.8789    2.1213 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3626    3.4824    0.2990 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4549    1.4279   -0.0868 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6248    1.4972    1.1915 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6804    2.0153   -1.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0990    2.9128    1.4356 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    3.4133   -0.9382 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9615    2.8847    0.1435 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9398    3.4976    1.1476 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9985   -0.3048    0.2841 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3452    2.9015    1.0274 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9358   -1.7570    0.7099 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2054    0.0051   -0.5801 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3997    1.4136    1.3442 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5078   -1.7912   -1.1387 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4606    0.5854    0.7029 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4464   -0.9639   -0.4964 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6467   -2.1866    1.8304 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4287    0.3135    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1675   -2.6648   -0.0189 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0924   -0.0180   -1.9701 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1304   -3.2885   -1.3929 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8000   -1.8318   -0.2652 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9025   -1.2199   -2.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6891    1.1586    0.3745 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2249   -0.7623    0.4317 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6820    0.3840   -0.2253 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2178   -1.5370   -0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5893   -3.5242    2.2222 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5388    0.5991   -0.7799 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1100   -4.0024    0.3729 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2024    0.2673   -2.7651 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8210   -4.4320    1.4934 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4257    0.5759   -2.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  1 11  1  0
  2 15  2  0
  3  7  1  0
  3  8  1  0
  3  9  1  0
  4  5  1  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  9 10  1  0
 10 12  1  0
 11 13  1  0
 11 14  1  0
 12 15  1  0
 13 19  2  0
 13 21  1  0
 14 20  2  0
 14 22  1  0
 15 17  1  0
 16 18  1  0
 16 23  1  0
 16 24  1  0
 16 25  1  0
 17 26  2  0
 17 27  1  0
 18 28  2  0
 18 29  1  0
 19 30  1  0
 20 31  1  0
 21 32  2  0
 22 33  2  0
 26 28  1  0
 27 29  2  0
 30 34  2  0
 31 35  2  0
 32 34  1  0
 33 35  1  0
M  END
>  <InChIKey>  (12) 
MJJALKDDGIKVBE-UHFFFAOYSA-N

>  <PubChem_CID>  (12) 
3191

>  <BOM_1A2>  (12) 


>  <BOM_2A6>  (12) 


>  <BOM_2B6>  (12) 


>  <BOM_2C8>  (12) 


>  <BOM_2C9>  (12) 


>  <BOM_2C19>  (12) 


>  <BOM_2D6>  (12) 


>  <BOM_2E1>  (12) 


>  <BOM_3A4>  (12) 
<9,3;Dealkylation;R1>
<9,H;Dealkylation;R1>
<24,H;Hydroxylation;R2>
<23,H;Hydroxylation;R2>
<25,H;Hydroxylation;R2>

>  <References>  (12) 
Hashizume T, Imaoka S, Mise M, Terauchi Y, Fujii T, Miyazaki H, Kamataki T, Funae Y: Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther. 2002 Jan;300(1):298-304.

>  <FLAG_COMMENTS>  (12) 


>  <Name>  (12) 
Ebastine

>  <ID>  (12) 
3191

$$$$
5281037
     RDKit          3D

 30 32  0  0  0  0  0  0  0  0999 V2000
   -5.0276   -0.5367    1.7173 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6054   -1.6282   -1.4873 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3336   -0.0124   -3.0644 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3091   -4.9062    1.6025 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2975   -5.6627    0.8626 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0590    1.3459   -0.7322 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8670    2.9299    0.8126 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7060    2.1610    0.1545 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2050    2.1427    0.3178 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7820    3.5602    0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6922    0.3828   -1.6075 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2777    1.6116   -0.6329 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3050    3.5349    0.4968 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8111   -0.9644   -0.9475 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3712    2.5920    0.3268 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2098    0.9255   -1.4258 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2303    0.1772   -0.9280 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8871    4.9393    0.5056 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7845   -1.8992   -1.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9465   -1.2778   -0.2004 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5499   -0.0414    0.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8936   -3.1476   -0.4695 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0554   -2.5263    0.4122 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0291   -3.4611    0.2776 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8862    0.5104    0.9872 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1027   -0.4612   -1.9522 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3553    1.8023    0.8945 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1425   -4.7631    0.9159 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6689    1.9343    1.4302 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1539    0.7382    1.9116 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 25  1  0
  1 30  1  0
  2 26  1  0
  3 26  2  0
  4 28  1  0
  5 28  2  0
  6  8  1  0
  6 11  1  0
  6 12  1  0
  7  8  2  0
  7 15  1  0
  8  9  1  0
  9 10  1  0
 10 13  1  0
 11 14  1  0
 12 15  2  0
 12 16  1  0
 13 18  1  0
 14 19  2  0
 14 20  1  0
 16 17  2  0
 17 21  1  0
 17 26  1  0
 19 22  1  0
 20 23  2  0
 21 25  1  0
 22 24  2  0
 23 24  1  0
 24 28  1  0
 25 27  2  0
 27 29  1  0
 29 30  2  0
M  END
>  <InChIKey>  (13) 
OROAFUQRIXKEMV-LDADJPATSA-N

>  <PubChem_CID>  (13) 
5281037

>  <BOM_1A2>  (13) 


>  <BOM_2A6>  (13) 


>  <BOM_2B6>  (13) 


>  <BOM_2C8>  (13) 


>  <BOM_2C9>  (13) 


>  <BOM_2C19>  (13) 


>  <BOM_2D6>  (13) 


>  <BOM_2E1>  (13) 


>  <BOM_3A4>  (13) 


>  <References>  (13) 
"TEVETEN (Eprosartan Mesylate) 400mg, 600mg: Prescribing Information." U.S. Food and Drug Administration, 22 July 2014, www.accessdata.fda.gov/drugsatfda_docs/label/2014/020738s029lbl.pdf. Accessed 12 Apr. 2024.

>  <FLAG_COMMENTS>  (13) 
Eprosartan is not metabolized by the cytochrome P450 system. It is mainly eliminated as unchanged drug. Less than 2% of an oral dose is excreted in the urine as a glucuronide.

>  <Name>  (13) 
Eprosartan

>  <ID>  (13) 
5281037

$$$$
82146
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
    6.1672   -1.9222   -1.0330 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6076    0.2152   -1.6689 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1314   -1.8872    0.3159 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2164    0.6104   -1.0813 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6109   -1.6924   -0.0837 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7569   -0.8175   -1.3173 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3563   -0.5638    0.2792 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8550    0.5901   -0.3746 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1403   -2.5110    1.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4536   -2.8848   -0.6495 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1336    1.2814   -2.4732 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2123    1.4127   -0.2146 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0814   -0.4971    0.8849 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0820    1.7723   -0.3381 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3308    0.6770    0.8887 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8356    1.8159    0.2836 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9765    0.6739    1.5319 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0765    3.1034    0.2793 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2654    0.3400    0.8395 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0669    0.9909    2.8514 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9708    1.3584    0.2487 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6792   -0.9684    0.8298 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1688    1.0477   -0.3948 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8773   -1.2792    0.1865 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6221   -0.2711   -0.4259 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8712   -0.5949   -1.0965 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 26  1  0
  2 26  2  0
  3  5  1  0
  3  7  1  0
  3  9  1  0
  3 10  1  0
  4  6  1  0
  4  8  1  0
  4 11  1  0
  4 12  1  0
  5  6  1  0
  7  8  2  0
  7 13  1  0
  8 14  1  0
 13 15  2  0
 14 16  2  0
 15 16  1  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 17 20  2  0
 19 21  2  0
 19 22  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 24 25  1  0
 25 26  1  0
M  END
>  <InChIKey>  (14) 
NAVMQTYZDKMPEU-UHFFFAOYSA-N

>  <PubChem_CID>  (14) 
82146

>  <BOM_1A2>  (14) 


>  <BOM_2A6>  (14) 


>  <BOM_2B6>  (14) 


>  <BOM_2C8>  (14) 


>  <BOM_2C9>  (14) 
<6,H;Hydroxylation;R1>
<6,H;Oxidation;R2>
<5,H;Oxidation;R3>
<5,H;Hydroxylation;R4>

>  <BOM_2C19>  (14) 
<6,H;Hydroxylation;R1>
<6,H;Oxidation;R2>
<5,H;Oxidation;R3>
<5,H;Hydroxylation;R4>

>  <BOM_2D6>  (14) 


>  <BOM_2E1>  (14) 


>  <BOM_3A4>  (14) 
<6,H;Hydroxylation;R1>
<6,H;Oxidation;R2>
<5,H;Oxidation;R3>
<5,H;Hydroxylation;R4>

>  <References>  (14) 
Howell, Stanley R., et al. "Bexarotene metabolism in rat, dog, and human, synthesis of oxidative metabolites, and in vitro activity at retinoid receptors." Drug metabolism and disposition 29.7 (2001): 990-998.

>  <FLAG_COMMENTS>  (14) 


>  <Name>  (14) 
Bexarotene

>  <ID>  (14) 
82146

$$$$
154059
     RDKit          3D

 27 31  0  0  1  0  0  0  0  0999 V2000
    1.2996   -0.8132    0.5466 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0200   -2.8568   -0.4395 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5264   -0.4503   -0.8356 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8045   -1.4232   -0.1954 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3787    0.0726    1.4363 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6894   -1.1066    0.7261 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.3460    1.2966    0.5044 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8507   -0.3127    1.6408 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3662   -1.3490   -0.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0471    0.9488   -0.8185 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4824   -0.6410    0.2777 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5494   -1.7854   -0.0612 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3781   -0.2266    0.4849 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.7098   -2.3871   -0.8274 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8999   -0.1991    0.5256 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9480   -1.7510   -1.4418 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6563   -0.9151   -0.4165 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8198    1.0765   -0.0848 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5666    0.5743    1.4891 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0539   -0.8260   -0.4071 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7079    2.1932    0.7354 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4288    1.1329   -1.4175 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9598    0.6451    1.5031 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7024   -0.0505    0.5526 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1980    3.3830    0.2156 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0813    2.3227   -1.9372 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1966    3.4478   -1.1206 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  1  1  6
  1 12  1  0
  2 12  2  0
  3  9  1  0
  3 10  1  0
  3 11  1  0
  4 12  1  0
  4 13  1  0
  4 14  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  6  9  1  0
  7 10  1  0
  8 11  1  0
 13 15  1  0
 13 18  1  6
 14 16  1  0
 15 17  2  0
 15 19  1  0
 16 17  1  0
 17 20  1  0
 18 21  2  0
 18 22  1  0
 19 23  2  0
 20 24  2  0
 21 25  1  0
 22 26  2  0
 23 24  1  0
 25 27  2  0
 26 27  1  0
M  END
>  <InChIKey>  (15) 
FBOUYBDGKBSUES-VXKWHMMOSA-N

>  <PubChem_CID>  (15) 
154059

>  <BOM_1A2>  (15) 


>  <BOM_2A6>  (15) 


>  <BOM_2B6>  (15) 


>  <BOM_2C8>  (15) 


>  <BOM_2C9>  (15) 


>  <BOM_2C19>  (15) 


>  <BOM_2D6>  (15) 
<16,H;Hydroxylation;R1>

>  <BOM_2E1>  (15) 


>  <BOM_3A4>  (15) 
<16,H;Hydroxylation;R1>
<3,N;N-Oxidation;R2>

>  <References>  (15) 
Doroshyenko, Oxana, and Uwe Fuhr. "Clinical pharmacokinetics and pharmacodynamics of solifenacin." Clinical pharmacokinetics 48 (2009): 281-302.

>  <FLAG_COMMENTS>  (15) 


>  <Name>  (15) 
Solifenacin

>  <ID>  (15) 
154059

$$$$
155903259
     RDKit          3D

 35 37  0  0  1  0  0  0  0  0999 V2000
   -5.2651    0.3853    2.1308 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8314    2.2135    1.0849 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0158    2.1639    2.2891 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.8747   -1.8859   -1.5122 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0035    0.6408    0.8113 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4964    0.3236   -0.6689 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7449    2.9461    1.9493 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6890   -1.0865   -0.5681 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3460   -1.5920    0.7482 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6719    1.4254    0.2686 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2828    3.4118   -0.2800 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1671   -3.1201    1.8606 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4011   -3.4218   -0.4812 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.8334   -3.9081   -0.3288 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4027   -3.1035   -1.5436 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.1127   -2.1288    0.0777 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.5341   -1.6173   -1.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0815   -5.3814   -0.5422 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7379   -3.3010    0.7122 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5277   -1.8669   -0.3343 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7181    0.2182   -0.0939 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7133    1.1335   -0.7618 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.0657    2.3878   -1.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7515   -1.2850    0.6147 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2991    3.2418   -0.3672 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1514    3.2635   -2.0527 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0789    1.9478   -2.4966 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0750    0.1111    1.1604 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6419    1.2203    0.2219 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.9901    0.9930    0.2272 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5427   -2.3102    1.3122 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4285    1.2436   -1.0918 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8964    2.6052    0.7865 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7723    1.4370    1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3538    2.6954   -1.5233 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 34  1  0
  2 34  1  0
  3 34  1  0
  4 20  2  0
  5 21  2  0
  6 30  2  0
  7 33  2  0
  8 16  1  0
  8 17  1  0
  8 21  1  0
  9 20  1  0
  9 24  1  0
 22 10  1  1
 10 30  1  0
 11 33  1  0
 11 35  1  0
 12 31  3  0
 13 14  1  1
 13 15  1  0
 13 16  1  0
 14 15  1  0
 14 18  1  0
 14 19  1  0
 15 17  1  1
 16 20  1  6
 21 22  1  0
 22 23  1  0
 23 25  1  0
 23 26  1  0
 23 27  1  0
 24 28  1  1
 24 31  1  0
 29 28  1  1
 29 32  1  0
 29 33  1  0
 30 34  1  0
 32 35  1  0
M  END
>  <InChIKey>  (16) 
LIENCHBZNNMNKG-OJFNHCPVSA-N

>  <PubChem_CID>  (16) 
155903259

>  <BOM_1A2>  (16) 


>  <BOM_2A6>  (16) 


>  <BOM_2B6>  (16) 


>  <BOM_2C8>  (16) 


>  <BOM_2C9>  (16) 


>  <BOM_2C19>  (16) 


>  <BOM_2D6>  (16) 


>  <BOM_2E1>  (16) 


>  <BOM_3A4>  (16) 
<19,H;Hydroxylation;R1>
<18,H;Hydroxylation;R1>
<35,H;Hydroxylation;R2>
<27,H;Hydroxylation;R3>
<26,H;Hydroxylation;R3>
<25,H;Hydroxylation;R3>

>  <References>  (16) 
Chen, Wujun, et al. "Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection." Journal of Pharmaceutical Analysis 13.3 (2023): 255-261.

>  <FLAG_COMMENTS>  (16) 


>  <Name>  (16) 
Nirmatrelvir

>  <ID>  (16) 
155903259

$$$$
59634741
     RDKit          3D

 32 36  0  0  0  0  0  0  0  0999 V2000
   -4.2325    0.9070    1.1190 S   0  0  0  0  0  6  0  0  0  0  0  0
    2.3088    3.7859   -1.1469 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6076    0.5310    0.8487 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8945    1.5465    2.3760 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6150   -0.4785    0.0591 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8251    1.7505   -0.1198 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6382    1.8437   -0.1989 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3995   -1.1961   -0.9999 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7345   -1.6898    0.0384 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0377   -2.1806    1.4236 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4177   -3.0116    0.2334 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3168   -1.6634   -0.4329 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1610   -0.6937    0.0379 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9713    0.7020   -0.7415 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4146    0.5276    0.5791 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2703    1.9486   -0.2043 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9633    2.7294   -0.6201 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5163    2.5010   -0.5111 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1762    2.9386    0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1652    1.8464   -1.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5501    2.7213    0.7211 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5391    1.6291   -1.4339 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2315    2.0666   -0.3049 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2614   -0.5669    0.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4613   -1.4539   -0.0692 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6575   -2.6119   -0.1234 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2972   -0.8028    1.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6873   -2.8492    0.8649 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5089   -1.9451    1.9082 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8583   -3.5053   -1.1842 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8243   -3.2424   -2.1448 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5616   -2.0839   -2.0076 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  2  0
  1  4  2  0
  1  7  1  0
  1 24  1  0
  2 17  2  0
  5 12  1  0
  5 13  1  0
  5 14  1  0
  6 15  1  0
  6 16  1  0
  6 17  1  0
  7 23  1  0
  8 25  2  0
  8 32  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
 10 11  1  0
 13 15  1  0
 14 16  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
 24 25  1  0
 24 27  2  0
 25 26  1  0
 26 28  1  0
 26 30  2  0
 27 29  1  0
 28 29  2  0
 30 31  1  0
 31 32  2  0
M  END
>  <InChIKey>  (17) 
XAYGBKHKBBXDAK-UHFFFAOYSA-N

>  <PubChem_CID>  (17) 
59634741

>  <BOM_1A2>  (17) 
<12,5;Dealkylation;R1>
<12,H;Dealkylation;R1>

>  <BOM_2A6>  (17) 


>  <BOM_2B6>  (17) 


>  <BOM_2C8>  (17) 


>  <BOM_2C9>  (17) 


>  <BOM_2C19>  (17) 


>  <BOM_2D6>  (17) 
<12,5;Dealkylation;R1>
<12,H;Dealkylation;R1>

>  <BOM_2E1>  (17) 


>  <BOM_3A4>  (17) 
<12,5;Dealkylation;R1>
<12,H;Dealkylation;R1>
<15,6;Dealkylation;R2>
<15,H;Dealkylation;R2>
<13,5;Dealkylation;R2>
<13,H;Dealkylation;R2>
<16,6;Dealkylation;R2>
<16,H;Dealkylation;R2>
<14,5;Dealkylation;R2>
<14,H;Dealkylation;R2>

>  <References>  (17) 
Prakash, Chandra, et al. "An innovative phase I study in healthy subjects to determine the mass balance, elimination, metabolism, and absolute bioavailability of mitapivat." Clinical and Translational Science 16.10 (2023): 2021-2032.
U.S. Food and Drug Administration. (2024). Title of the document (216196Orig1s000). Retrieved June 25, 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/216196Orig1s000IntegratedR.pdf

>  <FLAG_COMMENTS>  (17) 
Although oxidative metabolites are formed as minor metabolites, the sites of oxidation and the structures of the metabolites cannot be identified.

>  <Name>  (17) 
Mitapivat

>  <ID>  (17) 
59634741

$$$$
5826
     RDKit          3D

 10 10  0  0  1  0  0  0  0  0999 V2000
   -3.5842   -0.4594    0.1201 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2228   -0.1767   -0.3441 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.2239   -0.4571    0.7933 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2170   -0.2338    0.4014 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1704    1.2731   -0.8263 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9466   -1.2850   -0.1310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7835    1.0181    0.5807 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2777   -1.0789   -0.4933 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1147    1.2242    0.2181 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8617    0.1756   -0.3189 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  5  1  1
  3  4  1  0
  4  6  2  0
  4  7  1  0
  6  8  1  0
  7  9  2  0
  8 10  2  0
  9 10  1  0
M  END
>  <InChIKey>  (18) 
KWTSXDURSIMDCE-QMMMGPOBSA-N

>  <PubChem_CID>  (18) 
5826

>  <BOM_1A2>  (18) 


>  <BOM_2A6>  (18) 


>  <BOM_2B6>  (18) 


>  <BOM_2C8>  (18) 


>  <BOM_2C9>  (18) 


>  <BOM_2C19>  (18) 


>  <BOM_2D6>  (18) 
<10,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>

>  <BOM_2E1>  (18) 


>  <BOM_3A4>  (18) 


>  <References>  (18) 
de la Torre R, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S: Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin Pharmacokinet. 2004;43(3):157-85. doi: 10.2165/00003088-200443030-00002. 
Brown CM, Reisfeld B, Mayeno AN: Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742 .

>  <FLAG_COMMENTS>  (18) 


>  <Name>  (18) 
Dextroamphetamine

>  <ID>  (18) 
5826

$$$$
24989044
     RDKit          3D

 35 39  0  0  0  0  0  0  0  0999 V2000
    9.6798   -2.4739   -0.3732 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1205    1.0023    1.1748 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8600   -0.5682    0.9973 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7930   -1.7489    0.4582 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1338   -1.2024   -0.4251 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8387    2.4046   -0.3103 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0256    4.5426   -0.5343 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5942    0.4960    0.2954 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8367    0.2442   -0.1212 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5399   -3.6345    0.6717 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3114   -1.9771   -0.8983 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6928   -3.7611   -0.2536 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2720   -0.0341   -0.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0686   -1.0052    0.6915 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8777   -1.4839   -1.6607 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1146   -0.0830    0.3992 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9653   -2.2311    0.8393 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7779   -2.6992   -1.4573 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7921    3.2888   -0.2566 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0273    3.1294   -0.6881 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4860    2.7269    0.1153 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1857    1.1122    0.2334 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4881    4.5626   -0.8392 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4492    1.3376    0.3774 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7279    1.0543   -0.0404 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9263    1.5594    0.8256 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7770    0.7690    0.7341 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6558    3.5221    0.2048 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8651    2.9292    0.5619 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7932   -1.1130    0.1356 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1510   -1.4253   -0.1031 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0974   -1.8171    0.0322 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3682   -2.9691    0.7417 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1161   -1.3626   -0.7802 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4535   -3.0912   -0.1551 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  1 18  1  0
  2 22  1  0
  2 26  1  0
  3 27  1  0
  3 31  1  0
  4 30  2  0
  5 13  1  0
  5 14  1  0
  5 15  1  0
  6 19  1  0
  6 20  1  0
  6 25  1  0
  7 19  2  0
  7 23  1  0
  8 24  1  0
  8 25  2  0
  9 25  1  0
  9 30  1  0
 10 33  2  0
 10 35  1  0
 11 34  1  0
 11 35  2  0
 12 35  1  0
 13 16  1  0
 14 17  1  0
 15 18  1  0
 16 22  1  0
 19 21  1  0
 20 23  1  0
 21 24  2  0
 21 28  1  0
 24 27  1  0
 26 27  2  0
 26 29  1  0
 28 29  2  0
 30 32  1  0
 32 33  1  0
 32 34  2  0
M  END
>  <InChIKey>  (19) 
PZBCKZWLPGJMAO-UHFFFAOYSA-N

>  <PubChem_CID>  (19) 
24989044

>  <BOM_1A2>  (19) 


>  <BOM_2A6>  (19) 


>  <BOM_2B6>  (19) 


>  <BOM_2C8>  (19) 


>  <BOM_2C9>  (19) 


>  <BOM_2C19>  (19) 


>  <BOM_2D6>  (19) 


>  <BOM_2E1>  (19) 


>  <BOM_3A4>  (19) 
<15,H;Oxidation;R1>
<14,H;Oxidation;R1>
<22,2;Dealkylation;R2>
<22,H;Dealkylation;R2>
<1,17;Dealkylation;R3>
<17,H;Dealkylation;R3>
<14,5;Dealkylation;R3>
<14,H;Dealkylation;R3>
<1,18;Dealkylation;R3>
<18,H;Dealkylation;R3>
<15,5;Dealkylation;R3>
<15,H;Dealkylation;R3>
<15,18;Dealkylation;R4>
<1,18;Dealkylation;R4>
<15,H;Dealkylation;R4>
<18,H;Dealkylation;R4>
<14,17;Dealkylation;R4>
<1,17;Dealkylation;R4>
<14,H;Dealkylation;R4>
<17,H;Dealkylation;R4>
<13,5;Dealkylation;R5>
<13,H;Dealkylation;R5>

>  <References>  (19) 
Gerisch M, Schwarz T, Lang D, Rohde G, Reif S, Genvresse I, Reschke S, van der Mey D, Granvil C: Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor
"ALIQOPA (Copanlisib) for Injection, for Intravenous Use." U.S. Food and Drug Administration, 7 Sept. 2023, www.accessdata.fda.gov/drugsatfda_docs/label/2023/209936s012lbl.pdf. Accessed 8 Mar. 2024.

>  <FLAG_COMMENTS>  (19) 
R4 is the reaction that produces M21 of Copanlisib, and this information can be found in Gerisch M et al.

>  <Name>  (19) 
Copanlisib

>  <ID>  (19) 
24989044

$$$$
3639
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    2.7010   -2.4152   -0.0041 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.3843    1.2390    0.0262 S   0  0  0  0  0  6  0  0  0  0  0  0
    2.9884    0.8025    0.1072 S   0  0  0  0  0  6  0  0  0  0  0  0
   -2.6655    1.5600    1.4114 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1586    2.2718   -0.9652 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8058    2.1097    0.7178 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9631   -0.1273    0.6553 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5780    0.1713   -0.5689 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3503   -1.8587   -0.0568 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2964    1.0065   -1.5598 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9702    0.1815    0.0403 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1247   -1.2131    0.0008 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6052   -1.1526    0.0785 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2871    0.7920    0.0681 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4314    0.0008    0.0573 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0498   -1.9826   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3139   -1.3856    0.0119 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  2  4  2  0
  2  5  2  0
  2  8  1  0
  2 11  1  0
  3  6  2  0
  3  7  2  0
  3 10  1  0
  3 15  1  0
  8 13  1  0
  9 12  1  0
  9 13  1  0
 11 12  2  0
 11 14  1  0
 12 16  1  0
 14 15  2  0
 15 17  1  0
 16 17  2  0
M  END
>  <InChIKey>  (20) 
JZUFKLXOESDKRF-UHFFFAOYSA-N

>  <PubChem_CID>  (20) 
3639

>  <BOM_1A2>  (20) 


>  <BOM_2A6>  (20) 


>  <BOM_2B6>  (20) 


>  <BOM_2C8>  (20) 


>  <BOM_2C9>  (20) 


>  <BOM_2C19>  (20) 


>  <BOM_2D6>  (20) 


>  <BOM_2E1>  (20) 


>  <BOM_3A4>  (20) 


>  <References>  (20) 
"MICROZIDE (Hydrochlorothiazide, USP) Capsules 12.5 mg: Prescribing Information." U.S. Food and Drug Administration, 20 Aug. 2020, www.accessdata.fda.gov/drugsatfda_docs/label/2020/020504s026lbl.pdf. Accessed 12 Apr. 2024.

>  <FLAG_COMMENTS>  (20) 
Hydrochlorothiazide is not metabolized. Following oral doses of 12.5 to 100 mg, 55% to 77% of the administered dose appears in urine and greater than 95% of the absorbed dose is excreted in urine as unchanged drug.

>  <Name>  (20) 
Hydrochlorothiazide

>  <ID>  (20) 
3639

$$$$
134018
     RDKit          3D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -2.7288    0.9775   -0.3464 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.6923   -0.2719    0.5275 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2772    2.0829   -0.8784 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5855    0.2868   -0.4454 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6251   -1.4953    0.4000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7635    3.1906    0.6741 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7746   -0.1375   -0.6949 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4160   -0.8308   -0.5610 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6210   -0.3218    0.5664 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5229   -0.6636   -1.9178 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3251   -0.2903    0.4348 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4497   -0.3865    0.2422 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5899    0.8910    0.4562 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6828   -1.5193    0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1991    0.8428    0.3596 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2921   -1.5674    0.2212 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8879   -0.4368    0.1427 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9536   -1.1748    0.1987 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2067    0.1186   -0.2075 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9640   -2.2271    0.4332 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2381    2.1610    0.5766 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4389    0.7720   -0.4998 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  1 19  1  0
  2  8  1  0
  2 11  1  0
  3 22  1  0
  4 22  2  0
  5 17  2  0
  5 18  1  0
  6 21  3  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
 11 13  2  0
 11 14  1  0
 12 15  2  0
 12 16  1  0
 12 17  1  0
 13 15  1  0
 13 21  1  0
 14 16  2  0
 18 19  2  0
 18 20  1  0
 19 22  1  0
M  END
>  <InChIKey>  (21) 
BQSJTQLCZDPROO-UHFFFAOYSA-N

>  <PubChem_CID>  (21) 
134018

>  <BOM_1A2>  (21) 
<7,H;Hydroxylation;R2>

>  <BOM_2A6>  (21) 


>  <BOM_2B6>  (21) 


>  <BOM_2C8>  (21) 
<7,H;Hydroxylation;R2>

>  <BOM_2C9>  (21) 
<10,H;Hydroxylation;R1>
<9,H;Hydroxylation;R1>

>  <BOM_2C19>  (21) 


>  <BOM_2D6>  (21) 


>  <BOM_2E1>  (21) 


>  <BOM_3A4>  (21) 


>  <References>  (21) 
Grabowski, Brian A., et al. "Metabolism and excretion of [14C] febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase, in healthy male subjects." The Journal of Clinical Pharmacology 51.2 (2011): 189-201.
"ULORIC (Febuxostat) Tablets, for Oral Use." U.S. Food and Drug Administration, 17 Apr. 2023, www.accessdata.fda.gov/drugsatfda_docs/label/2023/021856s015lbl.pdf. Accessed 8 Mar. 2024.

>  <FLAG_COMMENTS>  (21) 


>  <Name>  (21) 
Febuxostat

>  <ID>  (21) 
134018

$$$$
2337
     RDKit          3D

 12 12  0  0  0  0  0  0  0  0999 V2000
   -2.1131   -0.3568    0.0005 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7062    1.9089    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1634   -0.7318   -0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1082    0.3619    0.0009 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0960    1.3466   -0.0001 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4669   -0.9861    0.0012 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8017   -0.3646   -0.0004 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4427    0.9834   -0.0008 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8137   -1.3494    0.0006 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2959    0.7406    0.0008 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5238   -0.1131   -0.0009 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2535   -1.4395   -0.0009 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  1 11  1  0
  2 10  2  0
  3  7  1  0
  4  5  2  0
  4  6  1  0
  4 10  1  0
  5  8  1  0
  6  9  2  0
  7  8  2  0
  7  9  1  0
 11 12  1  0
M  END
>  <InChIKey>  (22) 
BLFLLBZGZJTVJG-UHFFFAOYSA-N

>  <PubChem_CID>  (22) 
2337

>  <BOM_1A2>  (22) 
<3,N;N-Oxidation;R1>

>  <BOM_2A6>  (22) 


>  <BOM_2B6>  (22) 
<3,N;N-Oxidation;R1>

>  <BOM_2C8>  (22) 


>  <BOM_2C9>  (22) 


>  <BOM_2C19>  (22) 
<3,N;N-Oxidation;R1>

>  <BOM_2D6>  (22) 
<3,N;N-Oxidation;R1>

>  <BOM_2E1>  (22) 
<3,N;N-Oxidation;R1>

>  <BOM_3A4>  (22) 


>  <References>  (22) 
Hartman NR, Mao JJ, Zhou H, Boyne MT 2nd, Wasserman AM, Taylor K, Racoosin JA, Patel V, Colatsky T: More methemoglobin is produced by benzocaine treatment than lidocaine treatment in human in vitro systems. Regul Toxicol Pharmacol. 2014 Oct;70(1):182-8. doi: 10.1016/j.yrtph.2014.07.002. Epub 2014 Jul 8.

>  <FLAG_COMMENTS>  (22) 
Reactions by esterase and N-acetyl transferase are not included in this data

>  <Name>  (22) 
Benzocaine

>  <ID>  (22) 
2337

$$$$
6533629
     RDKit          3D

 25 27  0  0  1  0  0  0  0  0999 V2000
   -1.7741    0.9202   -2.4039 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.6883   -3.2925    0.2094 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8411    0.2049    2.2164 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3473   -0.7261    1.8291 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1798    1.3029    2.0555 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6872   -2.4433    0.3576 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9629    2.8175    0.0112 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7221    0.4553    0.0477 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2215    1.2688   -0.0872 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3996    1.4984   -0.1739 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0198   -1.1715   -0.4317 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0966   -3.2200   -0.9160 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2538    1.5572   -0.7763 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.1237    1.7214    0.2651 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.9258    0.6862    1.1111 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6823   -0.4087   -0.3503 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4400    0.2620   -2.7834 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0605   -0.5017   -1.6373 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2265    1.1097    0.8513 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2926   -1.3205    0.6185 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5246    0.6368    0.2497 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8294   -0.7918    0.1205 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9716   -1.7678    0.5298 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0577   -2.4855   -0.4374 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9722    3.6883   -0.4755 C   0  0  0  0  0  0  0  0  0  0  0  0
 13  1  1  6
  1 17  1  0
  2 23  1  0
  2 24  1  0
  3 15  2  0
  4 20  1  0
  5 19  2  0
  6 20  2  0
  7 10  1  0
  7 25  1  0
  8 13  1  0
  8 15  1  0
  8 16  1  0
 14  9  1  6
  9 19  1  0
 10 21  2  0
 11 22  1  0
 11 24  2  0
 12 24  1  0
 13 14  1  0
 14 15  1  0
 16 18  2  0
 16 20  1  0
 17 18  1  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
M  END
>  <InChIKey>  (23) 
NNULBSISHYWZJU-LLKWHZGFSA-N

>  <PubChem_CID>  (23) 
6533629

>  <BOM_1A2>  (23) 


>  <BOM_2A6>  (23) 


>  <BOM_2B6>  (23) 


>  <BOM_2C8>  (23) 


>  <BOM_2C9>  (23) 


>  <BOM_2C19>  (23) 


>  <BOM_2D6>  (23) 


>  <BOM_2E1>  (23) 


>  <BOM_3A4>  (23) 


>  <References>  (23) 
Nakashima, N., Suzuki, K., Hashimoto, H., & Nishijima, K. (1981). Phase I Study of Ceftizoxime, a New Cephalosporin. Single Dose Study. The Journal of Clinical Pharmacology, 21(10), 388-395.

>  <FLAG_COMMENTS>  (23) 
Ceftizoxime is not metabolized and is excreted virtually unchanged by the kidneys in 24 hours.

>  <Name>  (23) 
Ceftizoxime

>  <ID>  (23) 
6533629

$$$$
60852
     RDKit          3D

 19 18  0  0  1  0  0  0  0  0999 V2000
    2.5682   -0.6734   -1.2736 P   0  0  0  0  0  5  0  0  0  0  0  0
    1.7834    1.8118    0.5149 P   0  0  0  0  0  5  0  0  0  0  0  0
    3.2202   -0.1722    1.1571 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2865   -2.0745   -0.9080 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8058    0.2810   -1.6914 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1318    2.4778   -0.0747 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8907    2.0685    2.1066 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4755   -0.7592   -2.2966 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5080    2.3013   -0.1065 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3755   -1.6420    1.0038 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0457    0.0048    0.3509 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9388   -0.8499    1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4112   -0.8038    0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6832   -1.5834    0.3505 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1929   -0.1437    0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5706   -0.0623   -0.3489 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9010   -3.0244    1.0714 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0686    1.3811   -0.4212 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4517    1.4626   -1.0471 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  1  5  1  0
  1  8  2  0
  1 11  1  0
  2  6  1  0
  2  7  1  0
  2  9  2  0
  2 11  1  0
  3 11  1  0
 10 13  1  0
 10 14  1  0
 10 17  1  0
 11 12  1  0
 12 13  1  0
 14 15  1  0
 15 16  1  0
 16 18  1  0
 18 19  1  0
M  END
>  <InChIKey>  (24) 
MPBVHIBUJCELCL-UHFFFAOYSA-N

>  <PubChem_CID>  (24) 
60852

>  <BOM_1A2>  (24) 


>  <BOM_2A6>  (24) 


>  <BOM_2B6>  (24) 


>  <BOM_2C8>  (24) 


>  <BOM_2C9>  (24) 


>  <BOM_2C19>  (24) 


>  <BOM_2D6>  (24) 


>  <BOM_2E1>  (24) 


>  <BOM_3A4>  (24) 


>  <References>  (24) 
"BONIVA (Ibandronate Sodium) Tablets: Prescribing Information." U.S. Food and Drug Administration, 7 Dec. 2016, www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf. Accessed 8 Mar. 2024.

>  <FLAG_COMMENTS>  (24) 
Ibandronate does not undergo hepatic metabolism and does not inhibit the hepatic cytochrome P450 system.

>  <Name>  (24) 
Ibandronate

>  <ID>  (24) 
60852

$$$$
25195624
     RDKit          3D

 32 35  0  0  1  0  0  0  0  0999 V2000
   -0.0445   -4.5145   -1.3373 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.4657    0.0791    0.1721 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1245    1.4091   -0.6583 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8901    3.8812    0.2509 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8857    1.9129   -1.6854 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6970    3.4767    0.7653 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0370   -0.5316    0.9193 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9779   -0.3338    1.1848 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6424    2.7951   -0.2930 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.7079    1.6116   -0.5582 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.7338    2.4274    0.7118 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.5089    0.3359   -0.8608 C   0  0  2  0  0  0  0  0  0  0  0  0
   -6.9725    2.5251   -1.0466 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4283    1.1255    0.3077 C   0  0  1  0  0  0  0  0  0  0  0  0
   -7.1974    3.5765    0.0002 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2956    3.8590   -1.1655 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6131   -0.8825   -0.9711 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4452    0.6793    1.3535 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8122   -1.2594    0.1071 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890   -1.6258   -2.1512 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8713    0.3182   -0.1333 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9874   -2.3795    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7642   -2.7459   -2.2532 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1452   -2.7511    1.1828 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9633   -3.1228   -1.1751 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9195   -0.8073    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2239   -2.1047    1.1837 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7471   -0.9148    1.1848 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3681   -0.7756    1.5817 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3414   -2.8388    0.7861 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6296   -0.1806    1.5823 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6030   -2.2438    0.7867 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 25  1  0
  2 12  1  0
  2 14  1  0
  3 13  1  0
  3 21  1  0
  9  4  1  1
 10  5  1  6
 11  6  1  6
  7 18  1  0
  8 26  1  0
  8 28  1  0
  9 10  1  0
  9 11  1  0
 10 12  1  0
 11 14  1  0
 12 17  1  1
 13 15  1  0
 13 16  1  0
 14 18  1  1
 15 16  1  0
 17 19  2  0
 17 20  1  0
 19 22  1  0
 20 23  2  0
 21 26  1  0
 22 24  1  0
 22 25  2  0
 23 25  1  0
 24 27  1  0
 27 29  2  0
 27 30  1  0
 28 31  2  0
 28 32  1  0
 29 31  1  0
 30 32  2  0
M  END
>  <InChIKey>  (25) 
BTCRKOKVYTVOLU-SJSRKZJXSA-N

>  <PubChem_CID>  (25) 
25195624

>  <BOM_1A2>  (25) 


>  <BOM_2A6>  (25) 


>  <BOM_2B6>  (25) 


>  <BOM_2C8>  (25) 
<13,3;Dealkylation;R2>
<13,H;Dealkylation;R2>

>  <BOM_2C9>  (25) 


>  <BOM_2C19>  (25) 


>  <BOM_2D6>  (25) 
<13,3;Dealkylation;R2>
<13,H;Dealkylation;R2>
<24,H;Hydroxylation;R3>

>  <BOM_2E1>  (25) 


>  <BOM_3A4>  (25) 
<21,3;Dealkylation;R1>
<21,H;Dealkylation;R1>
<13,3;Dealkylation;R2>
<13,H;Dealkylation;R2>
<24,H;Hydroxylation;R3>

>  <References>  (25) 
Zhang, Wenbin, et al. "Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans." Xenobiotica 50.5 (2020): 559-569.

>  <FLAG_COMMENTS>  (25) 


>  <Name>  (25) 
Bexagliflozin

>  <ID>  (25) 
25195624

$$$$
77050711
     RDKit          3D

 37 40  0  0  1  0  0  0  0  0999 V2000
   -2.9903   -2.5446    1.9077 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8581   -0.6038    2.8461 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6512    1.3859    2.3496 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8690    4.8229   -0.3707 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.5620    1.7419    0.0828 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.4922    0.1827   -1.4467 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.0910   -0.3141    0.6386 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9749   -0.8318    1.3152 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7988   -0.3113   -0.9206 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9197   -1.2120   -1.6103 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5445   -0.0133    1.5827 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6768   -0.5450   -2.7472 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8538   -0.9896   -2.5656 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8632   -0.4122   -3.3275 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7089   -0.6839    0.6367 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.6318   -1.2388    1.6421 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8036   -1.5683   -0.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4828    0.8067    0.3659 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2011   -1.1410    1.2293 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9772    1.7622    1.2538 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7815    1.2080   -0.7711 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6255   -2.1843    0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7700    3.1189    1.0049 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5744    2.5647   -1.0202 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4187   -0.9170    0.4992 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7098   -2.0624    0.1538 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2480   -1.4783   -1.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0687    3.5201   -0.1321 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7516    0.0696    1.2074 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8087   -0.7607    0.1307 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6286   -1.8827    0.0084 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3297    0.5124   -0.1009 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9693   -1.7315   -0.3452 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6705    0.6635   -0.4544 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4903   -0.4584   -0.5766 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4431    0.8976   -0.5209 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9107    0.6279   -0.3129 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 16  1  0
  2 16  1  0
  3 20  1  0
  4 28  1  0
  5 37  1  0
  6 37  1  0
  7 37  1  0
 15  8  1  1
  9 35  1  0
  9 36  1  0
 10 12  1  0
 10 17  1  0
 10 27  1  0
 11 19  2  0
 11 29  1  0
 12 14  2  0
 13 14  1  0
 13 27  2  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
 16 19  1  0
 18 20  2  0
 18 21  1  0
 19 22  1  0
 20 23  1  0
 21 24  2  0
 22 26  2  0
 23 28  2  0
 24 28  1  0
 25 26  1  0
 25 29  2  0
 25 30  1  0
 30 31  2  0
 30 32  1  0
 31 33  1  0
 32 34  2  0
 33 35  2  0
 34 35  1  0
 36 37  1  0
M  END
>  <InChIKey>  (26) 
IDUYJRXRDSPPRC-NRFANRHFSA-N

>  <PubChem_CID>  (26) 
77050711

>  <BOM_1A2>  (26) 


>  <BOM_2A6>  (26) 


>  <BOM_2B6>  (26) 


>  <BOM_2C8>  (26) 


>  <BOM_2C9>  (26) 


>  <BOM_2C19>  (26) 


>  <BOM_2D6>  (26) 


>  <BOM_2E1>  (26) 


>  <BOM_3A4>  (26) 


>  <References>  (26) 
"VIVJOA (Oteseconazole) Capsules, for Oral Use: Prescribing Information." U.S. Food and Drug Administration, 26 Apr. 2022, www.accessdata.fda.gov/drugsatfda_docs/label/2022/215888s000lbl.pdf. Accessed 9 Feb. 2024.

>  <FLAG_COMMENTS>  (26) 
Oteseconazole does not undergo significant metabolism.

>  <Name>  (26) 
Oteseconazole

>  <ID>  (26) 
77050711

$$$$
10113978
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    3.7320    2.8450    0.0000 S   0  0  0  0  0  6  0  0  0  0  0  0
    4.7320    2.8450    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7320    2.8450    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3241   -2.1550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1962   -3.1550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7404   -2.9597    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641   -0.1550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3301   -1.6550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981   -1.6550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    3.8450    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7942   -1.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7942   -2.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7404   -1.3503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0622   -2.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9282   -3.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9282   -1.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0622   -1.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0511   -0.3997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3301   -2.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    1.8450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3241   -2.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    1.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981    0.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1962   -4.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981    1.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    0.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641   -1.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641   -3.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.8450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981   -2.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  2  0
  1 10  1  0
  1 20  1  0
  4  6  1  0
  4 13  1  0
  4 21  1  0
  5 14  1  0
  5 19  1  0
  5 24  1  0
  6 12  2  0
  7 23  1  0
  7 28  1  0
  8 19  2  0
  8 28  1  0
  9 28  2  0
  9 31  1  0
 11 12  1  0
 11 13  2  0
 11 16  1  0
 12 15  1  0
 13 18  1  0
 14 15  2  0
 14 17  1  0
 16 17  2  0
 19 29  1  0
 20 22  2  0
 20 25  1  0
 22 26  1  0
 22 30  1  0
 23 25  2  0
 23 27  1  0
 26 27  2  0
 29 31  2  0
M  END
>  <InChIKey>  (27) 
CUIHSIWYWATEQL-UHFFFAOYSA-N

>  <PubChem_CID>  (27) 
10113978

>  <BOM_1A2>  (27) 
<24,5;Dealkylation;R1>
<24,H;Dealkylation;R1>
<18,H;Hydroxylation;R2>
<30,H;Hydroxylation;R3>
<21,4;Dealkylation;R4>
<21,H;Dealkylation;R4>

>  <BOM_2A6>  (27) 


>  <BOM_2B6>  (27) 


>  <BOM_2C8>  (27) 
<24,5;Dealkylation;R1>
<24,H;Dealkylation;R1>
<18,H;Hydroxylation;R2>
<30,H;Hydroxylation;R3>
<21,4;Dealkylation;R4>
<21,H;Dealkylation;R4>

>  <BOM_2C9>  (27) 


>  <BOM_2C19>  (27) 


>  <BOM_2D6>  (27) 


>  <BOM_2E1>  (27) 


>  <BOM_3A4>  (27) 
<24,5;Dealkylation;R1>
<24,H;Dealkylation;R1>
<18,H;Hydroxylation;R2>
<30,H;Hydroxylation;R3>
<21,4;Dealkylation;R4>
<21,H;Dealkylation;R4>

>  <References>  (27) 
Thorn, Caroline F., et al. "PharmGKB summary: pazopanib pathway, pharmacokinetics." Pharmacogenetics and genomics 27.8 (2017): 307-312.

>  <FLAG_COMMENTS>  (27) 


>  <Name>  (27) 
Pazopanib

>  <ID>  (27) 
10113978

$$$$
9854073
     RDKit          2D

 60 65  0  0  0  0  0  0  0  0999 V2000
    2.1157   -0.3730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890    0.0174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4210    1.1234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5156    2.0529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4839    2.0529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9075    1.4581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1731    1.4581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1986    0.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1731    0.1753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1986    2.0902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4486   -0.4664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7839   -0.7437    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4141   -1.1234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1494   -0.7194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4141   -1.8345    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7253    2.7874    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0708   -1.2526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6419   -2.9026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6419   -3.7277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3564   -4.1402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0708   -3.7277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0708   -2.9026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3564   -2.4901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3564   -1.6651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6419   -1.2526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0850    2.9166    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1477    0.3798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1477    1.1234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1477    1.9484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9075    0.1753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9075   -0.6496    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9845    1.2291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9845    0.4041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890    1.4859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890    2.3109    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4210    0.3798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1356   -0.0326    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2700    0.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8460    0.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4349    0.8401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1494    0.4276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1494   -0.3973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4349   -0.8098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7040    0.4276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7040   -0.3973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2750    0.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9895    0.8401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5607    0.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5607    1.6816    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2750   -0.3809    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9895    1.6651    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4183    3.3152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7040    2.9026    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7040    2.0776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4183    1.6651    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5034    2.7234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5608    3.5907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4183    4.1402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1329    2.9027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1329    3.7277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  7  2  0
  8  7  1  0
  7 10  1  0
 38  6  1  0
  5  6  1  0
  9  8  1  0
 30 38  1  0
 30  9  1  0
  1 30  1  0
 27  1  1  1
 36  3  1  1
 34  3  1  0
  2 36  1  0
 28 34  1  0
 27  2  1  0
  2 11  1  0
 27 28  1  0
  4 28  1  0
  4  5  1  0
  2 12  1  6
 13 12  1  0
 14 13  1  0
 15 13  2  0
  1 17  1  6
 16  4  2  0
  5 26  1  1
  8 39  1  6
 24 17  1  0
 23 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 23 22  1  0
 23 24  1  0
 24 25  2  0
 28 29  1  1
 30 31  1  1
 38 32  1  0
 38 33  1  0
 34 35  1  1
 36 37  1  0
 11 37  1  0
 48 39  1  0
 40 41  2  0
 40 44  1  0
 41 42  1  0
 42 43  2  0
 43 45  1  0
 47 44  1  0
 45 44  2  0
 47 46  1  0
 48 46  1  0
 46 50  1  6
 47 51  1  6
 48 49  2  0
 54 51  1  0
 53 52  1  0
 53 54  1  0
 54 55  2  0
 35 56  1  0
 26 57  1  0
 52 58  1  0
 52 59  1  0
 52 60  1  0
M  END
>  <InChIKey>  (28) 
BMQGVNUXMIRLCK-OAGWZNDDSA-N

>  <PubChem_CID>  (28) 
9854073

>  <BOM_1A2>  (28) 


>  <BOM_2A6>  (28) 


>  <BOM_2B6>  (28) 


>  <BOM_2C8>  (28) 
<26,57;Dealkylation;R1>
<57,H;Dealkylation;R1>
<35,56;Dealkylation;R2>
<56,H;Dealkylation;R2>

>  <BOM_2C9>  (28) 


>  <BOM_2C19>  (28) 


>  <BOM_2D6>  (28) 


>  <BOM_2E1>  (28) 


>  <BOM_3A4>  (28) 
<26,57;Dealkylation;R1>
<57,H;Dealkylation;R1>
<35,56;Dealkylation;R2>
<56,H;Dealkylation;R2>
<58,H;Hydroxylation;R3>
<59,H;Hydroxylation;R3>
<60,H;Hydroxylation;R3>

>  <References>  (28) 
Kort, A., et al. "Quantification of cabazitaxel, its metabolite docetaxel and the determination of the demethylated metabolites RPR112698 and RPR123142 as docetaxel equivalents in human plasma by liquid chromatography–tandem mass spectrometry." Journal of Chromatography B 925 (2013): 117-123.
Vrignaud, Patricia, et al. "Preclinical profile of cabazitaxel." Drug design, development and therapy (2014): 1851-1867.

>  <FLAG_COMMENTS>  (28) 


>  <Name>  (28) 
Cabazitaxel

>  <ID>  (28) 
9854073

$$$$
121301826
     RDKit          3D

 23 25  0  0  1  0  0  0  0  0999 V2000
    4.7770    0.8916    0.2606 S   0  0  0  0  0  6  0  0  0  0  0  0
    3.6987   -0.1390   -0.4478 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5202    0.7809   -2.1714 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9299   -2.5122    0.4208 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1035    2.1895    0.2293 O   0  0  0  0  0  1  0  0  0  0  0  0
    5.9625    0.8147   -0.5920 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9701    0.3397    1.6012 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1471    0.0556   -0.3227 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3855    0.1075   -0.0749 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6286   -0.4778   -0.4695 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9645    2.1788    0.4607 N   0  0  0  0  0  4  0  0  0  0  0  0
    1.8187   -0.6334    1.0424 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.3774   -1.2047   -0.8330 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.4681    0.0572    1.1038 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5491   -2.1197    0.6910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6491   -2.3340   -0.5634 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9959   -0.5168   -0.0029 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3882    0.4434   -1.0046 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7125   -1.4840   -0.2149 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1097    0.0762    1.4053 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9387    0.1881   -0.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8055    1.7050   -0.9458 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9750    1.5932    1.4129 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  1  0
  1  6  2  0
  1  7  2  0
  2  9  1  0
  3 18  2  0
  4 19  2  0
  8 13  1  0
  8 14  1  0
  8 18  1  0
  9 12  1  0
  9 18  1  0
 10 17  1  0
 10 19  1  0
 11 22  1  0
 11 23  1  0
 12 14  1  0
 12 15  1  6
 13 16  1  0
 13 19  1  1
 15 16  1  0
 17 20  1  0
 17 21  1  0
 20 23  1  0
 21 22  1  0
M  CHG  2   5  -1  11   1
M  END
>  <InChIKey>  (29) 
SMOBCLHAZXOKDQ-ZJUUUORDSA-N

>  <PubChem_CID>  (29) 
121301826

>  <BOM_1A2>  (29) 


>  <BOM_2A6>  (29) 


>  <BOM_2B6>  (29) 


>  <BOM_2C8>  (29) 


>  <BOM_2C9>  (29) 


>  <BOM_2C19>  (29) 


>  <BOM_2D6>  (29) 


>  <BOM_2E1>  (29) 


>  <BOM_3A4>  (29) 


>  <References>  (29) 
"RECARBRIO (Imipenem, Cilastatin, and Relebactam) for Injection, for Intravenous Use: Prescribing Information." U.S. Food and Drug Administration, 4 June 2020, www.accessdata.fda.gov/drugsatfda_docs/label/2020/212819s002lbl.pdf. Accessed 9 Feb. 2024.

>  <FLAG_COMMENTS>  (29) 
Relebactam does not undergo significant metabolism and can be found mostly unchanged in human plasma.

>  <Name>  (29) 
Relebactam

>  <ID>  (29) 
121301826

$$$$
125017
     RDKit          3D

 19 20  0  0  1  0  0  0  0  0999 V2000
   -1.3482    0.5910   -1.4914 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4342    2.2329   -0.2134 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8230   -2.8292    0.0218 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5751    0.1845   -0.1385 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3801   -0.6638    0.3003 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.6798    1.4509    0.7253 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8757   -0.6325   -0.0723 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9153    2.2860    0.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1063    0.2091   -0.4135 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1931    1.4566    0.4596 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2838   -2.0058   -0.4565 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9198    0.1179    0.1615 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6551    0.3933    1.2953 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3198    0.5261   -1.0936 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9263   -4.0583   -0.7655 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6520   -3.1459    1.4402 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8451    1.1100    1.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5098    1.2427   -1.2209 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2724    1.5346   -0.0901 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  2 19  1  0
  3 11  1  0
  3 15  1  0
  3 16  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  5 11  1  6
  5 12  1  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
  9 10  1  0
 12 13  2  0
 12 14  1  0
 13 17  1  0
 14 18  2  0
 17 19  2  0
 18 19  1  0
M  END
>  <InChIKey>  (30) 
KYYIDSXMWOZKMP-UHFFFAOYSA-N

>  <PubChem_CID>  (30) 
125017

>  <BOM_1A2>  (30) 


>  <BOM_2A6>  (30) 


>  <BOM_2B6>  (30) 


>  <BOM_2C8>  (30) 


>  <BOM_2C9>  (30) 
<16,3;Dealkylation;R1>
<16,H;Dealkylation;R1>
<15,3;Dealkylation;R1>
<15,H;Dealkylation;R1>

>  <BOM_2C19>  (30) 
<16,3;Dealkylation;R1>
<16,H;Dealkylation;R1>
<15,3;Dealkylation;R1>
<15,H;Dealkylation;R1>

>  <BOM_2D6>  (30) 


>  <BOM_2E1>  (30) 


>  <BOM_3A4>  (30) 
<16,3;Dealkylation;R1>
<16,H;Dealkylation;R1>
<15,3;Dealkylation;R1>
<15,H;Dealkylation;R1>

>  <References>  (30) 
Preskorn, Sheldon, et al. "Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers." Journal of clinical psychopharmacology 29.1 (2009): 39-43.
Holliday SM, Benfield P: Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs. 1995 Feb;49(2):280-94.

>  <FLAG_COMMENTS>  (30) 


>  <Name>  (30) 
Desvenlafaxine

>  <ID>  (30) 
125017

$$$$
3055168
     RDKit          2D

 28 31  0  0  1  0  0  0  0  0999 V2000
   12.5872   -1.3686    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.4939    0.4110    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    2.2770    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6576    0.1836    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2258   -3.0322    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4103    2.0817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4103    0.4723    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1964   -1.5377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4939    0.4110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9939   -0.4551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641    1.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9939    1.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4939    0.4110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641    0.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9939    1.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9885   -0.5596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981    2.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9939   -0.4551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9939    1.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4939    0.4110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7210    3.0322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981    0.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9939   -0.4551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9939    1.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    1.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3303   -2.0377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  1 27  1  0
  2 15  1  0
  2 20  1  0
  3 25  1  0
  3 28  1  0
  4 16  2  0
  5 27  2  0
  6 11  1  0
  6 12  1  0
  6 21  1  0
  7 12  2  0
  7 14  1  0
  8 16  1  0
  8 27  1  0
  9 10  1  0
  9 13  1  0
 10 16  1  0
 11 14  2  0
 11 17  1  0
 12 15  1  0
 13 18  2  0
 13 19  1  0
 14 22  1  0
 17 25  2  0
 18 23  1  0
 19 24  2  0
 20 23  2  0
 20 24  1  0
 22 26  2  0
 25 26  1  0
M  END
>  <InChIKey>  (31) 
XMSXOLDPMGMWTH-UHFFFAOYSA-N

>  <PubChem_CID>  (31) 
3055168

>  <BOM_1A2>  (31) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2>
<21,H;Dealkylation;R2>
<28,3;Dealkylation;R3>
<28,H;Dealkylation;R3>
<27,1;Oxidative-Cleavage(Ring);R4>
<27,8;Oxidative-Cleavage(Ring);R4>

>  <BOM_2A6>  (31) 


>  <BOM_2B6>  (31) 


>  <BOM_2C8>  (31) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2>
<21,H;Dealkylation;R2>
<28,3;Dealkylation;R3>
<28,H;Dealkylation;R3>
<27,1;Oxidative-Cleavage(Ring);R4>
<27,8;Oxidative-Cleavage(Ring);R4>

>  <BOM_2C9>  (31) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2>
<21,H;Dealkylation;R2>
<28,3;Dealkylation;R3>
<28,H;Dealkylation;R3>
<27,1;Oxidative-Cleavage(Ring);R4>
<27,8;Oxidative-Cleavage(Ring);R4>

>  <BOM_2C19>  (31) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2>
<21,H;Dealkylation;R2>
<28,3;Dealkylation;R3>
<28,H;Dealkylation;R3>
<27,1;Oxidative-Cleavage(Ring);R4>
<27,8;Oxidative-Cleavage(Ring);R4>

>  <BOM_2D6>  (31) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2>
<21,H;Dealkylation;R2>
<28,3;Dealkylation;R3>
<28,H;Dealkylation;R3>
<27,1;Oxidative-Cleavage(Ring);R4>
<27,8;Oxidative-Cleavage(Ring);R4>

>  <BOM_2E1>  (31) 


>  <BOM_3A4>  (31) 
<10,H;Hydroxylation;R1>
<21,6;Dealkylation;R2>
<21,H;Dealkylation;R2>
<28,3;Dealkylation;R3>
<28,H;Dealkylation;R3>
<27,1;Oxidative-Cleavage(Ring);R4>
<27,8;Oxidative-Cleavage(Ring);R4>

>  <References>  (31) 
Uchiyama, Minoru, et al. "In vitro metabolism of rivoglitazone, a novel peroxisome proliferator-activated receptor r agonist, in rat, monkey, and human liver microsomes and freshly isolated hepatocytes." Drug metabolism and disposition 39.7 (2011): 1311-1319.

>  <FLAG_COMMENTS>  (31) 
CYP-MAP:  <27,1;Oxidative-Cleavage(Ring);R4><27,8;Oxidative-Cleavage(Ring);R4>oxidative TZD ring opening

>  <Name>  (31) 
Rivoglitazone

>  <ID>  (31) 
3055168

$$$$
3826
     RDKit          3D

 19 21  0  0  1  0  0  0  0  0999 V2000
   -4.5944    1.6943    0.6581 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0057    1.7621   -0.9844 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8162   -2.3545    0.6129 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9658   -0.7134    0.2798 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2588   -0.2292    0.3050 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.7181   -0.3010    1.7575 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1799   -0.2786    1.6455 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0966   -0.6898   -0.4819 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1018   -1.1450   -0.4209 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7643   -1.1233   -1.7385 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3638   -1.4107   -1.6995 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5900    1.1738   -0.0871 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4276   -1.2829    0.0913 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4503   -0.1751    0.0484 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0821    1.0190   -0.5097 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6908   -0.4242    0.5705 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0277    2.0436   -0.5492 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6363    0.6006    0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3046    1.8344   -0.0288 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  2 12  2  0
  3 13  2  0
  4  7  1  0
  4  8  1  0
  4  9  1  0
  5  6  1  0
  5  8  1  0
  5 12  1  6
  6  7  1  0
  8 10  2  0
  9 11  2  0
  9 13  1  0
 10 11  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 15 17  1  0
 16 18  2  0
 17 19  2  0
 18 19  1  0
M  END
>  <InChIKey>  (32) 
OZWKMVRBQXNZKK-UHFFFAOYSA-N

>  <PubChem_CID>  (32) 
3826

>  <BOM_1A2>  (32) 


>  <BOM_2A6>  (32) 


>  <BOM_2B6>  (32) 


>  <BOM_2C8>  (32) 
<19,H;Hydroxylation;R1>

>  <BOM_2C9>  (32) 
<19,H;Hydroxylation;R1>

>  <BOM_2C19>  (32) 


>  <BOM_2D6>  (32) 


>  <BOM_2E1>  (32) 


>  <BOM_3A4>  (32) 


>  <References>  (32) 
Allegaert, Karel, et al. "Paracetamol and ketorolac pharmacokinetics and metabolism at delivery and during postpartum." Acta Anæsthesiologica Belgica 63.3 (2012): 121-125.
Välitalo, Pyry A., et al. "Body weight, gender and pregnancy affect enantiomer‐specific ketorolac pharmacokinetics." British journal of clinical pharmacology 83.9 (2017): 1966-1975.

>  <FLAG_COMMENTS>  (32) 


>  <Name>  (32) 
Ketorolac

>  <ID>  (32) 
3826

$$$$
122262
     RDKit          3D

 37 42  0  0  0  0  0  0  0  0999 V2000
   -7.4578    4.9057    0.7856 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.3180    0.4757   -2.0371 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.2288   -2.5514    0.5903 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1041   -2.2527    0.8047 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6227   -1.1930   -0.1736 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0619   -0.1916    0.5259 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3433    0.3928   -1.3581 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7427    3.0597    0.4702 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8579   -2.6632    1.0869 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4699   -3.5391    0.5186 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0210   -3.3727    0.0552 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2680   -1.7480   -0.6376 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0979   -1.9492    1.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4688   -2.4523    1.3082 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1339   -1.4139   -0.3996 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6900   -1.6699   -1.1992 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5472   -1.8790    1.1224 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1231   -1.1157    1.6653 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7447   -0.0427   -0.1001 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8510   -0.6416   -0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9706    0.8721    0.4925 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2328    0.6866   -0.2326 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2499    0.7741   -0.1136 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7557   -1.4248   -1.2878 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6155    2.0952    1.0816 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4913    1.1632   -0.6555 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1054    1.8957   -0.1013 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3684    1.5183    0.4993 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6609   -0.4253   -0.7194 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9646   -0.8708   -1.6575 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5201    3.1370    1.0439 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8413    2.4697   -0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3548    1.7729   -0.7030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7441    2.8209    0.8150 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9160   -0.5202   -1.3136 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9821    3.2969    0.4016 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7638    0.5806   -1.3053 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 36  1  0
  2 37  1  0
  3  9  1  0
  3 12  1  0
  3 13  1  0
  4 10  1  0
  4 14  1  0
  4 15  1  0
  5 16  1  0
  5 17  1  0
  5 20  1  0
  6 18  1  0
  6 19  1  0
  6 21  1  0
  7 26  2  0
  7 30  1  0
  8 27  2  0
  8 31  1  0
  9 11  1  0
 10 11  1  0
 12 16  1  0
 13 17  1  0
 14 18  1  0
 15 19  1  0
 20 22  2  0
 20 24  1  0
 21 23  2  0
 21 25  1  0
 22 26  1  0
 22 28  1  0
 23 27  1  0
 23 29  1  0
 24 30  2  0
 25 31  2  0
 26 32  1  0
 27 33  1  0
 28 34  2  0
 29 35  2  0
 32 36  2  0
 33 37  2  0
 34 36  1  0
 35 37  1  0
M  END
>  <InChIKey>  (33) 
UCRHFBCYFMIWHC-UHFFFAOYSA-N

>  <PubChem_CID>  (33) 
122262

>  <BOM_1A2>  (33) 


>  <BOM_2A6>  (33) 


>  <BOM_2B6>  (33) 


>  <BOM_2C8>  (33) 


>  <BOM_2C9>  (33) 


>  <BOM_2C19>  (33) 


>  <BOM_2D6>  (33) 


>  <BOM_2E1>  (33) 


>  <BOM_3A4>  (33) 
<10,4;Dealkylation;R1>
<10,H;Dealkylation;R1>
<9,3;Dealkylation;R1>
<9,H;Dealkylation;R1>
<8,N;N-Oxidation;R2>
<7,N;N-Oxidation;R2>
<12,H;Hydroxylation;R3>
<13,H;Hydroxylation;R3>
<14,H;Hydroxylation;R3>
<15,H;Hydroxylation;R3>
<16,H;Hydroxylation;R4>
<17,H;Hydroxylation;R4>
<18,H;Hydroxylation;R4>
<19,H;Hydroxylation;R4>

>  <References>  (33) 
Tarning, J., et al. "Characterization of human urinary metabolites of the antimalarial piperaquine." Drug metabolism and disposition 34.12 (2006): 2011-2019.
Lee, Tina Ming-Na, et al. "In vitro metabolism of piperaquine is primarily mediated by CYP3A4." Xenobiotica 42.11 (2012): 1088-1095.

>  <FLAG_COMMENTS>  (33) 


>  <Name>  (33) 
Piperaquine

>  <ID>  (33) 
122262

$$$$
4771
     RDKit          3D

 11 11  0  0  0  0  0  0  0  0999 V2000
    3.3888    0.0526   -0.5981 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0831    0.0002    0.0827 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9797   -0.0013   -1.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9984    1.2309    0.9959 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0660   -1.2787    0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4494   -0.0010   -0.5158 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0899   -1.2087   -0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0902    1.2072   -0.2966 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4089   -1.2084    0.1598 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4090    1.2076    0.1574 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0685   -0.0003    0.3855 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  7  9  1  0
  8 10  2  0
  9 11  2  0
 10 11  1  0
M  END
>  <InChIKey>  (34) 
DHHVAGZRUROJKS-UHFFFAOYSA-N

>  <PubChem_CID>  (34) 
4771

>  <BOM_1A2>  (34) 


>  <BOM_2A6>  (34) 


>  <BOM_2B6>  (34) 


>  <BOM_2C8>  (34) 


>  <BOM_2C9>  (34) 


>  <BOM_2C19>  (34) 


>  <BOM_2D6>  (34) 


>  <BOM_2E1>  (34) 


>  <BOM_3A4>  (34) 
<11,H;Hydroxylation;R1>
<1,N;N-Oxidation;R2>

>  <References>  (34) 
Choi, Yun Jeong, et al. "Determination of phentermine, N-hydroxyphentermine and mephentermine in urine using dilute and shoot liquid chromatography–tandem mass spectrometry." Journal of Chromatography B 1029 (2016): 22-27.
"QSYMIA (Phentermine and Topiramate Extended-Release Capsules), for Oral Use, CIV." U.S. Food and Drug Administration, 28 June 2023, www.accessdata.fda.gov/drugsatfda_docs/label/2023/022580s023lbl.pdf. Accessed 8 Mar. 2024.

>  <FLAG_COMMENTS>  (34) 


>  <Name>  (34) 
Phentermine

>  <ID>  (34) 
4771

$$$$
9966051
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.2033    0.1846   -1.4480 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4973    0.2127    0.0879 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1984    2.5037    0.0051 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4665    0.3711   -1.0049 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8047    0.9443    1.3217 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7785    1.8497   -1.2333 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1419    2.4023    1.0104 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7660   -0.9788    0.1516 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5215   -1.1453   -0.4938 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2763   -2.0692    0.8859 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1793   -2.3483   -0.4081 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5756   -3.2722    0.9717 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7411    0.4319   -0.5753 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3477   -3.4117    0.3247 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9778    0.2792   -1.2056 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6894    0.7876    0.7739 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1578    0.4813   -0.4894 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1035    0.8364    0.8584 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8693    0.9897    1.4899 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0882   -0.1013   -2.6476 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3646    1.0524    1.6247 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0
  1 13  1  0
  2  4  1  0
  2  5  1  0
  2  8  1  0
  3  6  1  0
  3  7  1  0
  4  6  1  0
  5  7  1  0
  8  9  1  0
  8 10  2  0
  9 11  2  0
 10 12  1  0
 11 14  1  0
 12 14  2  0
 13 15  2  0
 13 16  1  0
 15 17  1  0
 15 20  1  0
 16 19  2  0
 17 18  2  0
 18 19  1  0
 18 21  1  0
M  END
>  <InChIKey>  (35) 
YQNWZWMKLDQSAC-UHFFFAOYSA-N

>  <PubChem_CID>  (35) 
9966051

>  <BOM_1A2>  (35) 


>  <BOM_2A6>  (35) 
<1,S;S-Oxidation;R4>

>  <BOM_2B6>  (35) 
<3,N;N-Oxidation;R3>

>  <BOM_2C8>  (35) 
<1,S;S-Oxidation;R4>

>  <BOM_2C9>  (35) 
<14,H;Hydroxylation;R1>
<21,H;Hydroxylation;R2>
<3,N;N-Oxidation;R3>

>  <BOM_2C19>  (35) 
<3,N;N-Oxidation;R3>

>  <BOM_2D6>  (35) 
<14,H;Hydroxylation;R1>
<21,H;Hydroxylation;R2>

>  <BOM_2E1>  (35) 


>  <BOM_3A4>  (35) 
<1,S;S-Oxidation;R4>

>  <References>  (35) 
Hvenegaard, Mette G., et al. "Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004." Drug Metabolism and Disposition 40.7 (2012): 1357-1365.

>  <FLAG_COMMENTS>  (35) 


>  <Name>  (35) 
Vortioxetine

>  <ID>  (35) 
9966051

$$$$
6918638
     RDKit          3D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -2.8405   -0.4591   -1.2818 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0613   -1.2489   -1.3913 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1444   -0.0693   -2.5019 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7765   -1.2033    0.1710 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7754    1.0582   -0.9261 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1936    0.9442   -0.3464 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3934    0.8437   -0.8315 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7293   -1.3361   -0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3568   -1.1103   -0.3659 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5304   -1.8115    0.4509 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2144   -2.2630    0.6628 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0902    1.7154    0.1598 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0450   -2.7382    1.3737 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3273   -2.9639    1.4796 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1810    2.2786   -0.7276 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9457    1.8898    1.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9617   -1.5769    0.3406 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1111    3.0269   -0.2366 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8759    2.6383    2.0219 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0414    3.2068    1.1379 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5328   -0.4797   -0.2049 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0148   -0.3416   -0.2554 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  2  0
  1  6  1  0
  1  8  1  0
  4 22  2  0
  5  7  1  0
  6 12  1  0
  7 22  1  0
  8  9  2  0
  8 11  1  0
  9 10  1  0
 10 13  2  0
 10 17  1  0
 11 14  2  0
 12 15  2  0
 12 16  1  0
 13 14  1  0
 15 18  1  0
 16 19  2  0
 17 21  2  0
 18 20  2  0
 19 20  1  0
 21 22  1  0
M  END
>  <InChIKey>  (36) 
NCNRHFGMJRPRSK-MDZDMXLPSA-N

>  <PubChem_CID>  (36) 
6918638

>  <BOM_1A2>  (36) 


>  <BOM_2A6>  (36) 
<22,7;Hydrolysis;R1>
<7,5;Reduction;R2>

>  <BOM_2B6>  (36) 


>  <BOM_2C8>  (36) 


>  <BOM_2C9>  (36) 
<22,7;Hydrolysis;R1>
<7,5;Reduction;R2>

>  <BOM_2C19>  (36) 


>  <BOM_2D6>  (36) 


>  <BOM_2E1>  (36) 


>  <BOM_3A4>  (36) 
<22,7;Hydrolysis;R1>
<7,5;Reduction;R2>

>  <References>  (36) 
Dunn, Allison, et al. "The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers." Cancer Chemotherapy and Pharmacology (2024): 1-11.

>  <FLAG_COMMENTS>  (36) 


>  <Name>  (36) 
Belinostat

>  <ID>  (36) 
6918638

$$$$
9862076
     RDKit          3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -0.0923   -3.7384   -0.7328 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.1173    1.4107    0.6062 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4870    1.8835    0.6696 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2932    1.3985    1.7995 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2667   -0.2637    0.1779 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2809    2.1878   -0.6830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2156   -2.1431   -0.2859 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8098    0.0931    0.3359 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2353   -1.0666   -0.0473 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1640   -0.7139    0.0174 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4301   -0.8878    0.0401 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8495   -2.2613   -0.3415 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8164   -0.2448   -1.1216 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8594   -0.8436    1.2185 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9077    2.1408   -2.0279 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3292    3.5110   -0.3995 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8648   -0.0340    0.1417 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1676    0.0954   -1.0594 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2107   -0.5034    1.2808 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3098    0.3292    0.2089 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7365   -0.3493    0.2025 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  2  6  1  0
  5  9  1  0
  5 11  1  0
  6 15  1  0
  6 16  1  0
  7 11  2  0
  7 12  1  0
  8 21  3  0
  9 10  1  0
  9 12  2  0
 10 13  2  0
 10 14  1  0
 11 21  1  0
 13 18  1  0
 14 19  2  0
 17 18  2  0
 17 19  1  0
 17 20  1  0
M  END
>  <InChIKey>  (37) 
YXKMMRDKEKCERS-UHFFFAOYSA-N

>  <PubChem_CID>  (37) 
9862076

>  <BOM_1A2>  (37) 


>  <BOM_2A6>  (37) 


>  <BOM_2B6>  (37) 
<20,H;Hydroxylation;R1>

>  <BOM_2C8>  (37) 


>  <BOM_2C9>  (37) 
<20,H;Hydroxylation;R1>

>  <BOM_2C19>  (37) 
<20,H;Hydroxylation;R1>

>  <BOM_2D6>  (37) 


>  <BOM_2E1>  (37) 


>  <BOM_3A4>  (37) 


>  <References>  (37) 
Lee, H., et al. "Biotransformation and molecular docking of cyazofamid by human liver microsomes and cDNA-expressed human recombinant P450s." Applied Biological Chemistry 59 (2016): 649-653.

>  <FLAG_COMMENTS>  (37) 


>  <Name>  (37) 
Cyazofamid

>  <ID>  (37) 
9862076

$$$$
3652
     RDKit          3D

 23 24  0  0  1  0  0  0  0  0999 V2000
   -4.9068   -1.9876   -1.6099 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.2693   -2.9958    0.4835 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9165   -1.2358   -0.1070 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0406    2.4644   -0.3071 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1893   -0.0466    2.2104 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3087    1.6277    0.0766 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3903    0.8671   -1.2528 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4002    2.8618   -0.0060 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.3526   -0.3158   -1.1511 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5550   -1.7055   -0.3698 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8790    3.8197   -1.0921 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8345   -2.3716   -0.0046 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7079    1.6265    0.4999 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0583   -2.5775    0.7722 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2422   -1.9109    0.3332 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7118    0.7631   -0.0086 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4750    1.6215    1.8831 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4298   -0.0583    0.8856 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9890    0.7252   -1.3856 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2286    0.7826    2.6787 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4099   -0.8967    0.3615 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9747   -0.1228   -1.8825 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6858   -0.9346   -1.0076 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 23  1  0
  2 14  1  0
  3  9  1  0
  3 10  1  0
  3 12  1  0
  4  8  1  0
  4 13  1  0
  5 18  2  0
  5 20  1  0
  6  7  1  0
  6  8  1  0
  7  9  1  0
  8 11  1  6
 10 14  1  0
 12 15  1  0
 13 16  2  0
 13 17  1  0
 16 18  1  0
 16 19  1  0
 17 20  2  0
 18 21  1  0
 19 22  2  0
 21 23  2  0
 22 23  1  0
M  END
>  <InChIKey>  (38) 
XXSMGPRMXLTPCZ-UHFFFAOYSA-N

>  <PubChem_CID>  (38) 
3652

>  <BOM_1A2>  (38) 
<10,3;Dealkylation;R1>
<10,H;Dealkylation;R1>
<12,3;Dealkylation;R2>
<12,H;Dealkylation;R2>

>  <BOM_2A6>  (38) 


>  <BOM_2B6>  (38) 


>  <BOM_2C8>  (38) 
<10,3;Dealkylation;R1>
<10,H;Dealkylation;R1>
<12,3;Dealkylation;R2>
<12,H;Dealkylation;R2>

>  <BOM_2C9>  (38) 


>  <BOM_2C19>  (38) 
<10,3;Dealkylation;R1>
<10,H;Dealkylation;R1>
<12,3;Dealkylation;R2>
<12,H;Dealkylation;R2>

>  <BOM_2D6>  (38) 
<10,3;Dealkylation;R1>
<10,H;Dealkylation;R1>
<12,3;Dealkylation;R2>
<12,H;Dealkylation;R2>

>  <BOM_2E1>  (38) 


>  <BOM_3A4>  (38) 
<10,3;Dealkylation;R1>
<10,H;Dealkylation;R1>
<12,3;Dealkylation;R2>
<12,H;Dealkylation;R2>

>  <References>  (38) 
Rendic, Slobodan, and Frederick P. Guengerich. "Metabolism and interactions of chloroquine and hydroxychloroquine with human cytochrome P450 enzymes and drug transporters." Current drug metabolism 21.14 (2020): 1127-1135.

>  <FLAG_COMMENTS>  (38) 


>  <Name>  (38) 
Hydroxychloroquine

>  <ID>  (38) 
3652

$$$$
636822
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -1.2981   -2.3856    0.3322 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1218    1.8956   -0.2951 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0979   -0.7055   -0.3520 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9573   -0.0103    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4669   -1.3158    0.1777 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2787    0.8366   -0.1419 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7690   -0.4689   -0.1693 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0844    1.0659    0.0452 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8962   -1.5451   -0.0093 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3762    0.2558    0.4009 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0515    1.3271   -0.0696 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8725   -2.9346   -0.8516 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5409    3.1976   -0.2548 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5083    1.5639    0.1644 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9106   -0.7767    0.8181 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1 12  1  0
  2  6  1  0
  2 13  1  0
  3  7  1  0
  3 15  1  0
  4  5  2  0
  4  8  1  0
  4 10  1  0
  5  9  1  0
  6  7  1  0
  6  8  2  0
  7  9  2  0
 10 11  2  0
 11 14  1  0
M  END
>  <InChIKey>  (39) 
RKFAZBXYICVSKP-AATRIKPKSA-N

>  <PubChem_CID>  (39) 
636822

>  <BOM_1A2>  (39) 
<14,H;Hydroxylation;R2>

>  <BOM_2A6>  (39) 
<15,3;Dealkylation;R3>
<15,H;Dealkylation;R3>
<13,2;Dealkylation;R4>
<13,H;Dealkylation;R4>
<12,1;Dealkylation;R5>
<12,H;Dealkylation;R5>

>  <BOM_2B6>  (39) 
<11,10;Epoxidation;R1>
<14,H;Hydroxylation;R2>
<15,3;Dealkylation;R3>
<15,H;Dealkylation;R3>
<13,2;Dealkylation;R4>
<13,H;Dealkylation;R4>
<12,1;Dealkylation;R5>
<12,H;Dealkylation;R5>

>  <BOM_2C8>  (39) 
<14,H;Hydroxylation;R2>

>  <BOM_2C9>  (39) 
<14,H;Hydroxylation;R2>

>  <BOM_2C19>  (39) 
<14,H;Hydroxylation;R2>
<15,3;Dealkylation;R3>
<15,H;Dealkylation;R3>
<13,2;Dealkylation;R4>
<13,H;Dealkylation;R4>
<12,1;Dealkylation;R5>
<12,H;Dealkylation;R5>

>  <BOM_2D6>  (39) 
<14,H;Hydroxylation;R2>

>  <BOM_2E1>  (39) 
<14,H;Hydroxylation;R2>

>  <BOM_3A4>  (39) 
<11,10;Epoxidation;R1>
<14,H;Hydroxylation;R2>
<15,3;Dealkylation;R3>
<15,H;Dealkylation;R3>
<13,2;Dealkylation;R4>
<13,H;Dealkylation;R4>
<12,1;Dealkylation;R5>
<12,H;Dealkylation;R5>

>  <References>  (39) 
Cartus, Alexander T., and Dieter Schrenk. "Metabolism of carcinogenic alpha-asarone by human cytochrome P450 enzymes." Naunyn-Schmiedeberg's archives of pharmacology 393 (2020): 213-223.

>  <FLAG_COMMENTS>  (39) 


>  <Name>  (39) 
alpha-Asarone

>  <ID>  (39) 
636822

$$$$
30219
     RDKit          3D

 23 24  0  0  1  0  0  0  0  0999 V2000
    0.9446    0.7586    1.5355 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7155    2.7109   -2.5771 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3068    1.1383    1.2440 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.1215   -0.1606    1.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5248    1.8744   -0.0571 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0422    1.0797    0.6468 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7649    2.0247    2.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6680   -1.0792    0.1039 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1861    1.7627   -0.5494 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060    0.9691    0.1441 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5351    2.1702   -0.9021 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7871    0.5463    0.5148 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3371    0.6836    0.9925 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1796   -0.8553    0.0126 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8908    2.0469   -1.3979 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1831    1.6509   -1.0502 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6259   -1.2258    0.3559 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4633   -2.3540    0.1016 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9847   -2.6117   -0.1814 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5772   -2.6286   -0.6031 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4308   -2.9695    0.1224 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3278   -3.9294   -0.5599 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1626   -1.6022   -1.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  6  1  0
  2 15  1  0
  3  4  1  0
  3  5  1  0
  3  7  1  1
  4  8  1  0
  5 11  2  0
  6  9  2  0
  6 13  1  0
  8 18  1  0
  9 11  1  0
  9 15  1  0
 10 12  1  0
 10 13  2  0
 10 16  1  0
 12 14  1  0
 14 17  1  0
 15 16  2  0
 17 19  1  0
 18 20  2  3
 19 21  1  0
 20 22  1  0
 20 23  1  0
M  END
>  <InChIKey>  (40) 
UVOLYTDXHDXWJU-UHFFFAOYSA-N

>  <PubChem_CID>  (40) 
30219

>  <BOM_1A2>  (40) 


>  <BOM_2A6>  (40) 


>  <BOM_2B6>  (40) 


>  <BOM_2C8>  (40) 
<20,18;Epoxidation;R1>
<22,H;Hydroxylation;R2>
<23,H;Hydroxylation;R2>

>  <BOM_2C9>  (40) 
<20,18;Epoxidation;R1>
<22,H;Hydroxylation;R2>
<23,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <BOM_2C19>  (40) 


>  <BOM_2D6>  (40) 
<20,18;Epoxidation;R1>
<22,H;Hydroxylation;R2>
<23,H;Hydroxylation;R2>

>  <BOM_2E1>  (40) 


>  <BOM_3A4>  (40) 
<20,18;Epoxidation;R1>

>  <References>  (40) 
Roy, Pritam, et al. "Elucidating the Mechanism of Metabolism of Cannabichromene by Human Cytochrome P450s." Journal of Natural Products 87.4 (2024): 639-651.

>  <FLAG_COMMENTS>  (40) 


>  <Name>  (40) 
Cannabichromene

>  <ID>  (40) 
30219

$$$$
69537
     RDKit          3D

 22 21  0  0  0  0  0  0  0  0999 V2000
    0.9437    1.1022   -1.6890 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7652   -0.1654   -2.0926 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3043    2.1860   -0.8844 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0027    1.7201    0.7786 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1511   -1.8085   -0.0485 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.3951   -1.5418   -1.5478 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5378    1.4186    1.3954 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4752   -0.4712    1.4191 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.1927   -0.2137    1.7047 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.2921   -1.9203    0.9345 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.5393    1.4259   -0.0914 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6790   -0.2875   -0.7935 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8075    0.3228    1.2979 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1537   -1.3195   -0.3531 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0334    0.2878   -1.0837 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8102    1.1473   -0.1513 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7681   -0.9148   -0.5087 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9667    0.4835    0.5831 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7968   -0.6962    0.5905 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0679   -0.1513   -0.2569 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9693    0.1896    0.2484 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1875   -0.7938    0.5486 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 15  1  0
  2 15  1  0
  3 16  1  0
  4 16  1  0
  5 17  1  0
  6 17  1  0
  7 18  1  0
  8 18  1  0
  9 19  1  0
 10 19  1  0
 11 21  1  0
 12 21  1  0
 13 21  1  0
 14 22  1  0
 15 16  1  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
M  END
>  <InChIKey>  (41) 
GRJRKPMIRMSBNK-UHFFFAOYSA-N

>  <PubChem_CID>  (41) 
69537

>  <BOM_1A2>  (41) 


>  <BOM_2A6>  (41) 
<22,14;Oxidation;R1>

>  <BOM_2B6>  (41) 


>  <BOM_2C8>  (41) 


>  <BOM_2C9>  (41) 


>  <BOM_2C19>  (41) 


>  <BOM_2D6>  (41) 


>  <BOM_2E1>  (41) 


>  <BOM_3A4>  (41) 
<22,14;Oxidation;R1>

>  <References>  (41) 
Merino, Nancy, et al. "Roles of various enzymes in the biotransformation of 6: 2 fluorotelomer alcohol (6: 2 FTOH) by a white-rot fungus." Journal of Hazardous Materials 450 (2023): 131007.

>  <FLAG_COMMENTS>  (41) 


>  <Name>  (41) 
6:2 FTOH

>  <ID>  (41) 
69537

$$$$
10359044
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -0.5908    4.5876    0.9367 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.8725   -2.1273    1.3469 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.2483   -0.5160   -0.1031 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3621   -1.7153    0.9292 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8968   -2.6109    0.1112 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7740   -1.9745   -0.7328 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5170    0.6793    0.0735 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1618    0.6712    0.4583 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0047   -1.7268    0.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6975   -0.5603    0.4629 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9470   -1.9111    1.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3923   -0.7215   -0.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1814    1.9033   -0.1072 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0568   -0.4717   -0.1492 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4729    1.8935    0.7413 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5264    3.1072    0.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2073    3.1019    0.5932 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0315    0.2407   -1.7517 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0822   -1.2726    0.3354 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2760    0.4130   -1.1965 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3508   -1.1868   -0.2382 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5448    0.4984   -1.7699 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5821   -0.3015   -1.2908 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  2 19  1  0
  3  7  1  0
  3  9  1  0
  3 12  1  0
  4 10  2  0
  4 11  1  0
  5  6  1  0
  5  9  2  0
  6 12  2  0
  7  8  2  0
  7 13  1  0
  8 10  1  0
  8 15  1  0
  9 11  1  0
 10 14  1  0
 12 18  1  0
 13 16  2  0
 14 19  2  0
 14 20  1  0
 15 17  2  0
 16 17  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
M  END
>  <InChIKey>  (42) 
MPZVLJCMGPYWQQ-UHFFFAOYSA-N

>  <PubChem_CID>  (42) 
10359044

>  <BOM_1A2>  (42) 


>  <BOM_2A6>  (42) 


>  <BOM_2B6>  (42) 
<18,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <BOM_2C8>  (42) 


>  <BOM_2C9>  (42) 
<18,H;Hydroxylation;R1>

>  <BOM_2C19>  (42) 
<18,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <BOM_2D6>  (42) 


>  <BOM_2E1>  (42) 


>  <BOM_3A4>  (42) 
<18,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <References>  (42) 
Wagmann, Lea, et al. "Toxicokinetics and analytical toxicology of flualprazolam: metabolic fate, isozyme mapping, human plasma concentration and main urinary excretion products." Journal of Analytical Toxicology 44.6 (2020): 549-558.

>  <FLAG_COMMENTS>  (42) 


>  <Name>  (42) 
Flualprazolam

>  <ID>  (42) 
10359044

$$$$
3036780
     RDKit          2D

 20 23  0  0  1  0  0  0  0  0999 V2000
    7.9254   -1.3034    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.0438    1.5572    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4295   -1.7948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5438   -0.6334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6428   -0.1995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4078   -1.6182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9577   -0.9198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4447   -0.1995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4203    0.7754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9956   -2.6958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6673    0.7754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0438    1.5572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1973   -0.9197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3880    0.9147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6578    1.0977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6782    2.5326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1950   -0.6204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.8814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4268    0.3951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6494    2.6958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  2 11  1  0
  2 12  1  0
  3  6  1  0
  3  7  1  0
  3 10  1  0
  4  5  1  0
  4  6  1  6
  4  8  1  0
  5  7  1  1
  5  9  1  0
  8 11  2  0
  8 13  1  0
  9 12  2  0
  9 14  1  0
 11 15  1  0
 12 16  1  0
 13 17  2  0
 14 18  2  0
 15 19  2  0
 16 20  2  0
 17 19  1  0
 18 20  1  0
M  END
>  <InChIKey>  (43) 
VSWBSWWIRNCQIJ-GJZGRUSLSA-N

>  <PubChem_CID>  (43) 
3036780

>  <BOM_1A2>  (43) 
<3,N;N-Oxidation;R1>
<10,3;Dealkylation;R2>
<10,H;Dealkylation;R2>
<18,H;Hydroxylation;R3>

>  <BOM_2A6>  (43) 


>  <BOM_2B6>  (43) 


>  <BOM_2C8>  (43) 


>  <BOM_2C9>  (43) 


>  <BOM_2C19>  (43) 


>  <BOM_2D6>  (43) 
<3,N;N-Oxidation;R1>

>  <BOM_2E1>  (43) 


>  <BOM_3A4>  (43) 
<10,3;Dealkylation;R2>
<10,H;Dealkylation;R2>
<18,H;Hydroxylation;R3>

>  <References>  (43) 
Danek, Przemysaw J., et al. "Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects." Neurochemistry International 151 (2021): 105209.
EMA, 2010. Sycrest International Nonproprietary Name: Asenapine Procedure No.EMEA/H/C/001177 URL. https://www.ema.europa.eu/en/documents/assessment-report/sycrest-epar-public-assessment-report_en.pdf. (Accessed 19 May 2024).

>  <FLAG_COMMENTS>  (43) 


>  <Name>  (43) 
Asenapine

>  <ID>  (43) 
3036780

$$$$
44139752
     RDKit          2D

 17 19  0  0  1  0  0  0  0  0999 V2000
    4.9344    0.0823    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.5472    1.8776    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0771    2.3776    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0511   -3.1867    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5962    1.5686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0084    2.3776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5962    3.1867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5472    2.8776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2872    0.6176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4935    1.5729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4935    3.1824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9563   -0.1256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3090    0.4097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6473   -1.0766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.5414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6691   -1.2846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3601   -2.2356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  2  5  1  0
  2  8  1  0
  2 10  1  0
  3 10  2  0
  3 11  1  0
  4 17  3  0
  5  6  1  0
  5  9  1  1
  6  7  1  0
  7  8  1  0
  8 11  2  0
  9 12  2  0
  9 13  1  0
 12 14  1  0
 13 15  2  0
 14 16  2  0
 15 16  1  0
 16 17  1  0
M  END
>  <InChIKey>  (44) 
USUZGMWDZDXMDG-CYBMUJFWSA-N

>  <PubChem_CID>  (44) 
44139752

>  <BOM_1A2>  (44) 


>  <BOM_2A6>  (44) 


>  <BOM_2B6>  (44) 
<7,H;Hydroxylation;R1>

>  <BOM_2C8>  (44) 


>  <BOM_2C9>  (44) 


>  <BOM_2C19>  (44) 


>  <BOM_2D6>  (44) 
<7,H;Hydroxylation;R1>

>  <BOM_2E1>  (44) 


>  <BOM_3A4>  (44) 
<7,H;Hydroxylation;R1>

>  <References>  (44) 
EMA Summary of Product Characteristics: Isturisa (osilodrostat) oral tablets

>  <FLAG_COMMENTS>  (44) 


>  <Name>  (44) 
Osilodrostat

>  <ID>  (44) 
44139752

$$$$
24965990
     RDKit          3D

 32 36  0  0  1  0  0  0  0  0999 V2000
    7.9362   -0.8750   -2.5467 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.6968    0.4528    1.1887 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3558    1.0957    1.9753 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2757    0.7657    0.9380 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5582   -0.4738    1.3431 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2151   -1.1726   -0.3155 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9474    0.8284   -1.3480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9811    0.9632   -2.6836 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9649    1.9374   -0.5913 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6667    1.9029    1.6595 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.8461    1.7974    1.9415 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2845    0.4281    2.4703 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4479    0.0040   -0.0151 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3819   -1.0658    0.6992 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9667    3.2113    0.9194 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6314    0.4855    1.1896 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7984   -0.4467    0.6985 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2634   -0.6227    0.4649 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8938   -0.4267   -0.7639 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2236   -1.8960    1.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4967   -0.7226   -0.5214 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7951    0.2725    0.3977 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8139   -2.9734    0.3723 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4843   -1.5041   -1.4245 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4442   -2.7775   -0.8565 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4726   -1.0964   -1.4563 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0088    0.9450    0.4703 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7713   -4.3349    0.9794 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7111   -0.4398   -1.4143 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9714    0.5602   -0.4692 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0254    2.2931   -2.8027 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0154    2.8849   -1.5317 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 29  1  0
  2 17  1  0
  2 22  1  0
  3 16  2  0
  4 10  1  0
  4 13  1  0
  4 16  1  0
  5 12  1  0
  5 14  1  0
  5 17  1  0
  6 17  2  0
  6 21  1  0
  7  8  1  0
  7  9  1  0
  7 19  1  0
  8 31  2  0
  9 32  2  0
 10 11  1  0
 10 15  1  6
 11 12  1  0
 13 14  1  0
 16 18  1  0
 18 19  1  0
 18 20  2  0
 19 24  2  0
 20 23  1  0
 21 22  2  0
 21 26  1  0
 22 27  1  0
 23 25  2  0
 23 28  1  0
 24 25  1  0
 26 29  2  0
 27 30  2  0
 29 30  1  0
 31 32  1  0
M  END
>  <InChIKey>  (45) 
JYTNQNCOQXFQPK-MRXNPFEDSA-N

>  <PubChem_CID>  (45) 
24965990

>  <BOM_1A2>  (45) 


>  <BOM_2A6>  (45) 


>  <BOM_2B6>  (45) 


>  <BOM_2C8>  (45) 


>  <BOM_2C9>  (45) 
<28,H;Hydroxylation;R1>

>  <BOM_2C19>  (45) 
<28,H;Hydroxylation;R1>

>  <BOM_2D6>  (45) 
<28,H;Hydroxylation;R1>

>  <BOM_2E1>  (45) 


>  <BOM_3A4>  (45) 
<28,H;Hydroxylation;R1>
<15,H;Hydroxylation;R2>
<30,H;Hydroxylation;R3>

>  <References>  (45) 
Skillman, Britni, and Sarah Kerrigan. "CYP450-Mediated metabolism of suvorexant and investigation of metabolites in forensic case specimens." Forensic science international 312 (2020): 110307.

>  <FLAG_COMMENTS>  (45) 


>  <Name>  (45) 
Suvorexant

>  <ID>  (45) 
24965990

$$$$
11988953
     RDKit          3D

 30 32  0  0  1  0  0  0  0  0999 V2000
   -3.5191    0.1962    1.1693 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4710   -1.1141   -2.0765 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8957   -3.4153   -1.3774 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4373   -3.0510   -0.2889 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2847    0.2442    2.1993 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1469    2.6394   -1.8732 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8901   -2.0702   -0.2227 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1837   -1.2018   -0.8330 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.3992   -2.1079   -1.0663 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.5454    0.2226   -0.3775 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.3392   -2.2349    0.1379 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.8808   -0.8886    0.6330 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3314    1.1231   -0.2057 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8493   -1.0433    1.8072 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3523    0.7728    0.7215 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1974    2.2849   -0.9627 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7663    1.5883    0.8925 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9032    2.7521    0.1357 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0787    3.1004   -0.7918 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8044    1.1958    1.8919 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0920    3.6407    0.3009 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9013    0.3192    1.3238 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9268    3.8447   -2.6031 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5602   -0.7401    0.5024 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2186    0.5983    1.6406 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5706   -1.5476   -0.0199 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2289   -0.2093    1.1183 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9049   -1.2822    0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1572   -1.4569   -0.4551 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8412   -2.1595   -1.6084 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  1 12  1  0
  8  2  1  6
  9  3  1  1
 11  4  1  6
  5 14  1  0
  6 16  1  0
  6 23  1  0
  7 28  1  0
  7 29  1  0
  8  9  1  0
  8 10  1  0
  9 11  1  0
 10 13  1  1
 11 12  1  0
 12 14  1  1
 13 15  2  0
 13 16  1  0
 15 17  1  0
 16 19  2  0
 17 18  2  0
 17 20  1  0
 18 19  1  0
 18 21  1  0
 20 22  1  0
 22 24  2  0
 22 25  1  0
 24 26  1  0
 25 27  2  0
 26 28  2  0
 27 28  1  0
 29 30  1  0
M  END
>  <InChIKey>  (46) 
WHSOLWOTCHFFBK-ZQGJOIPISA-N

>  <PubChem_CID>  (46) 
11988953

>  <BOM_1A2>  (46) 


>  <BOM_2A6>  (46) 


>  <BOM_2B6>  (46) 


>  <BOM_2C8>  (46) 


>  <BOM_2C9>  (46) 


>  <BOM_2C19>  (46) 


>  <BOM_2D6>  (46) 
<29,7;Dealkylation;R1>
<29,H;Dealkylation;R1>
<23,6;Dealkylation;R2>
<23,H;Dealkylation;R2>

>  <BOM_2E1>  (46) 


>  <BOM_3A4>  (46) 
<29,7;Dealkylation;R1>
<29,H;Dealkylation;R1>
<23,6;Dealkylation;R2>
<23,H;Dealkylation;R2>

>  <References>  (46) 
Samukawa, Yoshishige, et al. "Pharmacokinetics and pharmacodynamics of luseogliflozin, a selective SGLT2 inhibitor, in Japanese patients with type 2 diabetes with mild to severe renal impairment." Clinical Pharmacology in Drug Development 7.8 (2018): 820-828.

>  <FLAG_COMMENTS>  (46) 


>  <Name>  (46) 
Luseogliflozin

>  <ID>  (46) 
11988953

$$$$
5578
     RDKit          3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -2.6987    2.5018    0.5331 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7534   -2.1358   -0.6625 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9726    0.3515   -0.6609 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8404   -0.9052   -0.7646 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8224    1.4185   -0.1267 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2723   -2.4149    0.1769 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3815    0.6079   -1.6816 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0829   -0.3313    1.7553 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2528   -0.1509    1.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2494   -0.1025    0.8154 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8913   -1.2361    0.5168 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8638    1.1031    1.1202 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1131    1.2718    0.5231 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1406   -1.0674   -0.0803 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7514    0.1866   -0.0773 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8016   -1.1049    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7843    1.1476    0.6914 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2945    0.3616   -0.8148 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4122    3.3649   -0.5656 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6094   -2.9217    0.1643 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0701    0.0555   -2.0521 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0
  1 19  1  0
  2 14  1  0
  2 20  1  0
  3 15  1  0
  3 21  1  0
  4 16  2  0
  4 18  1  0
  5 17  1  0
  5 18  2  0
  6 16  1  0
  7 18  1  0
  8  9  1  0
  8 10  1  0
  9 11  2  0
  9 12  1  0
 10 16  1  0
 10 17  2  0
 11 14  1  0
 12 13  2  0
 13 15  1  0
 14 15  2  0
M  END
>  <InChIKey>  (47) 
IEDVJHCEMCRBQM-UHFFFAOYSA-N

>  <PubChem_CID>  (47) 
5578

>  <BOM_1A2>  (47) 
<5,N;N-Oxidation;R1>

>  <BOM_2A6>  (47) 


>  <BOM_2B6>  (47) 


>  <BOM_2C8>  (47) 


>  <BOM_2C9>  (47) 
<20,2;Dealkylation;R3>
<20,H;Dealkylation;R3>
<19,1;Dealkylation;R3>
<19,H;Dealkylation;R3>

>  <BOM_2C19>  (47) 
<4,N;N-Oxidation;R2>

>  <BOM_2D6>  (47) 


>  <BOM_2E1>  (47) 


>  <BOM_3A4>  (47) 
<4,N;N-Oxidation;R2>
<21,3;Dealkylation;R4>
<21,H;Dealkylation;R4>
<8,H;Hydroxylation;R5>

>  <References>  (47) 
Goldman, Jennifer L., et al. "In vitro hepatic oxidative biotransformation of trimethoprim." Drug Metabolism and Disposition 43.9 (2015): 1372-1380.

>  <FLAG_COMMENTS>  (47) 


>  <Name>  (47) 
Trimethoprim

>  <ID>  (47) 
5578

$$$$
10184665
     RDKit          2D

 32 33  0  0  0  0  0  0  0  0999 V2000
    2.8295    1.2219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8295    0.3968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1149   -0.0156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4003    0.3968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4003    1.2219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1149    1.6345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6748    1.6410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0353    1.2309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7321    1.6334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4359    1.2271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1359    1.6315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8378    1.2261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5388    1.6309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2439    1.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2486    0.4110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5496    0.0021    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6748    2.4661    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8460    0.4030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1470   -0.0057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4435    0.3950    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7444   -0.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7490   -0.8236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0500   -1.2324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0546   -2.0574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7715   -2.4661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4705   -2.0571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4659   -1.2320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1912   -0.8078    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6701   -0.8221    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.5441    1.6345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2486    1.2276    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5441   -0.0156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  7 17  1  6
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 22 27  1  0
 27 28  1  0
 23 29  1  0
  1 30  1  0
 30 31  1  0
  2 32  1  0
M  END
>  <InChIKey>  (48) 
DAFYYTQWSAWIGS-DEOSSOPVSA-N

>  <PubChem_CID>  (48) 
10184665

>  <BOM_1A2>  (48) 


>  <BOM_2A6>  (48) 


>  <BOM_2B6>  (48) 


>  <BOM_2C8>  (48) 


>  <BOM_2C9>  (48) 


>  <BOM_2C19>  (48) 


>  <BOM_2D6>  (48) 


>  <BOM_2E1>  (48) 


>  <BOM_3A4>  (48) 
<21,20;Dealkylation;R1>
<21,H;Dealkylation;R1>
<8,9;Dealkylation;R2>
<8,H;Dealkylation;R2>
<18,16;Dealkylation;R3>
<18,H;Dealkylation;R3>
<19,20;Dealkylation;R4>
<19,H;Dealkylation;R4>
<30,H;Oxidation;R5>

>  <References>  (48) 
Harrell AW, Siederer SK, Bal J, Patel NH, Young GC, Felgate CC, Pearce SJ, Roberts AD, Beaumont C, Emmons AJ, Pereira AI, Kempsford RD: Metabolism and disposition of vilanterol, a long-acting beta(2)-adrenoceptor agonist for inhalation use in humans. Drug Metab Dispos. 2013 Jan;41(1):89-100. doi: 10.1124/dmd.112.048603. Epub 2012 Oct 4.

>  <FLAG_COMMENTS>  (48) 


>  <Name>  (48) 
Vilanterol

>  <ID>  (48) 
10184665

$$$$
3964
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    2.0000   -1.4271    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.8374   -2.7541    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9036    0.3375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0358    2.1394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3374   -0.5635    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9064    0.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4669    1.1637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4725    1.3132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0330    2.0647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3374   -0.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6019    3.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7139   -1.3453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9364   -2.3202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9609   -1.3453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7234   -1.0230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7384   -2.3202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1839   -3.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9544   -1.7255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1862   -2.7410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9514   -1.0230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4909   -3.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7204   -1.7256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4886   -2.7411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 18  1  0
  2 13  1  0
  2 16  1  0
  3  6  1  0
  3  7  1  0
  3 10  1  0
  4  8  1  0
  4  9  1  0
  4 11  1  0
  5 10  2  0
  5 14  1  0
  6  8  1  0
  7  9  1  0
 10 12  1  0
 12 13  2  0
 12 15  1  0
 13 17  1  0
 14 16  2  0
 14 20  1  0
 15 18  2  0
 16 21  1  0
 17 19  2  0
 18 19  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
M  END
>  <InChIKey>  (49) 
XJGVXQDUIWGIRW-UHFFFAOYSA-N

>  <PubChem_CID>  (49) 
3964

>  <BOM_1A2>  (49) 
<11,4;Dealkylation;R2>
<11,H;Dealkylation;R2>
<4,N;N-Oxidation;R3>
<22,H;Hydroxylation;R4>

>  <BOM_2A6>  (49) 


>  <BOM_2B6>  (49) 
<23,H;Hydroxylation;R1>
<4,N;N-Oxidation;R3>

>  <BOM_2C8>  (49) 


>  <BOM_2C9>  (49) 


>  <BOM_2C19>  (49) 
<23,H;Hydroxylation;R1>
<11,4;Dealkylation;R2>
<11,H;Dealkylation;R2>
<4,N;N-Oxidation;R3>

>  <BOM_2D6>  (49) 
<23,H;Hydroxylation;R1>
<4,N;N-Oxidation;R3>

>  <BOM_2E1>  (49) 


>  <BOM_3A4>  (49) 
<23,H;Hydroxylation;R1>
<11,4;Dealkylation;R2>
<11,H;Dealkylation;R2>
<4,N;N-Oxidation;R3>

>  <References>  (49) 
Luo, Jiang Ping, et al. "In vitro identification of the human cytochrome p450 enzymes involved in the oxidative metabolism of loxapine." Biopharmaceutics & Drug Disposition 32.7 (2011): 398-407.

>  <FLAG_COMMENTS>  (49) 


>  <Name>  (49) 
Loxapine

>  <ID>  (49) 
3964

$$$$
16004692
     RDKit          3D

 32 34  0  0  0  0  0  0  0  0999 V2000
   -0.0649   -5.0070   -1.1447 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -8.8883   -1.4674    0.2919 Br  0  0  0  0  0  0  0  0  0  0  0  0
    5.2020    0.8230   -0.5475 S   0  0  0  0  0  6  0  0  0  0  0  0
   -0.8684    1.4171    0.4085 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1345    0.0689   -1.3660 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4298    2.2369   -0.3136 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6264    1.2493   -0.0371 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0739    0.0449    0.9853 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6211    0.5826   -1.1958 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9011    2.7235   -0.5348 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6649    3.1339    0.2641 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4200    0.5750    1.2541 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3296    0.1149   -1.1097 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0721   -1.4339    1.0069 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3213    0.9132   -0.3931 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5679    1.4252   -0.6892 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9414   -1.9434    2.4369 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9940   -0.4850   -0.5706 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4003    1.8231    0.0851 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9502   -3.4632    2.5233 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1982   -1.3873    0.4735 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4741   -0.9308   -1.7858 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7555    2.4172    0.8942 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8828   -2.7351    0.3023 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1587   -2.2787   -1.9570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9163    3.5105   -0.0612 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1066    1.7872    1.1729 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3630   -3.1808   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8410    0.6201    0.0392 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6155   -0.0494    1.2923 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5277   -0.4954   -0.9989 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2237   -0.6090    0.1874 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 28  1  0
  2 32  1  0
  3  5  2  0
  3  6  2  0
  3  8  1  0
  3  9  1  0
  4 19  1  0
  4 23  1  0
  7 27  1  0
  7 29  1  0
  8 14  1  0
  9 16  1  0
 10 16  2  0
 10 26  1  0
 11 19  1  0
 11 26  2  0
 12 29  2  0
 12 30  1  0
 13 29  1  0
 13 31  2  0
 14 17  1  0
 15 16  1  0
 15 18  1  0
 15 19  2  0
 17 20  1  0
 18 21  2  0
 18 22  1  0
 21 24  1  0
 22 25  2  0
 23 27  1  0
 24 28  2  0
 25 28  1  0
 30 32  2  0
 31 32  1  0
M  END
>  <InChIKey>  (50) 
JGCMEBMXRHSZKX-UHFFFAOYSA-N

>  <PubChem_CID>  (50) 
16004692

>  <BOM_1A2>  (50) 


>  <BOM_2A6>  (50) 


>  <BOM_2B6>  (50) 


>  <BOM_2C8>  (50) 
<14,8;Dealkylation;R1>
<14,H;Dealkylation;R1>

>  <BOM_2C9>  (50) 
<14,8;Dealkylation;R1>
<14,H;Dealkylation;R1>
<27,7;Dealkylation;R2>
<27,H;Dealkylation;R2>

>  <BOM_2C19>  (50) 
<14,8;Dealkylation;R1>
<14,H;Dealkylation;R1>

>  <BOM_2D6>  (50) 


>  <BOM_2E1>  (50) 


>  <BOM_3A4>  (50) 
<14,8;Dealkylation;R1>
<14,H;Dealkylation;R1>

>  <References>  (50) 
Sidharta, P. N., A. Treiber, and J. Dingemanse. "Clinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentan." Clinical pharmacokinetics 54 (2015): 457-471.
"OPSUMIT (Macitentan) Tablets, for Oral Use." U.S. Food and Drug Administration, 26 May 2023, www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process. Accessed 8 Mar. 2024.

>  <FLAG_COMMENTS>  (50) 


>  <Name>  (50) 
Macitentan

>  <ID>  (50) 
16004692

$$$$
110635
     RDKit          3D

 29 34  0  0  1  0  0  0  0  0999 V2000
   -0.7505    3.2326    2.1493 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0223    1.4582   -2.6928 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1891   -1.9061    1.9257 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4332   -3.9194    0.6238 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5469    1.3952   -0.8731 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3085   -0.9817   -1.2692 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0182    3.3792    0.2087 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1512    2.2619    0.1205 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.0017    0.0674   -1.2873 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.1537    1.5441    1.0528 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3768   -0.1217   -0.7593 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9386    0.5430    0.3025 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9172    2.9669    0.9595 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2662    0.0650    0.4633 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5591    1.9613   -1.6698 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9118   -1.0199   -0.8058 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9573    3.3523   -1.2418 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4736   -0.8911   -0.5372 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3172    0.3467    1.3588 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6084   -0.8550    0.3907 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0510   -2.1908   -1.5669 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6844   -1.5770   -0.6848 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2253    3.8354    0.8778 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4347   -1.8841    0.7931 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5328   -0.3333    1.2221 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8946   -3.2178   -1.1369 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7116   -1.2793    0.2151 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5740   -3.0337    0.0498 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8194   -3.1983    1.8114 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  2  0
  2 15  2  0
  3 24  1  0
  3 29  1  0
  4 28  1  0
  4 29  1  0
  5  8  1  0
  5  9  1  0
  5 15  1  0
  6 11  1  0
  6 18  1  0
  7 13  1  0
  7 17  1  0
  7 23  1  0
  8 10  1  1
  8 13  1  0
  9 11  1  0
  9 16  1  1
 10 12  1  0
 11 12  2  0
 12 14  1  0
 14 18  2  0
 14 19  1  0
 15 17  1  0
 16 20  1  0
 16 21  2  0
 18 22  1  0
 19 25  2  0
 20 24  2  0
 21 26  1  0
 22 27  2  0
 24 28  1  0
 25 27  1  0
 26 28  2  0
M  END
>  <InChIKey>  (51) 
WOXKDUGGOYFFRN-IIBYNOLFSA-N

>  <PubChem_CID>  (51) 
110635

>  <BOM_1A2>  (51) 


>  <BOM_2A6>  (51) 


>  <BOM_2B6>  (51) 


>  <BOM_2C8>  (51) 


>  <BOM_2C9>  (51) 


>  <BOM_2C19>  (51) 


>  <BOM_2D6>  (51) 


>  <BOM_2E1>  (51) 


>  <BOM_3A4>  (51) 
<29,4;Dealkylation;R1>
<29,3;Dealkylation;R1>
<29,H;Dealkylation;R1>

>  <References>  (51) 
Dalvie, Deepak, et al. "Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites." Chemical research in toxicology 22.2 (2009): 357-368.
"CIALIS (Tadalafil) Tablets, for Oral Use." U.S. Food and Drug Administration, 15 Feb. 2018, www.accessdata.fda.gov/drugsatfda_docs/label/2018/021368s030lbl.pdf. Accessed 8 Mar. 2024.
Forgue, S. Thomas, et al. "Tadalafil pharmacokinetics in healthy subjects." British journal of clinical pharmacology 61.3 (2006): 280-288.

>  <FLAG_COMMENTS>  (51) 


>  <Name>  (51) 
Tadalafil

>  <ID>  (51) 
110635

$$$$
44623998
     RDKit          3D

 33 37  0  0  1  0  0  0  0  0999 V2000
   -4.2440   -3.0258   -1.2614 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9330   -2.5027    0.0041 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8860   -1.8467   -2.0625 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3639   -0.3281    1.0488 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4697   -1.1296   -1.7811 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3131    1.0511   -1.1478 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0994   -0.5047    1.6854 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6064    0.4092   -0.2243 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7801    0.6328    0.0421 C   0  0  1  0  0  0  0  0  0  0  0  0
   -7.2168    0.7060    1.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2137    1.4548   -1.1824 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2810    1.6902   -1.0146 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4797    0.2073    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3799    0.6158   -0.0967 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7602    1.4020   -1.2865 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4560    1.5374    0.8616 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0154    2.4071   -0.3025 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0943    0.3875   -0.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2385    0.1367    0.5673 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5251   -0.5182   -0.6177 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7123   -0.5690    1.6904 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3866   -0.7627   -0.5465 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8507    0.2185    0.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4075    1.5401    0.1845 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8479   -1.1929    2.5974 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9817   -0.4032    1.2527 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8462   -0.0772   -1.1915 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9920   -0.7602   -0.5142 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3053    0.3923   -0.1323 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0129    1.5425    0.2172 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4739   -1.0966    2.3572 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1004   -2.0085   -0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8051    0.3951   -0.0984 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 32  1  0
  2 32  1  0
  3 32  1  0
  4 26  1  0
  4 33  1  0
  5 27  1  0
  6 27  2  0
  7 13  1  0
  7 21  1  0
  8 10  1  0
  8 11  1  0
  8 18  1  0
  9 12  1  0
  9 13  1  0
  9 20  1  6
 10 16  1  0
 11 17  1  0
 12 15  1  0
 13 14  2  0
 14 15  1  0
 14 19  1  0
 16 17  1  0
 18 22  2  0
 18 24  1  0
 19 21  2  0
 19 23  1  0
 20 27  1  0
 21 25  1  0
 22 28  1  0
 22 32  1  0
 23 26  2  0
 24 30  2  0
 25 31  2  0
 26 31  1  0
 28 29  2  0
 29 30  1  0
 29 33  1  0
M  END
>  <InChIKey>  (52) 
MVGWUTBTXDYMND-QGZVFWFLSA-N

>  <PubChem_CID>  (52) 
44623998

>  <BOM_1A2>  (52) 


>  <BOM_2A6>  (52) 


>  <BOM_2B6>  (52) 


>  <BOM_2C8>  (52) 
<17,H;Hydroxylation;R1>
<16,H;Hydroxylation;R1>

>  <BOM_2C9>  (52) 
<17,H;Hydroxylation;R1>
<16,H;Hydroxylation;R1>

>  <BOM_2C19>  (52) 
<17,H;Hydroxylation;R1>
<16,H;Hydroxylation;R1>

>  <BOM_2D6>  (52) 


>  <BOM_2E1>  (52) 


>  <BOM_3A4>  (52) 
<17,H;Hydroxylation;R1>
<16,H;Hydroxylation;R1>

>  <References>  (52) 
Lee, Caroline A., et al. "Disposition and mass balance of etrasimod in healthy subjects and in vitro determination of the enzymes responsible for Its oxidative metabolism." Clinical Pharmacology in Drug Development 12.6 (2023): 553-571.

>  <FLAG_COMMENTS>  (52) 


>  <Name>  (52) 
Etrasimod

>  <ID>  (52) 
44623998

$$$$
59634912
     RDKit          3D

 28 31  0  0  0  0  0  0  0  0999 V2000
    2.7529   -1.7378    1.2167 S   0  0  0  0  0  6  0  0  0  0  0  0
   -4.2484   -1.8618   -1.4666 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1772   -1.9478    1.0357 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1164   -2.1450    2.4546 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9737    0.2422   -0.4852 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1746    2.3520    1.0319 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9118   -2.4089   -0.1286 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8650    0.0488   -0.9074 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1335    1.2515    0.1713 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3430    0.6728   -0.7639 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8431    1.8548    1.3827 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9974    1.2765    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5450   -1.0157   -0.9164 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1355   -1.3759   -0.7126 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5414   -2.0596   -0.3266 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4581   -0.0056    1.0028 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1918   -1.0826   -1.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7406   -2.0112    0.4648 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1467   -1.4244   -1.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4022   -2.3530    0.6579 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0549    0.6909   -0.0446 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7830    2.0698   -0.1645 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6125    0.6285    1.9162 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9322    2.7079    0.7539 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3490    1.9868    1.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3837    2.7716   -1.2184 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2189    2.1127   -2.1091 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4249    0.7625   -1.9109 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  2  0
  1  4  2  0
  1  7  1  0
  1 16  1  0
  2 13  2  0
  5  9  1  0
  5 10  1  0
  5 13  1  0
  6 11  1  0
  6 12  1  0
  7 15  1  0
  8 21  2  0
  8 28  1  0
  9 11  1  0
 10 12  1  0
 13 14  1  0
 14 17  2  0
 14 18  1  0
 15 19  2  0
 15 20  1  0
 16 21  1  0
 16 23  2  0
 17 19  1  0
 18 20  2  0
 21 22  1  0
 22 24  1  0
 22 26  2  0
 23 25  1  0
 24 25  2  0
 26 27  1  0
 27 28  2  0
M  END
>  <InChIKey>  (53) 
RVGADWBBGNTVBK-UHFFFAOYSA-N

>  <PubChem_CID>  (53) 
59634912

>  <BOM_1A2>  (53) 


>  <BOM_2A6>  (53) 


>  <BOM_2B6>  (53) 


>  <BOM_2C8>  (53) 


>  <BOM_2C9>  (53) 


>  <BOM_2C19>  (53) 


>  <BOM_2D6>  (53) 


>  <BOM_2E1>  (53) 


>  <BOM_3A4>  (53) 
<11,6;Dealkylation;R1>
<11,H;Dealkylation;R1>
<9,5;Dealkylation;R1>
<9,H;Dealkylation;R1>
<12,6;Dealkylation;R2>
<12,H;Dealkylation;R2>
<10,5;Dealkylation;R2>
<10,H;Dealkylation;R2>
<11,H;Oxidation;R2>
<12,H;Oxidation;R2>
<10,H;Oxidation;R3>
<9,H;Oxidation;R3>

>  <References>  (53) 
Prakash, Chandra, et al. "An innovative phase I study in healthy subjects to determine the mass balance, elimination, metabolism, and absolute bioavailability of mitapivat." Clinical and Translational Science 16.10 (2023): 2021-2032.

>  <FLAG_COMMENTS>  (53) 


>  <Name>  (53) 
M396

>  <ID>  (53) 
59634912

$$$$
60835
     RDKit          3D

 21 23  0  0  1  0  0  0  0  0999 V2000
   -1.5366   -1.8702    1.6645 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1372    0.3493   -0.8990 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6900    1.9586   -0.4704 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2748    0.2805   -0.0442 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.3929    1.1277   -0.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6658    1.1498    0.1816 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6367   -1.1784    0.1187 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9939    0.9109   -0.3784 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1925    0.1853   -0.2824 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3379    0.8106    0.2652 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0462   -2.0393   -0.8478 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9254    2.2338    0.0597 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2796   -1.1470   -0.7181 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2509    2.1430    0.7008 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0518    2.8488    0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5366    0.0852    0.3611 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2935   -3.3338   -0.3065 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0558   -3.3816    1.0495 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9228    1.9570    0.3039 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4787   -1.8527   -0.6150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6051   -1.2377   -0.0764 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0
  1 18  1  0
  2  4  1  0
  2  8  1  0
  3  6  1  0
  3 19  1  0
  4  5  1  6
  4  7  1  0
  5  6  1  0
  7 11  2  0
  8  9  1  0
  8 12  2  0
  9 10  2  0
  9 13  1  0
 10 14  1  0
 10 16  1  0
 11 17  1  0
 12 15  1  0
 13 20  2  0
 14 15  2  0
 16 21  2  0
 17 18  2  0
 20 21  1  0
M  END
>  <InChIKey>  (54) 
ZEUITGRIYCTCEM-KRWDZBQOSA-N

>  <PubChem_CID>  (54) 
60835

>  <BOM_1A2>  (54) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<21,H;Hydroxylation;R3>

>  <BOM_2A6>  (54) 


>  <BOM_2B6>  (54) 


>  <BOM_2C8>  (54) 


>  <BOM_2C9>  (54) 
<16,H;Hydroxylation;R2>
<21,H;Hydroxylation;R3>

>  <BOM_2C19>  (54) 


>  <BOM_2D6>  (54) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<21,H;Hydroxylation;R3>

>  <BOM_2E1>  (54) 


>  <BOM_3A4>  (54) 


>  <References>  (54) 
Knadler MP, Lobo E, Chappell J, Bergstrom R: Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2011 May;50(5):281-94. doi: 10.2165/11539240-000000000-00000.
Vey, Eric L., and Inna Kovelman. "Adverse events, toxicity and post-mortem data on duloxetine: case reports and literature survey." Journal of forensic and legal medicine 17.4 (2010): 175-185.

>  <FLAG_COMMENTS>  (54) 


>  <Name>  (54) 
Duloxetine

>  <ID>  (54) 
60835

$$$$
3702
     RDKit          3D

 24 26  0  0  1  0  0  0  0  0999 V2000
    5.8085   -0.5802   -0.0632 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7693    1.8229    0.6627 S   0  0  0  0  0  6  0  0  0  0  0  0
   -0.4949   -2.2165   -1.3957 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6958    2.4401    1.4249 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0836    1.6535    1.2612 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2513   -0.7668    0.1711 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8943   -0.6089    0.2300 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9406    2.6466   -0.8230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9572   -1.4353    1.2699 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.4318   -0.9560    1.1909 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2971    0.2985    0.3881 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0203    0.3568   -0.1833 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8415   -2.9474    1.1455 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2416    1.2854    0.1651 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6657    1.4262   -0.9923 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8858    2.3642   -0.6450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6073    2.4344   -1.2191 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0840   -1.3803   -0.5947 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3807   -1.1677   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8382    0.0581   -0.0219 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2128    0.2567    0.1063 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2350   -2.2040   -0.7719 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0986   -0.7750   -0.2044 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6097   -2.0054   -0.6435 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 23  1  0
  2  4  2  0
  2  5  2  0
  2  8  1  0
  2 21  1  0
  3 18  2  0
  6  7  1  0
  6  9  1  0
  6 12  1  0
  7 18  1  0
  9 10  1  0
  9 13  1  6
 10 11  1  0
 11 12  2  0
 11 14  1  0
 12 15  1  0
 14 16  2  0
 15 17  2  0
 16 17  1  0
 18 19  1  0
 19 20  2  0
 19 22  1  0
 20 21  1  0
 21 23  2  0
 22 24  2  0
 23 24  1  0
M  END
>  <InChIKey>  (55) 
NDDAHWYSQHTHNT-UHFFFAOYSA-N

>  <PubChem_CID>  (55) 
3702

>  <BOM_1A2>  (55) 


>  <BOM_2A6>  (55) 


>  <BOM_2B6>  (55) 


>  <BOM_2C8>  (55) 
<10,9;Dehydrogenation;R1>

>  <BOM_2C9>  (55) 


>  <BOM_2C19>  (55) 
<10,9;Dehydrogenation;R1>

>  <BOM_2D6>  (55) 


>  <BOM_2E1>  (55) 


>  <BOM_3A4>  (55) 
<10,9;Dehydrogenation;R1>
<16,H;Hydroxylation;R2>
<14,16;Epoxidation;R3>

>  <References>  (55) 
Zisaki, Aikaterini, Ljubisa Miskovic, and Vassily Hatzimanikatis. "Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches." Current pharmaceutical design 21.6 (2015): 806-822.
Caruso, Frank S., Romana R. Szabadi, and Robert A. Vukovich. "Pharmacokinetics and clinical pharmacology of indapamide." American heart journal 106.1 (1983): 212-220.
Sun, Hao, et al. "Dehydrogenation of the Indoline-Containing Drug, Indapamide, by CYP3A4: Correlation with in silico Predictions." Drug metabolism and disposition: the biological fate of chemicals 37.3 (2009): 672.

>  <FLAG_COMMENTS>  (55) 


>  <Name>  (55) 
Indapamide

>  <ID>  (55) 
3702

$$$$
5329102
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
    7.3421   -1.9332    2.0237 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1676    1.7851   -0.8482 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1660    1.2214   -1.8222 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8561   -0.7407   -0.0641 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750    1.7829    0.9513 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1485   -0.4445   -0.2615 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4453    0.6024   -1.8711 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5025   -0.4874    0.4124 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1875    0.9254    0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1856   -0.0763    0.0942 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9279    0.4914    0.6216 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4965   -0.7178   -0.7057 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6279    2.0648    0.6329 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8331   -0.4842    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9840   -2.1164   -0.5491 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5446    0.8201   -0.3592 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2742    0.0935    0.0284 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2519    0.0047    0.8814 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6466   -0.3695    0.2033 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3372   -1.4640   -0.3924 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3142   -0.0357   -0.9788 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1962    3.4047    0.8793 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1617    0.7243   -1.3294 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7189    0.9391    1.5152 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3720   -2.3738   -1.1106 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3108   -1.0109    1.2317 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6499   -0.3230   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6648   -1.3116    1.0487 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3278   -0.9709   -0.1455 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 28  1  0
  2 16  2  0
  3 23  2  0
  4  8  1  0
  4 14  1  0
  4 15  1  0
  5 11  1  0
  5 13  1  0
  6 12  1  0
  6 16  1  0
  7 21  1  0
  7 23  1  0
  8 12  1  0
  9 10  1  0
  9 13  2  0
  9 16  1  0
 10 11  2  0
 10 20  1  0
 11 18  1  0
 13 22  1  0
 14 24  1  0
 15 25  1  0
 17 18  2  0
 17 19  1  0
 17 23  1  0
 19 21  2  0
 19 26  1  0
 21 27  1  0
 26 28  2  0
 27 29  2  0
 28 29  1  0
M  END
>  <InChIKey>  (56) 
WINHZLLDWRZWRT-ATVHPVEESA-N

>  <PubChem_CID>  (56) 
5329102

>  <BOM_1A2>  (56) 
<14,4;Dealkylation;R1>
<14,H;Dealkylation;R1>
<15,4;Dealkylation;R1>
<15,H;Dealkylation;R1>
<28,1;Dehalogenation;R2>

>  <BOM_2A6>  (56) 


>  <BOM_2B6>  (56) 


>  <BOM_2C8>  (56) 


>  <BOM_2C9>  (56) 


>  <BOM_2C19>  (56) 


>  <BOM_2D6>  (56) 


>  <BOM_2E1>  (56) 


>  <BOM_3A4>  (56) 
<14,4;Dealkylation;R1>
<14,H;Dealkylation;R1>
<15,4;Dealkylation;R1>
<15,H;Dealkylation;R1>
<28,1;Dehalogenation;R2>

>  <References>  (56) 
Amaya, Gracia M., et al. "Cytochromes P450 1A2 and 3A4 catalyze the metabolic activation of sunitinib." Chemical research in toxicology 31.7 (2018): 570-584.

>  <FLAG_COMMENTS>  (56) 


>  <Name>  (56) 
Sunitinib

>  <ID>  (56) 
5329102

$$$$
46220502
     RDKit          3D

 37 41  0  0  0  0  0  0  0  0999 V2000
    5.8656    0.8872    2.4062 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.2571   -2.4484   -1.1817 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2163   -0.3322    0.7640 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8798    1.7361   -0.3823 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9741    3.0976   -0.3553 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5538    3.2786    1.1976 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8391   -1.7310    0.5915 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0280   -3.6948   -0.4417 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7695   -2.1493   -0.2138 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1499   -4.3095   -1.2116 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5304   -0.0084    1.3325 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6291    0.8511    0.1234 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4675    0.5527    0.2575 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5665    1.4110   -0.9521 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3227   -0.8634    1.7914 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7735    2.2691   -1.4086 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1788   -1.6383    1.1934 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1113    2.6754   -0.8144 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9744    3.4918   -1.3221 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3321    1.8105   -0.0455 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3645   -2.9245    0.6986 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9081   -1.0914    1.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7310    3.9377    0.4129 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3194    1.9503    0.9259 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5844    2.9809   -0.9353 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    3.0381   -2.7355 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8906    0.5739   -0.5173 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4917   -0.5618    0.0354 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2890   -3.6146    0.1504 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9125    0.7987    1.4702 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0581   -2.9793    0.1207 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6026    5.4073    0.3328 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4849   -0.4537    1.0116 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0745   -1.8694   -0.4115 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3804   -3.3691   -0.6313 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9669   -2.7457   -0.9945 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4433   -3.9633   -1.3788 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 30  1  0
  2 36  1  0
  3 11  1  0
  3 12  1  0
  3 15  1  0
  4 13  1  0
  4 14  1  0
  4 16  1  0
  5 19  1  0
  5 20  1  0
  5 23  1  0
  6 23  2  0
  6 24  1  0
  7 22  2  0
  7 31  1  0
  8 31  1  0
  8 35  1  0
  9 34  2  0
  9 35  1  0
 10 35  2  0
 10 37  1  0
 11 13  1  0
 12 14  1  0
 15 17  1  0
 16 18  1  0
 17 21  2  0
 17 22  1  0
 19 25  1  0
 19 26  1  0
 20 24  2  0
 20 27  1  0
 21 29  1  0
 23 32  1  0
 24 30  1  0
 27 28  2  0
 28 33  1  0
 28 34  1  0
 29 31  2  0
 30 33  2  0
 34 36  1  0
 36 37  2  0
M  END
>  <InChIKey>  (57) 
UZWDCWONPYILKI-UHFFFAOYSA-N 

>  <PubChem_CID>  (57) 
46220502

>  <BOM_1A2>  (57) 


>  <BOM_2A6>  (57) 


>  <BOM_2B6>  (57) 


>  <BOM_2C8>  (57) 


>  <BOM_2C9>  (57) 


>  <BOM_2C19>  (57) 


>  <BOM_2D6>  (57) 


>  <BOM_2E1>  (57) 


>  <BOM_3A4>  (57) 
<16,4;Dealkylation;R1>
<16,H;Dealkylation;R1>
<32,H;Hydroxylation;R2>

>  <References>  (57) 
Martínez-Chávez, Alejandra, et al. "Simultaneous quantification of abemaciclib and its active metabolites in human and mouse plasma by UHPLC–MS/MS." Journal of Pharmaceutical and Biomedical Analysis 203 (2021): 114225.

>  <FLAG_COMMENTS>  (57) 


>  <Name>  (57) 
Abemaciclib

>  <ID>  (57) 
46220502

$$$$
37542
     RDKit          3D

 17 18  0  0  1  0  0  0  0  0999 V2000
    1.3923   -0.5531   -1.0023 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8880    2.3434    1.0678 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8653    1.0931   -0.3151 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8679   -3.2215   -0.2838 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4406   -1.8540    0.5635 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4685    0.7913   -0.4022 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1659   -0.3029   -0.0614 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5350    1.5008   -0.3852 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8037   -0.0596    0.2197 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0429    0.2641    0.5061 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.7292    0.9690    0.7805 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5982   -0.9473   -0.3074 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.9865    0.7451   -0.5279 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.2793   -2.1586    0.5578 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2891    1.8588   -0.5931 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4105    0.1792   -0.0652 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5364   -0.6477    0.2482 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  1 13  1  0
 11  2  1  6
 10  3  1  6
  4 14  1  0
  5 17  2  0
  6  7  1  0
 13  6  1  1
  6 15  1  0
  7 16  2  0
  8 15  2  0
  8 16  1  0
  9 17  1  0
 10 11  1  0
 10 12  1  0
 11 13  1  0
 12 14  1  1
 16 17  1  0
M  END
>  <InChIKey>  (58) 
IWUCXVSUMQZMFG-AFCXAGJDSA-N

>  <PubChem_CID>  (58) 
37542

>  <BOM_1A2>  (58) 


>  <BOM_2A6>  (58) 


>  <BOM_2B6>  (58) 


>  <BOM_2C8>  (58) 


>  <BOM_2C9>  (58) 


>  <BOM_2C19>  (58) 


>  <BOM_2D6>  (58) 


>  <BOM_2E1>  (58) 


>  <BOM_3A4>  (58) 


>  <References>  (58) 
"REBETOL (Ribavirin USP) Capsules, for Oral Use: Prescribing Information." U.S. Food and Drug Administration, 16 Mar. 2022, www.accessdata.fda.gov/drugsatfda_docs/label/2022/020903s057,021546s013lbl.pdf. Accessed 9 Feb. 2024.

>  <FLAG_COMMENTS>  (58) 
Results of in vitro studies using both human and rat liver microsome preparations indicated little or no cytochrome P-450 enzyme-mediated metabolism of ribavirin.

>  <Name>  (58) 
Ribavirin

>  <ID>  (58) 
37542

$$$$
24757213
     RDKit          3D

 28 30  0  0  0  0  0  0  0  0999 V2000
   -5.0836    0.5448    0.1909 S   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2666    0.1643    0.9401 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2245    1.2427   -1.0726 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6477    3.2452   -1.1103 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7732   -2.2832    0.6642 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0176    1.4131    1.2290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1684   -0.9398   -0.1109 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6691    1.6238    0.8098 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3254   -2.0397    0.7322 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2899   -1.0095   -1.1922 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7254   -3.2792   -0.5869 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6149    1.1287    1.5773 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4059    2.3251   -0.3669 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0343    2.0365   -0.0083 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6039   -3.2096    0.4943 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5684   -2.1793   -1.4301 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2974    1.3350    1.1682 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0885    2.5315   -0.7758 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9538   -4.5300   -0.8413 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3663    2.2558   -0.4433 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3760    1.2273   -0.0672 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7286    0.4120   -0.1701 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6629    1.3574   -0.4617 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5912   -0.4911    0.8839 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8894    0.4097   -0.9438 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6144   -1.3967    1.1643 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9127   -0.4958   -0.6633 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7751   -1.3990    0.3906 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  2  0
  1  6  1  0
  1  7  1  0
  4 20  2  0
  5 28  1  0
  6  8  1  0
  7  9  2  0
  7 10  1  0
  8 12  2  0
  8 13  1  0
  9 15  1  0
 10 16  2  0
 11 15  2  0
 11 16  1  0
 11 19  1  0
 12 17  1  0
 13 18  2  0
 14 17  2  0
 14 18  1  0
 14 20  1  0
 20 21  1  0
 21 23  2  0
 22 23  1  0
 22 24  2  0
 22 25  1  0
 24 26  1  0
 25 27  2  0
 26 28  2  0
 27 28  1  0
M  END
>  <InChIKey>  (59) 
KDODYFOOJCIHGK-GIDUJCDVSA-N

>  <PubChem_CID>  (59) 
24757213

>  <BOM_1A2>  (59) 
<19,H;Hydroxylation;R1>
<26,H;Hydroxylation;R2>
<27,H;Hydroxylation;R2>

>  <BOM_2A6>  (59) 


>  <BOM_2B6>  (59) 


>  <BOM_2C8>  (59) 
<19,H;Hydroxylation;R1>

>  <BOM_2C9>  (59) 
<19,H;Hydroxylation;R1>

>  <BOM_2C19>  (59) 
<19,H;Hydroxylation;R1>

>  <BOM_2D6>  (59) 
<19,H;Hydroxylation;R1>
<26,H;Hydroxylation;R2>
<27,H;Hydroxylation;R2>

>  <BOM_2E1>  (59) 


>  <BOM_3A4>  (59) 
<19,H;Hydroxylation;R1>
<26,H;Hydroxylation;R2>
<27,H;Hydroxylation;R2>

>  <References>  (59) 
Lee, Boram, et al. "In vitro characterization of 4′-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s." Xenobiotica 46.4 (2016): 350-356.

>  <FLAG_COMMENTS>  (59) 


>  <Name>  (59) 
TSAHC

>  <ID>  (59) 
24757213

$$$$
11949652 
     RDKit          3D

 30 34  0  0  1  0  0  0  0  0999 V2000
    7.6733   -0.6990    2.1617 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.9253   -0.1324   -1.8936 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5679   -0.0510   -0.5223 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5092    1.9970   -1.1315 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1004   -1.0462   -0.3127 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0604   -0.2345    0.1246 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4128   -0.5928    0.1606 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6159   -1.1803    0.2775 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6366    0.9111   -0.3102 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.8284    0.3409    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0313    1.1118   -0.0862 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.2612    1.4010   -1.6054 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5174    0.5485   -1.3099 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0506   -0.5391    0.7629 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6349   -0.4647   -1.5747 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0405   -1.5885    0.5445 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0378    0.1965   -0.7112 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4049   -1.4577   -0.1505 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1008   -1.1336   -0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2852    0.2419    1.4835 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6579   -1.9083    0.8196 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9894   -2.6974   -0.2429 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3509   -2.4658    0.0298 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2994    0.7849    0.3586 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4398   -3.4566    0.0648 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1144    1.3086    0.8568 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3728    1.6104    0.0537 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0005    2.6849    1.0539 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2590    2.9866    0.2506 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0728    3.5238    0.7508 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 20  1  0
  1 21  1  0
  2 17  2  0
  9  3  1  6
  3 13  1  0
  3 14  1  0
  4 11  1  0
  4 12  1  0
  5 15  1  0
  5 16  1  0
  5 18  1  0
  6 17  1  0
  6 19  1  0
  6 20  1  0
  7  8  1  0
  7 18  1  0
  7 24  1  0
  8 23  2  0
  9 10  1  0
  9 12  1  0
 10 11  1  0
 11 17  1  6
 13 15  1  0
 14 16  1  0
 18 22  2  0
 19 21  1  0
 22 23  1  0
 23 25  1  0
 24 26  2  0
 24 27  1  0
 26 28  1  0
 27 29  2  0
 28 30  2  0
 29 30  1  0
M  END
>  <InChIKey>  (60) 
WGRQANOPCQRCME-PMACEKPBSA-N

>  <PubChem_CID>  (60) 
11949652 

>  <BOM_1A2>  (60) 


>  <BOM_2A6>  (60) 


>  <BOM_2B6>  (60) 


>  <BOM_2C8>  (60) 


>  <BOM_2C9>  (60) 


>  <BOM_2C19>  (60) 


>  <BOM_2D6>  (60) 
<1,S;S-Oxidation;R1>
<25,H;Hydroxylation;R3>

>  <BOM_2E1>  (60) 


>  <BOM_3A4>  (60) 
<1,S;S-Oxidation;R1>
<17,6;Hydrolysis;R2>

>  <References>  (60) 
Nakamaru, Yoshinobu, et al. "Metabolism and disposition of the dipeptidyl peptidase IV inhibitor teneligliptin in humans." Xenobiotica 44.3 (2014): 242-253.

>  <FLAG_COMMENTS>  (60) 


>  <Name>  (60) 
Teneligliptin

>  <ID>  (60) 
11949652 

$$$$
969470
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -0.6615   -2.0388   -0.5183 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8327   -1.2722    0.6713 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6692    0.6815   -0.5062 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0369    0.2143    0.0232 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0938   -2.7536   -0.1224 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7709   -0.4614    0.2621 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5055    2.7920   -1.6976 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9616    2.3582   -1.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5268    1.8691   -1.0814 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2774    0.6865   -0.3465 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4011    2.2459   -0.2225 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9186    1.1953    0.5689 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3531   -1.1595    0.0049 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6875   -1.5681    0.5958 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3912   -0.0653    0.0945 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8674    2.2489   -1.3302 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2804    3.1861    0.3328 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3221    1.1011    1.9102 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7040    0.3257   -0.1723 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9436    1.4873   -0.8854 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0525   -3.5441    0.6609 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6814   -2.4086   -1.4237 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6778    3.0818    1.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1972    2.0409    2.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3032   -2.7395    0.9718 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1094   -3.6545   -2.1804 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1358   -0.2517    0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2597   -1.2000    0.5701 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8650   -2.3973    1.2714 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  2  0
  2 27  1  0
  2 28  1  0
  3 27  2  0
  4 10  1  0
  4 12  1  0
  4 13  1  0
  5 14  1  0
  5 21  1  0
  5 22  1  0
  6 19  1  0
  6 27  1  0
  7  8  1  0
  7  9  1  0
  8 11  1  0
  9 10  2  0
  9 16  1  0
 10 15  1  0
 11 12  2  0
 11 17  1  0
 12 18  1  0
 13 14  1  0
 15 19  2  0
 16 20  2  0
 17 23  2  0
 18 24  2  0
 19 20  1  0
 21 25  1  0
 22 26  1  0
 23 24  1  0
 28 29  1  0
M  END
>  <InChIKey>  (61) 
AYQBYSPEGRYKFA-UHFFFAOYSA-N

>  <PubChem_CID>  (61) 
969470

>  <BOM_1A2>  (61) 


>  <BOM_2A6>  (61) 


>  <BOM_2B6>  (61) 


>  <BOM_2C8>  (61) 


>  <BOM_2C9>  (61) 


>  <BOM_2C19>  (61) 


>  <BOM_2D6>  (61) 


>  <BOM_2E1>  (61) 


>  <BOM_3A4>  (61) 
<21,5;Dealkylation;R1>
<21,H;Dealkylation;R1>
<22,5;Dealkylation;R1>
<22,H;Dealkylation;R1>

>  <References>  (61) 
Cherian, Milu T., et al. "Identification and characterization of CINPA1 metabolites facilitates structure-activity studies of the constitutive androstane receptor." Drug Metabolism and Disposition 44.11 (2016): 1759-1770.

>  <FLAG_COMMENTS>  (61) 


>  <Name>  (61) 
Cinpa1

>  <ID>  (61) 
969470

$$$$
3965
     RDKit          3D

 18 19  0  0  1  0  0  0  0  0999 V2000
    4.8111    1.1902    0.9558 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4161   -1.2669    0.3225 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3575   -1.5844    1.2154 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8055   -0.0449    0.3686 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.7477   -1.1942   -0.6395 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0150   -1.9933   -0.3648 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0904   -0.9362   -0.1472 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0334    1.1783   -0.0834 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2987    0.1962    0.4566 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5541    0.9053   -0.1924 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0331    0.4485   -1.3933 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2599    1.1154    0.9102 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1655    0.4028   -0.3928 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3350    0.1958   -1.4942 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6280    0.8626    0.8094 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6282    0.1327   -0.5006 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.5077    1.3783   -0.2691 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0911   -0.9864    0.4389 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  2  0
  2 18  1  0
  3 18  2  0
  4  5  1  0
  4  8  1  6
  4  9  1  0
  5  6  1  0
  6  7  1  0
  7  9  1  0
  8 10  1  0
 10 11  2  0
 10 12  1  0
 11 14  1  0
 12 15  2  0
 13 14  2  0
 13 15  1  0
 13 16  1  0
 16 17  1  1
 16 18  1  0
M  END
>  <InChIKey>  (62) 
YMBXTVYHTMGZDW-UHFFFAOYSA-N

>  <PubChem_CID>  (62) 
3965

>  <BOM_1A2>  (62) 


>  <BOM_2A6>  (62) 


>  <BOM_2B6>  (62) 


>  <BOM_2C8>  (62) 


>  <BOM_2C9>  (62) 


>  <BOM_2C19>  (62) 


>  <BOM_2D6>  (62) 


>  <BOM_2E1>  (62) 


>  <BOM_3A4>  (62) 
<6,H;Hydroxylation;R1>
<7,H;Hydroxylation;R2>

>  <References>  (62) 
Shrestha, Riya, et al. "Exploring the metabolism of loxoprofen in liver microsomes: The role of cytochrome P450 and UDP-glucuronosyltransferase in its biotransformation." Pharmaceutics 10.3 (2018): 112.

>  <FLAG_COMMENTS>  (62) 


>  <Name>  (62) 
Loxoprofen

>  <ID>  (62) 
3965

$$$$
118861389
     RDKit          3D

 41 44  0  0  0  0  0  0  0  0999 V2000
    6.4651   -3.0891    0.7184 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.0518   -4.1796   -0.5421 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.5748   -3.7910    1.5503 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.1150   -2.2079   -0.1918 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9791    1.3620   -2.0227 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9396    2.3746   -1.1319 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9489   -0.2277    0.5851 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3407    3.8254    1.9835 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0172    0.0540   -0.6569 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3801   -2.5380   -0.7297 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8044   -1.9194   -0.1378 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1980    2.1969   -1.7048 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2026   -4.2383   -0.3987 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0058    3.2551    0.0128 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7753    0.0183    1.0236 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0185    0.6508    1.0931 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9926   -1.2687    0.4567 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2430    2.9281    0.8391 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2798    1.1235   -1.0312 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3384   -1.3904    0.1979 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9259    1.0692   -1.3201 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0571   -2.3174    0.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6368    0.7079    1.4857 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1807    1.9436    1.6037 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5428    2.7792   -2.3817 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0123   -1.2851   -0.8359 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2874   -0.1618   -1.2181 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3690    0.0253    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3625   -1.1255   -0.5688 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7839    2.0017    1.9990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0372    2.6081    2.0561 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4365    3.3981    3.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7179    3.8842    2.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9408   -2.9174   -0.4061 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4530   -3.6387    0.2088 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4737   -4.5651   -0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4933   -1.9693    0.0661 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1641    2.2770   -2.0227 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1548   -3.2680    0.4479 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5626    3.6679   -2.3863 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8259    3.9475   -2.7218 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 39  1  0
  2 39  1  0
  3 39  1  0
  4 29  1  0
  4 37  1  0
  5 38  2  0
  6 14  1  0
  6 19  1  0
  6 25  1  0
  7 16  1  0
  7 20  1  0
  7 28  1  0
  8 18  1  0
  8 32  1  0
  8 33  1  0
  9 19  2  0
  9 29  1  0
 10 26  1  0
 10 34  1  0
 11 22  2  0
 11 34  1  0
 12 21  1  0
 12 38  1  0
 13 34  2  0
 13 36  1  0
 14 18  1  0
 15 16  2  0
 15 17  1  0
 15 23  1  0
 16 24  1  0
 17 20  2  0
 17 22  1  0
 19 21  1  0
 21 27  2  0
 22 35  1  0
 23 30  2  0
 24 31  2  0
 26 27  1  0
 26 29  2  0
 30 31  1  0
 35 36  2  0
 37 39  1  0
 38 40  1  0
 40 41  2  0
M  END
>  <InChIKey>  (63) 
GHKOONMJXNWOIW-UHFFFAOYSA-N

>  <PubChem_CID>  (63) 
118861389

>  <BOM_1A2>  (63) 
<37,4;Dealkylation;R2>
<37,H;Dealkylation;R2>
<25,6;Dealkylation;R3>
<25,H;Dealkylation;R3>

>  <BOM_2A6>  (63) 
<37,4;Dealkylation;R2>
<37,H;Dealkylation;R2>
<25,6;Dealkylation;R3>
<25,H;Dealkylation;R3>

>  <BOM_2B6>  (63) 
<37,4;Dealkylation;R2>
<37,H;Dealkylation;R2>
<25,6;Dealkylation;R3>
<25,H;Dealkylation;R3>
<26,10;Dealkylation;R5>

>  <BOM_2C8>  (63) 
<32,8;Dealkylation;R1>
<32,H;Dealkylation;R1>
<33,8;Dealkylation;R1>
<33,H;Dealkylation;R1>
<37,4;Dealkylation;R2>
<37,H;Dealkylation;R2>
<25,6;Dealkylation;R3>
<25,H;Dealkylation;R3>
<26,10;Dealkylation;R5>

>  <BOM_2C9>  (63) 
<32,8;Dealkylation;R1>
<32,H;Dealkylation;R1>
<33,8;Dealkylation;R1>
<33,H;Dealkylation;R1>
<37,4;Dealkylation;R2>
<37,H;Dealkylation;R2>
<25,6;Dealkylation;R3>
<25,H;Dealkylation;R3>
<26,10;Dealkylation;R5>

>  <BOM_2C19>  (63) 
<32,8;Dealkylation;R1>
<32,H;Dealkylation;R1>
<33,8;Dealkylation;R1>
<33,H;Dealkylation;R1>
<37,4;Dealkylation;R2>
<37,H;Dealkylation;R2>
<25,6;Dealkylation;R3>
<25,H;Dealkylation;R3>
<26,10;Dealkylation;R5>

>  <BOM_2D6>  (63) 
<25,6;Dealkylation;R3>
<25,H;Dealkylation;R3>
<26,10;Dealkylation;R5>

>  <BOM_2E1>  (63) 
<32,8;Dealkylation;R1>
<32,H;Dealkylation;R1>
<33,8;Dealkylation;R1>
<33,H;Dealkylation;R1>
<37,4;Dealkylation;R2>
<37,H;Dealkylation;R2> 
<25,6;Dealkylation;R3>
<25,H;Dealkylation;R3>
<26,10;Dealkylation;R5>

>  <BOM_3A4>  (63) 
<32,8;Dealkylation;R1>
<32,H;Dealkylation;R1>
<33,8;Dealkylation;R1>
<33,H;Dealkylation;R1> 
<25,6;Dealkylation;R3>
<25,H;Dealkylation;R3> 
<14,6;Dealkylation;R4>
<14,H;Dealkylation;R4> 
<26,10;Dealkylation;R5>

>  <References>  (63) 
Liu, Xiao-yun, et al. "Alflutinib (AST2818), primarily metabolized by CYP3A4, is a potent CYP3A4 inducer." Acta Pharmacologica Sinica 41.10 (2020): 1366-1376.

>  <FLAG_COMMENTS>  (63) 


>  <Name>  (63) 
Alflutinib

>  <ID>  (63) 
118861389

$$$$
3034396
     RDKit          3D

 29 32  0  0  1  0  0  0  0  0999 V2000
    5.4080   -1.1924    0.2988 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7850    2.6139    0.9291 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2829    0.0548   -1.6664 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4735    0.9505    2.3604 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1705   -1.8715   -0.3163 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6656    1.3477   -0.8415 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0903   -0.5143   -0.9254 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.6303   -1.6964   -0.0305 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.5846   -0.2424   -0.5606 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.1948    0.3826   -0.3440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4582   -2.5041   -0.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2819    0.0444   -0.7014 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9655   -2.7250   -0.7244 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3965   -0.7027   -0.3828 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3049   -2.1749   -0.1793 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6258   -1.7917    1.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6680    0.6281    0.0025 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5016    0.1858   -0.2941 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0160    1.4652   -0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7312   -3.2305    1.9588 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8706    0.0323    0.0029 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3069    1.3953    1.2317 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8896    0.7306   -0.5414 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8376    2.5984   -0.5954 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7018    1.1582   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1912    2.4204   -0.2968 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4134   -1.5754    1.6691 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4071    3.4242    2.0474 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2560    0.7891   -2.3903 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 21  1  0
  1 27  1  0
  2 22  1  0
  2 28  1  0
  3 23  1  0
  3 29  1  0
  4 22  2  0
  5  7  1  0
  5 11  1  0
  5 13  1  0
  6 12  1  0
  6 19  1  0
  7 10  1  1
  7 12  1  0
  8  9  1  0
  8 11  1  0
  8 16  1  1
  9 10  1  0
  9 17  1  1
 12 14  2  0
 13 15  1  0
 14 15  1  0
 14 18  1  0
 16 20  1  0
 17 22  1  0
 17 23  2  0
 18 19  2  0
 18 21  1  0
 19 24  1  0
 21 25  2  0
 24 26  2  0
 25 26  1  0
M  END
>  <InChIKey>  (64) 
LELBFTMXCIIKKX-QVRQZEMUSA-N

>  <PubChem_CID>  (64) 
3034396

>  <BOM_1A2>  (64) 


>  <BOM_2A6>  (64) 


>  <BOM_2B6>  (64) 


>  <BOM_2C8>  (64) 


>  <BOM_2C9>  (64) 


>  <BOM_2C19>  (64) 
<27,1;Dealkylation;R1>
<27,H;Dealkylation;R1>
<28,2;Hydrolysis;R3>
<28,H;Hydrolysis;R3>

>  <BOM_2D6>  (64) 
<27,1;Dealkylation;R1>
<27,H;Dealkylation;R1>
<28,2;Hydrolysis;R3>
<28,H;Hydrolysis;R3>

>  <BOM_2E1>  (64) 


>  <BOM_3A4>  (64) 
<27,1;Dealkylation;R1>
<27,H;Dealkylation;R1>
<14,H;Hydroxylation;R2>

>  <References>  (64) 
Basiliere, Stephanie, and Sarah Kerrigan. "CYP450-mediated metabolism of mitragynine and investigation of metabolites in human urine." Journal of analytical toxicology 44.4 (2020): 301-313.

>  <FLAG_COMMENTS>  (64) 


>  <Name>  (64) 
Mitragynine

>  <ID>  (64) 
3034396

$$$$
1032830
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -1.1709    4.7285    0.2028 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -0.9974   -1.8101   -2.0292 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.2211   -0.3403    0.0513 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2209   -1.5369    1.4381 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0828   -2.2790    0.6465 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8637   -1.7510   -0.3526 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3798    0.7939    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0456    0.7407    0.4722 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1200   -1.4184    0.9014 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6854   -0.5372    0.7682 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1199   -1.4869    1.9887 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3554   -0.5846   -0.6786 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9121    2.0106   -0.4336 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0661   -0.7003    0.2229 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6987    1.9317    0.5375 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1486    3.1773   -0.3849 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1482    3.1414    0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8650    0.2236   -1.8062 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2937   -1.2645   -1.0268 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1274   -0.2686    1.0104 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6005   -1.3990   -1.4957 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4341   -0.4029    0.5413 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6707   -0.9681   -0.7116 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  2 19  1  0
  3  7  1  0
  3  9  1  0
  3 12  1  0
  4 10  2  0
  4 11  1  0
  5  6  1  0
  5  9  2  0
  6 12  2  0
  7  8  2  0
  7 13  1  0
  8 10  1  0
  8 15  1  0
  9 11  1  0
 10 14  1  0
 12 18  1  0
 13 16  2  0
 14 19  2  0
 14 20  1  0
 15 17  2  0
 16 17  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
M  END
>  <InChIKey>  (65) 
BUTCFAZTKZDYCN-UHFFFAOYSA-N

>  <PubChem_CID>  (65) 
1032830

>  <BOM_1A2>  (65) 


>  <BOM_2A6>  (65) 


>  <BOM_2B6>  (65) 
<18,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <BOM_2C8>  (65) 


>  <BOM_2C9>  (65) 


>  <BOM_2C19>  (65) 
<18,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <BOM_2D6>  (65) 


>  <BOM_2E1>  (65) 


>  <BOM_3A4>  (65) 
<18,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <References>  (65) 
Wagmann L, Manier SK, Felske C, Gampfer TM, Richter MJ, Eckstein N, Meyer MR. Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam. J Anal Toxicol. 2021 Nov 9;45(9):1014-1027. doi: 10.1093/jat/bkaa161. PMID: 33048135.

>  <FLAG_COMMENTS>  (65) 


>  <Name>  (65) 
Phenazolam

>  <ID>  (65) 
1032830

$$$$
5320621
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    4.6775   -2.1553   -0.0285 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4303   -0.5016   -0.0517 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9208    1.9097    0.1192 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6411   -0.1399   -0.7039 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8406   -0.8151    0.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0570    0.1491   -0.6906 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3503   -0.7026    1.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7164   -2.2623   -0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1911   -0.8856    0.0298 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1920    0.0586    0.0165 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5703    0.8253    0.1509 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8593   -0.5311    0.0968 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6894    0.7777   -0.2927 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9163    1.4095    0.0698 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5755    1.7955    0.1384 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0968   -1.9043   -0.0804 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1632    1.2559    0.2237 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3085    0.2304   -0.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1084    0.5050   -0.1313 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2564    0.9813   -0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0
  1 16  1  0
  2 10  1  0
  2 16  1  0
  3 13  2  0
  4  6  1  0
  4 13  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  9 10  2  0
  9 12  1  0
 10 14  1  0
 11 12  2  0
 11 15  1  0
 11 17  1  0
 13 18  1  0
 14 15  2  0
 17 19  2  0
 18 20  2  0
 19 20  1  0
M  END
>  <InChIKey>  (66) 
WHAAPCGHVWVUEX-GGWOSOGESA-N

>  <PubChem_CID>  (66) 
5320621

>  <BOM_1A2>  (66) 
<16,1;Dealkylation;R1>
<16,2;Dealkylation;R1>
<16,H;Dealkylation;R1>

>  <BOM_2A6>  (66) 


>  <BOM_2B6>  (66) 


>  <BOM_2C8>  (66) 


>  <BOM_2C9>  (66) 


>  <BOM_2C19>  (66) 
<16,1;Dealkylation;R1>
<16,2;Dealkylation;R1>
<16,H;Dealkylation;R1>
<4,N;N-Oxidation;R2>

>  <BOM_2D6>  (66) 
<16,1;Dealkylation;R1>
<16,2;Dealkylation;R1>
<16,H;Dealkylation;R1>
<4,N;N-Oxidation;R2>

>  <BOM_2E1>  (66) 


>  <BOM_3A4>  (66) 
<16,1;Dealkylation;R1>
<16,2;Dealkylation;R1>
<16,H;Dealkylation;R1>
<4,N;N-Oxidation;R2>

>  <References>  (66) 
Chi, Yuqian, et al. "Metabolic activation and cytochrome P450 inhibition of piperlonguminine mediated by CYP3A4." International Journal of Biological Macromolecules 268 (2024): 131502.

>  <FLAG_COMMENTS>  (66) 


>  <Name>  (66) 
Piperlonguminine

>  <ID>  (66) 
5320621

$$$$
10280735
     RDKit          3D

 37 40  0  0  1  0  0  0  0  0999 V2000
   -7.9274    1.1070    0.9534 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3188   -3.1018   -2.1954 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.3105    1.2936   -0.7796 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1128   -0.5266   -2.7540 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0897    4.2652   -1.4203 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1930    4.7198    0.1993 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3943    0.1270   -0.5699 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4122    2.7054    0.3042 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4171   -0.2058    0.9935 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2041   -5.6917    0.3009 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1187   -2.2063    0.2007 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3500    2.3937   -0.2201 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0941    0.8020   -0.0859 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0967    1.3509   -0.8918 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.8266    2.4649    0.1355 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.2748    0.8081    0.3160 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.5992    1.0835   -1.0323 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4988    2.1862    1.4842 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9939    1.9240    1.3236 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7550    0.6595    0.1216 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9402   -0.7485   -1.5542 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2963    3.5759   -0.4899 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2874   -1.9398   -1.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7192   -0.9375    2.0476 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8530   -0.4423    0.9159 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5327   -3.4142    0.3092 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8531   -4.0343   -0.8798 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9021   -4.0096    1.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5384   -5.3562   -0.9816 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2999   -5.4945    1.4563 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7505    3.6318   -0.1296 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7074   -7.0642    0.2657 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6988    2.0790    0.0647 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5088    3.1164    0.4766 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8374    2.8176    0.7579 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3919    0.5498    0.1966 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2953    1.5122    0.6178 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 37  1  0
  2 23  1  0
  2 27  1  0
  3 20  2  0
  4 21  2  0
  5 22  2  0
  6 31  2  0
 14  7  1  1
  7 21  1  0
 15  8  1  1
  8 22  1  0
  9 20  1  0
  9 24  1  0
  9 25  1  0
 10 29  1  0
 10 30  1  0
 10 32  1  0
 11 23  2  0
 11 26  1  0
 12 31  1  0
 12 33  1  0
 13 33  2  0
 13 36  1  0
 14 15  1  0
 14 17  1  0
 15 18  1  0
 16 17  1  0
 16 19  1  0
 16 20  1  6
 18 19  1  0
 21 23  1  0
 22 31  1  0
 26 27  2  0
 26 28  1  0
 27 29  1  0
 28 30  1  0
 33 34  1  0
 34 35  2  0
 35 37  1  0
 36 37  2  0
M  END
>  <InChIKey>  (67) 
HGVDHZBSSITLCT-JLJPHGGASA-N

>  <PubChem_CID>  (67) 
10280735

>  <BOM_1A2>  (67) 


>  <BOM_2A6>  (67) 


>  <BOM_2B6>  (67) 


>  <BOM_2C8>  (67) 


>  <BOM_2C9>  (67) 


>  <BOM_2C19>  (67) 


>  <BOM_2D6>  (67) 


>  <BOM_2E1>  (67) 


>  <BOM_3A4>  (67) 
<32,10;Dealkylation;R1>
<32,H;Dealkylation;R1>
<25,9;Dealkylation;R2>
<25,H;Dealkylation;R2>
<24,9;Dealkylation;R2>
<24,H;Dealkylation;R2>
<10,N;N-Oxidation;R1>

>  <References>  (67) 
Parasrampuria, Dolly A., and Kenneth E. Truitt. "Pharmacokinetics and pharmacodynamics of edoxaban, a non-vitamin K antagonist oral anticoagulant that inhibits clotting factor Xa." Clinical pharmacokinetics 55 (2016): 641-655.

>  <FLAG_COMMENTS>  (67) 


>  <Name>  (67) 
Edoxaban

>  <ID>  (67) 
10280735

$$$$
71566267
     RDKit          3D

 32 36  0  0  1  0  0  0  0  0999 V2000
   -1.9978   -3.7964    0.4581 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2268    0.1736   -2.3031 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0834   -1.3434   -0.9355 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0760    1.5462    0.7887 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3191    0.2826    0.1228 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4309    2.2933    1.8464 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8688    0.5231    0.4318 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4991    0.4052    0.7517 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9053    1.2881   -0.6651 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9203   -1.6728   -0.0822 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.2278   -2.2302   -0.9291 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3395   -2.6566    1.0148 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8881   -2.4863   -1.3722 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2024   -3.4103   -0.2061 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5454   -2.1104   -0.2172 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3545   -0.0812   -1.4743 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5429    1.0531   -1.0185 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3241   -0.9645   -0.3782 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9900   -3.1458    0.6052 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9175    1.8246    0.0817 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5473   -0.8535    0.2831 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3719    1.3534   -1.7146 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2132   -3.0352    1.2663 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9919   -1.8889    1.1055 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1213    2.8965    0.4854 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0493    3.1970   -0.2109 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4240    2.4254   -1.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8998    4.3436    0.2202 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5678    1.6934    2.2101 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8339    0.6181    1.3508 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8878    1.6110    0.3279 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9197    2.1474   -0.5328 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  1 14  1  0
  2 16  2  0
  3 10  1  0
  3 13  1  0
  3 16  1  0
  4  6  1  0
  4  7  1  0
  4 20  1  0
  5  8  1  0
  5  9  1  0
  5 21  1  0
  6 29  2  0
  7 30  2  0
  8 31  2  0
  9 32  2  0
 10 11  1  6
 10 12  1  0
 11 15  1  0
 13 14  1  0
 15 18  2  0
 15 19  1  0
 16 17  1  0
 17 20  1  0
 17 22  2  0
 18 21  1  0
 19 23  2  0
 20 25  2  0
 21 24  2  0
 22 27  1  0
 23 24  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 29 30  1  0
 31 32  1  0
M  END
>  <InChIKey>  (68) 
GKPHAIOJCHBZCT-HXUWFJFHSA-N

>  <PubChem_CID>  (68) 
71566267

>  <BOM_1A2>  (68) 
<28,H;Hydroxylation;R2>

>  <BOM_2A6>  (68) 


>  <BOM_2B6>  (68) 


>  <BOM_2C8>  (68) 
<28,H;Hydroxylation;R2>

>  <BOM_2C9>  (68) 
<21,5;Dealkylation;R1>
<31,H;Hydroxylation;R3>
<32,H;Hydroxylation;R3>
<28,H;Hydroxylation;R2>

>  <BOM_2C19>  (68) 
<21,5;Dealkylation;R1>
<31,H;Hydroxylation;R3>
<32,H;Hydroxylation;R3>
<28,H;Hydroxylation;R2>

>  <BOM_2D6>  (68) 
<31,H;Hydroxylation;R3>
<32,H;Hydroxylation;R3>
<28,H;Hydroxylation;R2>

>  <BOM_2E1>  (68) 


>  <BOM_3A4>  (68) 
<28,H;Hydroxylation;R2>
<13,14;Dehydrogenation;R4>
<13,H;Hydroxylation;R5>
<14,H;Hydroxylation;R6>
<11,H;Hydroxylation;R7>

>  <References>  (68) 
Treiber, Alexander, et al. "The metabolism of the orexin-1 selective receptor antagonist nivasorexant." Xenobiotica 54.3 (2024): 124-137.

>  <FLAG_COMMENTS>  (68) 


>  <Name>  (68) 
Nivasorexant

>  <ID>  (68) 
71566267

$$$$
56640146
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   11.5942    2.9554    0.0000 S   0  0  0  0  0  6  0  0  0  0  0  0
    4.5981    2.9279    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -1.0721    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981   -4.0721    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0909    3.8234    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.0976    2.0875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981   -1.0721    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -2.5721    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7263    3.4521    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    1.9279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    1.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981    1.9279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    2.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3660    1.0619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3660    2.7940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641    1.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981   -0.0721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641    0.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3301    1.9279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1962    1.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0622    1.9279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3301    2.9279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0622    2.9279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1962    3.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -1.5721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641   -1.5721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9561    1.3933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9561    3.4626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8622    2.9487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641    3.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8622    1.9071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4641   -2.5721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5981   -3.0721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4622    2.4588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  2  0
  1  6  2  0
  1  9  1  0
  1 35  1  0
  2 12  1  0
  2 31  1  0
  3 26  2  0
  4 34  2  0
  7 18  1  0
  7 26  1  0
  7 27  1  0
  8 26  1  0
  8 34  1  0
  9 30  1  0
 10 11  1  0
 10 13  1  0
 10 14  1  0
 10 15  1  0
 11 12  2  0
 11 17  1  0
 12 16  1  0
 16 19  2  0
 16 20  1  0
 17 18  2  0
 18 19  1  0
 20 21  2  0
 20 23  1  0
 21 22  1  0
 22 24  2  0
 22 28  1  0
 23 25  2  0
 24 25  1  0
 24 29  1  0
 27 33  2  0
 28 32  2  0
 29 30  2  0
 30 32  1  0
 33 34  1  0
M  END
>  <InChIKey>  (69) 
NBRBXGKOEOGLOI-UHFFFAOYSA-N

>  <PubChem_CID>  (69) 
56640146

>  <BOM_1A2>  (69) 


>  <BOM_2A6>  (69) 


>  <BOM_2B6>  (69) 


>  <BOM_2C8>  (69) 
<15,H;Hydroxylation;R1>
<14,H;Hydroxylation;R1>
<13,H;Hydroxylation;R1>

>  <BOM_2C9>  (69) 


>  <BOM_2C19>  (69) 


>  <BOM_2D6>  (69) 


>  <BOM_2E1>  (69) 


>  <BOM_3A4>  (69) 
<15,H;Hydroxylation;R1>
<14,H;Hydroxylation;R1>
<13,H;Hydroxylation;R1>

>  <References>  (69) 
Shen, Jianwei, et al. "Metabolism and disposition of hepatitis C polymerase inhibitor dasabuvir in humans." Drug Metabolism and Disposition 44.8 (2016): 1139-1147.

>  <FLAG_COMMENTS>  (69) 


>  <Name>  (69) 
Dasabuvir

>  <ID>  (69) 
56640146

$$$$
6450551
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    5.1350   -1.6565    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.2690   -3.1565    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6793   -1.4612    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.2629   -0.6565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5369   -3.1565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6113    2.9998    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7331   -0.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7331   -1.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6793    0.1482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8671   -1.6565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0010   -1.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8671    0.3435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0010   -0.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2690   -1.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9900    1.0987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4030   -1.6565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2690   -0.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9685    1.3050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5369   -1.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4030    0.3435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4030   -2.6565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5369   -0.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2791    2.2555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2576    2.4617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5683    3.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5369   -4.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9220    3.9503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9005    4.1565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  1 14  1  0
  2 21  2  0
  3  4  1  0
  3  8  1  0
  4  9  2  0
  5 21  1  0
  5 26  1  0
  6 23  2  0
  6 27  1  0
  7  8  2  0
  7  9  1  0
  7 12  1  0
  8 10  1  0
  9 15  1  0
 10 11  2  0
 11 13  1  0
 12 13  2  0
 14 16  2  0
 14 17  1  0
 15 18  2  0
 16 19  1  0
 16 21  1  0
 17 20  2  0
 18 23  1  0
 19 22  2  0
 20 22  1  0
 23 24  1  0
 24 25  2  0
 25 28  1  0
 27 28  2  0
M  END
>  <InChIKey>  (70) 
RITAVMQDGBJQJZ-FMIVXFBMSA-N

>  <PubChem_CID>  (70) 
6450551

>  <BOM_1A2>  (70) 
<6,N;N-Oxidation;R2>
<15,18;Epoxidation;R3>

>  <BOM_2A6>  (70) 


>  <BOM_2B6>  (70) 


>  <BOM_2C8>  (70) 


>  <BOM_2C9>  (70) 


>  <BOM_2C19>  (70) 
<26,H;Hydroxylation;R1>
<6,N;N-Oxidation;R2>
<1,S;S-Oxidation;R4>

>  <BOM_2D6>  (70) 


>  <BOM_2E1>  (70) 


>  <BOM_3A4>  (70) 
<26,H;Hydroxylation;R1>
<6,N;N-Oxidation;R2>
<1,S;S-Oxidation;R4>

>  <References>  (70) 
Zientek, Michael A., et al. "In vitro kinetic characterization of axitinib metabolism." Drug Metabolism and Disposition 44.1 (2016): 102-114.

>  <FLAG_COMMENTS>  (70) 


>  <Name>  (70) 
Axitinib

>  <ID>  (70) 
6450551

$$$$
208908
     RDKit          2D

 40 44  0  0  0  0  0  0  0  0999 V2000
   12.3832   -2.5389    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.9136   -2.6366    0.0000 S   0  0  0  0  0  6  0  0  0  0  0  0
   18.4623   -1.1091    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.1010    0.5210    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -2.2299    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8271   -3.0434    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1267   -1.5590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7215   -0.7050    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6859    0.4809    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6975    3.5502    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6036    1.9947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3148   -1.6186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3203   -1.7231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7161   -0.6005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1228    0.3131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0715    2.0155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2055    1.5155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8036    2.0155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9375    1.5155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6228    1.1791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2919    1.9222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8036    3.0155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0715    3.0155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6975    1.4808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5068   -3.5502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9375    3.5155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5461   -0.0291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6036    3.0363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5346   -1.0290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4179    0.4609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2665   -1.0490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3947   -1.5390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2781   -0.0491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9984   -1.0691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8586   -1.5790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7304   -1.0891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8470   -2.5790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5905   -1.5991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7072   -3.0890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5790   -2.5990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 32  1  0
  2  5  2  0
  2  6  2  0
  2 13  1  0
  2 25  1  0
  3 38  1  0
  4 15  1  0
  4 17  1  0
  7 31  1  0
  7 34  1  0
  8 12  1  0
  8 14  1  0
  9 24  1  0
  9 27  1  0
 10 22  2  0
 10 28  1  0
 11 24  1  0
 11 28  2  0
 12 13  1  0
 14 15  1  0
 15 20  2  0
 16 17  1  0
 16 19  2  0
 16 23  1  0
 17 21  2  0
 18 19  1  0
 18 22  1  0
 18 24  2  0
 20 21  1  0
 22 26  1  0
 23 26  2  0
 27 29  2  0
 27 30  1  0
 29 32  1  0
 30 33  2  0
 31 32  2  0
 31 33  1  0
 34 35  1  0
 35 36  2  0
 35 37  1  0
 36 38  1  0
 37 39  2  0
 38 40  2  0
 39 40  1  0
M  END
>  <InChIKey>  (71) 
BCFGMOOMADDAQU-UHFFFAOYSA-N

>  <PubChem_CID>  (71) 
208908

>  <BOM_1A2>  (71) 


>  <BOM_2A6>  (71) 


>  <BOM_2B6>  (71) 


>  <BOM_2C8>  (71) 


>  <BOM_2C9>  (71) 


>  <BOM_2C19>  (71) 


>  <BOM_2D6>  (71) 


>  <BOM_2E1>  (71) 


>  <BOM_3A4>  (71) 
<8,N;N-Oxidation;R1>
<12,8;Dealkylation;R2>
<12,H;Dealkylation;R2>
<34,7;Dealkylation;R3>
<34,H;Dealkylation;R3>

>  <References>  (71) 
Hardy, Klarissa D., et al. "Studies on the role of metabolic activation in tyrosine kinase inhibitor?dependent hepatotoxicity: Induction of CYP3A4 enhances the cytotoxicity of lapatinib in HepaRG cells."Â Drug Metabolism and DispositionÂ 42.1 (2014): 162-171.

>  <FLAG_COMMENTS>  (71) 


>  <Name>  (71) 
Lapatinib

>  <ID>  (71) 
208908

$$$$
10926754
     RDKit          3D

 27 31  0  0  1  0  0  0  0  0999 V2000
    1.1782   -0.7821    1.7764 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1546   -2.6997   -0.7756 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5806    2.5890    0.0242 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5577    1.3466   -0.5721 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3576    2.4942   -0.5276 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2725    0.8356    0.6152 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9994   -1.7377   -0.3978 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.0544   -0.6726   -0.2461 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.9259   -1.5260    0.7939 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.2559   -1.2755   -0.9599 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.1408   -0.5339    1.2682 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1724   -3.0187   -0.3292 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1918   -0.7844    0.4207 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5915   -0.7101   -0.5414 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2047    0.6127    0.4249 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3458   -1.5089    0.0724 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8684    0.6468   -0.7268 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5565   -1.5408    0.0338 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3815    1.2438    0.0775 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5248   -0.8452   -0.2752 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1024    1.1695   -0.3394 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7903   -1.0182    0.4209 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5105    0.5344   -0.2631 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0633    0.3369    0.2343 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9617    2.6468   -0.3875 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0108    3.3787    0.5362 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3160    0.8186   -0.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0
  1 11  1  0
  2 10  1  0
  2 12  1  0
  3 19  1  0
  3 25  1  0
  4 23  1  0
  4 25  1  0
  5 21  1  0
  5 26  1  0
  6 24  1  0
  6 27  1  0
  7  8  1  0
  7  9  1  0
  7 12  1  1
  8 10  1  0
  8 11  1  1
  9 13  1  6
 10 14  1  1
 13 15  1  0
 13 16  2  0
 14 17  2  0
 14 18  1  0
 15 19  2  0
 16 20  1  0
 17 21  1  0
 18 22  2  0
 19 23  1  0
 20 23  2  0
 21 24  2  0
 22 24  1  0
M  END
>  <InChIKey>  (72) 
AWOGQCSIVCQXBT-LATRNWQMSA-N

>  <PubChem_CID>  (72) 
10926754

>  <BOM_1A2>  (72) 
<27,6;Dealkylation;R2>
<27,H;Dealkylation;R2>
<26,5;Dealkylation;R3>
<26,H;Dealkylation;R3>

>  <BOM_2A6>  (72) 


>  <BOM_2B6>  (72) 
<27,6;Dealkylation;R2>
<27,H;Dealkylation;R2>
<26,5;Dealkylation;R3>
<26,H;Dealkylation;R3>

>  <BOM_2C8>  (72) 
<25,3;Dealkylation;R1>
<25,4;Dealkylation;R1>
<25,H;Dealkylation;R1>

>  <BOM_2C9>  (72) 
<25,3;Dealkylation;R1>
<25,4;Dealkylation;R1>
<25,H;Dealkylation;R1>
<27,6;Dealkylation;R2>
<27,H;Dealkylation;R2>
<26,5;Dealkylation;R3>
<26,H;Dealkylation;R3>

>  <BOM_2C19>  (72) 
<25,3;Dealkylation;R1>
<25,4;Dealkylation;R1>
<25,H;Dealkylation;R1>
<27,6;Dealkylation;R2>
<27,H;Dealkylation;R2>
<26,5;Dealkylation;R3>
<26,H;Dealkylation;R3>

>  <BOM_2D6>  (72) 
<27,6;Dealkylation;R2>
<27,H;Dealkylation;R2>
<26,5;Dealkylation;R3>
<26,H;Dealkylation;R3>

>  <BOM_2E1>  (72) 


>  <BOM_3A4>  (72) 
<25,3;Dealkylation;R1>
<25,4;Dealkylation;R1>
<25,H;Dealkylation;R1>
<27,6;Dealkylation;R2>
<27,H;Dealkylation;R2>
<26,5;Dealkylation;R3>
<26,H;Dealkylation;R3>

>  <References>  (72) 
Lee, Min Seo, et al. "Comparative metabolism of fargesin in human, dog, monkey, mouse, and rat hepatocytes." Toxicological Research 40.1 (2024): 125-137.

>  <FLAG_COMMENTS>  (72) 


>  <Name>  (72) 
Fargesin

>  <ID>  (72) 
10926754

$$$$
155884675
     RDKit          3D

 29 33  0  0  1  0  0  0  0  0999 V2000
   -5.7381   -1.4296   -0.1075 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0196   -1.4810   -0.9627 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6716    2.1702   -0.3614 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9173   -0.0742   -0.1084 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5162   -0.2677    0.3378 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2460    0.8734   -0.1302 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5097    1.2778   -0.6327 C   0  0  2  0  0  0  0  0  0  0  0  0
   -6.6146    1.5107    1.1692 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6210    0.6879    0.4227 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8015    1.9544   -0.0911 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7084   -0.1678   -0.0907 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9398    0.9977   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7009   -0.3864   -0.0913 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4722   -1.0625   -0.0752 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3081   -0.2845   -0.1147 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1168    0.2901    0.3106 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.9403    1.4802   -0.6354 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9200   -1.0542   -0.0907 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9017   -0.5836    0.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3007    1.1717   -0.1154 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5019   -2.4600   -0.0596 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6142    3.4091   -1.1441 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9491   -2.4574   -0.0729 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2498   -0.5677   -0.1654 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7228   -3.1403   -0.0575 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8114    0.8076    1.2814 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6637   -1.0631   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7069    0.3368    2.7179 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3238   -0.4878   -1.3168 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 15  2  0
  2 24  2  0
  3  7  1  0
  3 17  1  0
  3 22  1  0
  4 15  1  0
  4 18  1  0
  4 20  1  0
  5 24  1  0
  5 26  1  0
  5 27  1  0
  6  8  1  0
  6  9  1  0
  6 15  1  0
  7 10  1  1
  7 11  1  0
  8  9  1  0
 10 12  1  0
 11 14  1  0
 11 19  2  0
 12 13  1  0
 12 20  2  0
 13 14  2  0
 13 18  1  0
 14 21  1  0
 16 17  1  0
 16 19  1  0
 16 24  1  6
 18 23  2  0
 21 25  2  0
 23 25  1  0
 26 28  1  0
 27 29  1  0
M  END
>  <InChIKey>  (73) 
RAFUPYYDHPFASC-DYESRHJHSA-N

>  <PubChem_CID>  (73) 
155884675

>  <BOM_1A2>  (73) 
<22,3;Dealkylation;R1>
<22,H;Dealkylation;R1>
<26,5;Dealkylation;R2>
<26,H;Dealkylation;R2>
<27,5;Dealkylation;R2>
<27,H;Dealkylation;R2>

>  <BOM_2A6>  (73) 


>  <BOM_2B6>  (73) 


>  <BOM_2C8>  (73) 
<22,3;Dealkylation;R1>
<22,H;Dealkylation;R1>
<26,5;Dealkylation;R2>
<26,H;Dealkylation;R2>
<27,5;Dealkylation;R2>
<27,H;Dealkylation;R2>
<28,H;Hydroxylation;R3>
<29,H;Hydroxylation;R3>

>  <BOM_2C9>  (73) 


>  <BOM_2C19>  (73) 
<22,3;Dealkylation;R1>
<22,H;Dealkylation;R1>

>  <BOM_2D6>  (73) 


>  <BOM_2E1>  (73) 


>  <BOM_3A4>  (73) 
<22,3;Dealkylation;R1>
<22,H;Dealkylation;R1>
<26,5;Dealkylation;R2>
<26,H;Dealkylation;R2>
<27,5;Dealkylation;R2>
<27,H;Dealkylation;R2>
<28,H;Hydroxylation;R3>
<29,H;Hydroxylation;R3>

>  <References>  (73) 
Gampfer, Tanja M., et al. "Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assay." Journal of pharmaceutical and biomedical analysis 245 (2024): 116187.

>  <FLAG_COMMENTS>  (73) 


>  <Name>  (73) 
1cP-LSD

>  <ID>  (73) 
155884675

$$$$
131411
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -4.9945    3.6614    0.6659 Br  0  0  0  0  0  0  0  0  0  0  0  0
    2.8944    0.2378    0.9878 S   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2625    0.6631   -0.0404 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0337   -2.3026    0.1413 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1109   -1.8908   -2.1094 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0490    2.0344   -0.1088 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3431   -1.7837    0.2844 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6097    0.5606   -0.3408 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3187    1.8930   -0.0402 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6310    0.8405   -0.4412 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3700   -0.0913   -0.5916 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9557    0.1438   -0.3407 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3475   -1.2684   -0.6530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3104    2.8330    0.2617 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9582    1.0731   -0.0405 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0964    0.7004   -0.5862 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7665    3.2686    0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6383    2.3966    0.2558 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1453   -1.4664   -0.9420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7430   -3.1408   -0.0876 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8199   -1.7623    1.6502 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6190    0.2464    0.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2623   -3.6887   -0.1368 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9779    0.5632   -0.7904 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5954   -0.0632    1.4598 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4328   -4.4324    1.1707 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3234    0.5701   -1.1579 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9411   -0.0562    1.0923 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3050    0.2605   -0.2166 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 18  1  0
  2 16  1  0
  2 22  1  0
  3 15  1  0
  4 19  1  0
  4 23  1  0
  5 19  2  0
  6  9  1  0
  6 10  1  0
  6 17  1  0
  7 13  1  0
  7 20  1  0
  7 21  1  0
  8  9  2  0
  8 11  1  0
  8 12  1  0
  9 14  1  0
 10 11  2  0
 10 16  1  0
 11 19  1  0
 12 13  1  0
 12 15  2  0
 14 18  2  0
 15 18  1  0
 22 24  2  0
 22 25  1  0
 23 26  1  0
 24 27  1  0
 25 28  2  0
 27 29  2  0
 28 29  1  0
M  END
>  <InChIKey>  (74) 
KCFYEAOKVJSACF-UHFFFAOYSA-N

>  <PubChem_CID>  (74) 
131411

>  <BOM_1A2>  (74) 
<20,7;Dealkylation;R1>
<20,H;Dealkylation;R1>
<21,7;Dealkylation;R1>
<21,H;Dealkylation;R1>
<2,S;S-Oxidation;R2>

>  <BOM_2A6>  (74) 


>  <BOM_2B6>  (74) 


>  <BOM_2C8>  (74) 


>  <BOM_2C9>  (74) 


>  <BOM_2C19>  (74) 
<20,7;Dealkylation;R1>
<20,H;Dealkylation;R1>
<21,7;Dealkylation;R1>
<21,H;Dealkylation;R1>
<2,S;S-Oxidation;R2>

>  <BOM_2D6>  (74) 
<20,7;Dealkylation;R1>
<20,H;Dealkylation;R1>
<21,7;Dealkylation;R1>
<21,H;Dealkylation;R1>
<2,S;S-Oxidation;R2>

>  <BOM_2E1>  (74) 
<20,7;Dealkylation;R1>
<20,H;Dealkylation;R1>
<21,7;Dealkylation;R1>
<21,H;Dealkylation;R1>
<2,S;S-Oxidation;R2>

>  <BOM_3A4>  (74) 
<20,7;Dealkylation;R1>
<20,H;Dealkylation;R1>
<21,7;Dealkylation;R1>
<21,H;Dealkylation;R1>
<2,S;S-Oxidation;R2>

>  <References>  (74) 
Deng P, Zhong D, Yu K, Zhang Y, Wang T, Chen X: Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans. Antimicrob Agents Chemother. 2013 Apr;57(4):1743-55. doi: 10.1128/AAC.02282-12. Epub 2013 Jan 28.

>  <FLAG_COMMENTS>  (74) 


>  <Name>  (74) 
Umifenovir

>  <ID>  (74) 
131411

$$$$
10477896
     RDKit          3D

 27 26  0  0  0  0  0  0  0  0999 V2000
    0.9881   -2.9223   -0.3650 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.6627   -1.8442    1.4993 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9643   -1.5695   -1.6056 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5761   -2.5908    0.2174 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4595   -0.2348    1.6121 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8367    0.8318   -0.1848 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0315   -0.1047   -1.5385 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6835   -1.1941    0.2297 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6495    1.2276    1.6471 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0282    2.2276   -0.1833 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9110    0.2800    0.3213 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6951    2.4532    0.3124 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2454    1.3113   -1.4814 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.5835   -1.7269    0.1484 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5495   -0.6435   -0.3219 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8709   -1.5227   -0.2508 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9855   -0.9377    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9902    0.1357   -0.3018 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5321   -0.2462    0.2571 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4281   -0.1708    0.1232 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9856   -0.1002   -0.1755 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3750    0.9664   -0.2673 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7150    1.1496    0.2924 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8184    0.6493    0.1269 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7582    1.7995   -0.2335 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1542    1.3010   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1994    1.4752    0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 14  1  0
  2 14  1  0
  3 16  1  0
  4 16  1  0
  5 19  1  0
  6 19  1  0
  7 21  1  0
  8 21  1  0
  9 23  1  0
 10 23  1  0
 11 26  1  0
 12 26  1  0
 13 26  1  0
 14 15  1  0
 14 16  1  0
 15 17  1  0
 16 19  1  0
 17 18  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
 21 23  1  0
 22 24  1  0
 23 26  1  0
 24 25  1  0
 25 27  1  0
M  END
>  <InChIKey>  (75) 
WRYIIOKOQSICTB-UHFFFAOYSA-N

>  <PubChem_CID>  (75) 
10477896

>  <BOM_1A2>  (75) 


>  <BOM_2A6>  (75) 


>  <BOM_2B6>  (75) 


>  <BOM_2C8>  (75) 


>  <BOM_2C9>  (75) 


>  <BOM_2C19>  (75) 


>  <BOM_2D6>  (75) 


>  <BOM_2E1>  (75) 


>  <BOM_3A4>  (75) 


>  <References>  (75) 
"MIEBO (Perfluorohexyloctane Ophthalmic Solution), for Topical Ophthalmic Use: Prescribing Information." U.S. Food and Drug Administration, 18 May 2023, www.accessdata.fda.gov/drugsatfda_docs/label/2023/216675s000lbl.pdf. Accessed 9 Feb. 2024.

>  <FLAG_COMMENTS>  (75) 
Perfluorohexyloctane was not metabolized by human liver microsomes in vitro.

>  <Name>  (75) 
Perfluorohexyloctane

>  <ID>  (75) 
10477896

$$$$
9867812
     RDKit          3D

 28 31  0  0  1  0  0  0  0  0999 V2000
    4.6647   -1.1517   -3.0802 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -5.5043   -0.9434   -1.3497 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4908    0.8883    0.0530 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9317    2.1453    0.4567 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7818   -0.3759    0.2766 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9708    2.9030    1.3542 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0088   -2.3087    1.0843 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1712    0.9399   -0.2061 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.4400    1.9870    0.5677 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6850    1.0591   -0.0399 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8114    1.3287   -0.2968 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5294   -0.0261   -0.5597 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2440    3.2886    1.1565 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4279   -0.7916    0.1107 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4126   -0.0422   -0.8017 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0657    3.7123    1.7197 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9816    1.9058   -0.8175 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3839   -0.7503   -1.4094 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5903    3.8493    1.3939 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7412   -2.1424    0.6643 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8308    1.1641   -1.6395 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5249   -0.1566   -1.9474 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9111    0.0526   -0.6266 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2431   -3.1061    0.7126 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1018   -4.3469    1.2368 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3069   -3.5276    1.5874 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3991   -4.5699    1.6847 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9335   -0.9844   -1.2847 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0
  2 23  1  0
  2 28  1  0
  3 23  2  0
  4  9  1  0
  4 11  1  0
  4 13  1  0
  5  8  1  0
  5 14  2  0
  6  9  2  0
  6 16  1  0
  7 20  2  0
  7 26  1  0
  8  9  1  0
  8 10  1  1
 10 15  1  0
 11 12  2  0
 11 17  1  0
 12 14  1  0
 12 18  1  0
 13 16  2  0
 13 19  1  0
 14 20  1  0
 15 23  1  0
 17 21  2  0
 18 22  2  0
 20 24  1  0
 21 22  1  0
 24 25  2  0
 25 27  1  0
 26 27  2  0
M  END
>  <InChIKey>  (76) 
CYHWMBVXXDIZNZ-KRWDZBQOSA-N

>  <PubChem_CID>  (76) 
9867812

>  <BOM_1A2>  (76) 


>  <BOM_2A6>  (76) 


>  <BOM_2B6>  (76) 


>  <BOM_2C8>  (76) 


>  <BOM_2C9>  (76) 


>  <BOM_2C19>  (76) 


>  <BOM_2D6>  (76) 


>  <BOM_2E1>  (76) 


>  <BOM_3A4>  (76) 


>  <References>  (76) 
Freyer N, Knospel F, Damm G, Greuel S, Schneider C, Seehofer D, Stohr T, Petersen KU, Zeilinger K: Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Devel Ther. 2019 Apr 2;13:1033-1047. doi: 10.2147/DDDT.S186759. eCollection 2019.
"BYFAVO (Remimazolam) for Injection, for Intravenous Use, CIV: Prescribing Information." U.S. Food and Drug Administration, 13 Jan. 2023, www.accessdata.fda.gov/drugsatfda_docs/label/2023/212295s003lbl.pdf. Accessed 9 Feb. 2024.

>  <FLAG_COMMENTS>  (76) 
Remimazolam does not appear to undergo biotransformation via hepatic cytochrome P450 enzymes, nor does it induce or inhibit these enzymes.6 Its primary route of metabolism is hydrolysis via hepatic carboxylesterase-1 (CES1) to yield the inactive CNS7054 metabolite, which then undergoes glucuronidation and hydroxylation prior to elimination.6,1 CNS7054 possesses a 300-fold lesser affinity for GABA(A) receptors as compared to the parent drug.

>  <Name>  (76) 
Remimazolam

>  <ID>  (76) 
9867812

$$$$
10146
     RDKit          3D

 22 25  0  0  1  0  0  0  0  0999 V2000
   -1.9195   -2.1419   -0.1105 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9155   -0.3500   -0.2010 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6044    2.9313   -0.2565 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4487    1.5208    0.1851 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0103    1.0087    0.0537 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3865    0.5751   -0.5992 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0598    1.9214   -0.0247 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5934    3.7755    0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2367   -0.3878    0.0764 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8023    3.4009   -0.0897 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1965   -0.8650   -0.1779 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9046   -1.3285    0.1523 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5712   -0.8240   -0.0094 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3731    1.4497   -0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9383    3.4631    0.0431 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6267    0.0838   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2970   -1.7358   -0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7723   -2.6734    0.5417 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1354   -3.0649    0.2191 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8753   -3.5315    0.5748 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0290   -2.6794   -1.4248 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6288   -0.5480    1.0173 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0
  1 21  1  0
  2 16  1  0
  2 22  1  0
  3  4  1  0
  3  8  1  0
  3 15  1  0
  4  5  1  0
  4  6  1  6
  5  7  2  0
  5  9  1  0
  6 11  1  0
  7 10  1  0
  7 14  1  0
  8 10  1  0
  9 12  1  0
  9 13  2  0
 11 12  2  0
 11 17  1  0
 12 18  1  0
 13 16  1  0
 14 16  2  0
 17 19  2  0
 18 20  2  0
 19 20  1  0
M  END
>  <InChIKey>  (77) 
ORJVQPIHKOARKV-OAHLLOKOSA-N

>  <PubChem_CID>  (77) 
10146

>  <BOM_1A2>  (77) 
<15,3;Dealkylation;R1>
<15,H;Dealkylation;R1>
<22,2;Dealkylation;R2>
<22,H;Dealkylation;R2>

>  <BOM_2A6>  (77) 
<15,3;Dealkylation;R1>
<15,H;Dealkylation;R1>

>  <BOM_2B6>  (77) 
<15,3;Dealkylation;R1>
<15,H;Dealkylation;R1>
<22,2;Dealkylation;R2>
<22,H;Dealkylation;R2>

>  <BOM_2C8>  (77) 
<15,3;Dealkylation;R1>
<15,H;Dealkylation;R1>
<22,2;Dealkylation;R2>
<22,H;Dealkylation;R2>

>  <BOM_2C9>  (77) 
<15,3;Dealkylation;R1>
<15,H;Dealkylation;R1>
<22,2;Dealkylation;R2>
<22,H;Dealkylation;R2>

>  <BOM_2C19>  (77) 
<15,3;Dealkylation;R1>
<15,H;Dealkylation;R1>
<22,2;Dealkylation;R2>
<22,H;Dealkylation;R2>

>  <BOM_2D6>  (77) 
<22,2;Dealkylation;R2>
<22,H;Dealkylation;R2>

>  <BOM_2E1>  (77) 


>  <BOM_3A4>  (77) 
<15,3;Dealkylation;R1>
<15,H;Dealkylation;R1>
<22,2;Dealkylation;R2>
<22,H;Dealkylation;R2>

>  <References>  (77) 
Gao, Hua, et al. "Metabolic profiling of nuciferine in vivo and in vitro." Journal of Agricultural and Food Chemistry 68.48 (2020): 14135-14147.

>  <FLAG_COMMENTS>  (77) 


>  <Name>  (77) 
Nuciferine

>  <ID>  (77) 
10146

$$$$
114431
     RDKit          3D

  9 10  0  0  1  0  0  0  0  0999 V2000
    2.4936    0.6978   -0.1378 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3104   -0.0371    0.7363 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2827    0.0166   -0.4470 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5767   -0.7149   -0.3659 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5704    1.2196    0.8007 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5680   -1.3013    0.6881 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5651    1.3074   -0.3615 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7599   -1.1794   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2001   -0.0087   -0.6967 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  4  1  0
  2  3  1  0
  2  5  1  6
  2  6  1  0
  3  4  1  1
  5  7  1  0
  6  8  1  0
  7  9  1  0
  8  9  2  0
M  END
>  <InChIKey>  (78) 
OLKHRYQRCJLWLL-UHFFFAOYSA-N

>  <PubChem_CID>  (78) 
114431

>  <BOM_1A2>  (78) 


>  <BOM_2A6>  (78) 


>  <BOM_2B6>  (78) 
<8,9;Epoxidation;R1>

>  <BOM_2C8>  (78) 


>  <BOM_2C9>  (78) 


>  <BOM_2C19>  (78) 


>  <BOM_2D6>  (78) 


>  <BOM_2E1>  (78) 
<8,9;Epoxidation;R1>

>  <BOM_3A4>  (78) 


>  <References>  (78) 
S. M. FONTAINE et al. (2001); ROLE OF INDUCTION OF SPECIFIC HEPATIC CYTOCHROME P450 ISOFORMS IN EPOXIDATION OF 4-VINYLCYCLOHEXENE; DRUG METABOLISM AND DISPOSITION; Vol. 29, No. 9

>  <FLAG_COMMENTS>  (78) 


>  <Name>  (78) 
Epoxy-4-vinylcyclohexene

>  <ID>  (78) 
114431

$$$$
41384 
     RDKit          2D

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.4275    1.2927    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    0.1574    2.0723    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.6975    2.6959    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    1.5077    2.5400    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.9063    3.2623    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    1.3425    3.8646    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    2.0005    4.3624    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    0.9163    4.5710    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    0.5955    3.5146    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    1.7777    1.7605    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.5878    1.6046    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    2.3178    0.2014    0.0000 O   0  0  0  0  0  0  0  0  0 13  0  0
    3.6680    0.6691    0.0000 N   0  0  0  0  0  0  0  0  0 14  0  0
    3.9381   -0.1105    0.0000 S   0  0  0  0  0  0  0  0  0 15  0  0
    4.7482   -0.2664    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
    5.0182   -1.0459    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    5.8284   -1.2018    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    6.0984   -1.9814    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    6.9086   -2.1373    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    5.2883    0.3573    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    6.0984    0.2014    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    6.6385    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    7.4486    0.6691    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    4.2081    1.2927    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    1.2376    1.1368    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  3  9  1  0
  4 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 16 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 14 25  1  0
 10 26  2  0
  1 26  1  0
M  END
>  <InChIKey>  (79) 
JLQUFIHWVLZVTJ-UHFFFAOYSA-N

>  <PubChem_CID>  (79) 
41384 

>  <BOM_1A2>  (79) 
<14,15;Hydrolysis;R1>

>  <BOM_2A6>  (79) 
<14,15;Hydrolysis;R1>

>  <BOM_2B6>  (79) 
<14,15;Hydrolysis;R1>
<15,S;S-Oxidation;R2>

>  <BOM_2C8>  (79) 
<14,15;Hydrolysis;R1>

>  <BOM_2C9>  (79) 


>  <BOM_2C19>  (79) 
<14,15;Hydrolysis;R1>
<15,S;S-Oxidation;R2>

>  <BOM_2D6>  (79) 


>  <BOM_2E1>  (79) 


>  <BOM_3A4>  (79) 
<14,15;Hydrolysis;R1>
<15,S;S-Oxidation;R2>

>  <References>  (79) 
Abass, K. et al. (2010). Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chem. Biol. Interact., Vol. 185, No. 3, (163-173).

>  <FLAG_COMMENTS>  (79) 


>  <Name>  (79) 
Carbosulfan

>  <ID>  (79) 
41384 

$$$$
3082
     RDKit          2D

 12 11  0  0  0  0  0  0  0  0999 V2000
    0.8250    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
    1.2375   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.8250   -1.4289    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    2.0625   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    2.4750   -1.4289    0.0000 S   0  0  0  0  0  0  0  0  0  5  0  0
    3.3000   -1.4289    0.0000 P   0  0  0  0  0  5  0  0  0  6  0  0
    3.3000   -2.2539    0.0000 S   0  0  0  0  0  0  0  0  0  7  0  0
    4.1250   -1.4289    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    4.5375   -2.1434    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    3.3000   -0.6039    0.0000 O   0  0  0  0  0  0  0  0  0 10  0  0
    4.0145   -0.1914    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.0670    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  6 10  1  0
 10 11  1  0
  1 12  1  0
M  END
>  <InChIKey>  (80) 
MCWXGJITAZMZEV-UHFFFAOYSA-N

>  <PubChem_CID>  (80) 
3082

>  <BOM_1A2>  (80) 
<7,6;Desulfuration;R1>

>  <BOM_2A6>  (80) 
<7,6;Desulfuration;R1>

>  <BOM_2B6>  (80) 
<7,6;Desulfuration;R1>

>  <BOM_2C8>  (80) 
<7,6;Desulfuration;R1>

>  <BOM_2C9>  (80) 
<7,6;Desulfuration;R1>

>  <BOM_2C19>  (80) 
<7,6;Desulfuration;R1>

>  <BOM_2D6>  (80) 


>  <BOM_2E1>  (80) 


>  <BOM_3A4>  (80) 
<7,6;Desulfuration;R1>

>  <References>  (80) 
(R1) Buratti, F.M. and Testai, E. (2007). Evidences for CYP3A4 autoactivation in the desulfuration of dimethoate by the human liver. Toxicology, Vol. 241, No. 1-2, (33-46).

>  <FLAG_COMMENTS>  (80) 


>  <Name>  (80) 
Dimethoate

>  <ID>  (80) 
3082

$$$$
3346
     RDKit          2D

 16 16  0  0  0  0  0  0  0  0999 V2000
   -4.7989    2.0187    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -4.0845    1.6062    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -3.3700    2.0187    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -3.3700    2.8437    0.0000 P   0  0  0  0  0  5  0  0  0  4  0  0
   -2.5450    2.8437    0.0000 S   0  0  0  0  0  0  0  0  0  5  0  0
   -3.3700    3.6687    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
   -2.6555    4.0812    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -4.1950    2.8437    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
   -4.6075    3.5582    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -4.0845    0.7812    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -4.7989    0.3687    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -5.5134    0.7812    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -6.2279    0.3687    0.0000 S   0  0  0  0  0  0  0  0  0 13  0  0
   -6.2279   -0.4563    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -5.5134    1.6062    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -4.7989   -0.4563    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  1  0
  2 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  2  0
  1 15  1  0
 11 16  1  0
M  END
>  <InChIKey>  (81) 
PNVJTZOFSHSLTO-UHFFFAOYSA-N

>  <PubChem_CID>  (81) 
3346

>  <BOM_1A2>  (81) 
<5,4;Desulfuration;R1>
<13,S;S-Oxidation;R2>

>  <BOM_2A6>  (81) 


>  <BOM_2B6>  (81) 
<5,4;Desulfuration;R1>
<13,S;S-Oxidation;R2>

>  <BOM_2C8>  (81) 


>  <BOM_2C9>  (81) 
<5,4;Desulfuration;R1>
<13,S;S-Oxidation;R2>

>  <BOM_2C19>  (81) 
<5,4;Desulfuration;R1>
<13,S;S-Oxidation;R2>

>  <BOM_2D6>  (81) 


>  <BOM_2E1>  (81) 


>  <BOM_3A4>  (81) 
<5,4;Desulfuration;R1>
<13,S;S-Oxidation;R2>

>  <References>  (81) 
(R1) Leoni, C. et al. (2008). The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol. Appl. Pharmacol., Vol. 233, No. 2, (343-352).

>  <FLAG_COMMENTS>  (81) 
CYP-MAP:  Referring to the existing reference Leoni, C. et al., S-oxidation has been added to the data as noted in EBoMD.

>  <Name>  (81) 
Fenthion

>  <ID>  (81) 
3346

$$$$
941361
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -3.0735   -5.4571   -0.5171 F   0  0  0  0  0  0  0  0  0  1  0  0
   -6.8332    3.0606   -0.5322 F   0  0  0  0  0  0  0  0  0  2  0  0
   -1.0724    0.5166    0.0313 N   0  0  0  0  0  0  0  0  0  3  0  0
    1.5217    1.7903    0.1158 N   0  0  0  0  0  0  0  0  0  4  0  0
   -0.9373    1.9533    0.3014 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.1169   -0.2063    0.4983 C   0  0  0  0  0  0  0  0  0  6  0  0
   -2.2821   -0.0171    0.6538 C   0  0  2  0  0  0  0  0  0  7  0  0
    0.3320    2.5139   -0.3493 C   0  0  0  0  0  0  0  0  0  8  0  0
    1.3860    0.3535   -0.1534 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.7308    2.3235   -0.5087 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.4959   -1.4900    0.3374 C   0  0  0  0  0  0  0  0  0 11  0  0
   -3.5145    0.8157    0.3334 C   0  0  0  0  0  0  0  0  0 12  0  0
    3.9635    1.6434    0.0090 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.1472   -2.2831    1.2599 C   0  0  0  0  0  0  0  0  0 14  0  0
   -3.8506    1.8599    1.1706 C   0  0  0  0  0  0  0  0  0 15  0  0
   -2.0324   -1.9883   -0.8631 C   0  0  0  0  0  0  0  0  0 16  0  0
   -4.2588    0.5021   -0.7856 C   0  0  0  0  0  0  0  0  0 17  0  0
   -3.3435   -3.6332    0.9691 C   0  0  0  0  0  0  0  0  0 18  0  0
   -4.9802    2.6236    0.8762 C   0  0  0  0  0  0  0  0  0 19  0  0
   -2.2289   -3.3382   -1.1538 C   0  0  0  0  0  0  0  0  0 20  0  0
   -5.3881    1.2660   -1.0801 C   0  0  0  0  0  0  0  0  0 21  0  0
    4.8187    0.9712   -0.7778 C   0  0  0  0  0  0  0  0  0 22  0  0
   -2.8844   -4.1608   -0.2378 C   0  0  0  0  0  0  0  0  0 23  0  0
   -5.7489    2.3267   -0.2492 C   0  0  0  0  0  0  0  0  0 24  0  0
    6.0483    0.3027   -0.3203 C   0  0  0  0  0  0  0  0  0 25  0  0
    6.1868   -0.0218    1.0202 C   0  0  0  0  0  0  0  0  0 26  0  0
    7.0445    0.0096   -1.2382 C   0  0  0  0  0  0  0  0  0 27  0  0
    7.3513   -0.6556    1.4537 C   0  0  0  0  0  0  0  0  0 28  0  0
    8.2090   -0.6243   -0.8048 C   0  0  0  0  0  0  0  0  0 29  0  0
    8.3623   -0.9568    0.5412 C   0  0  0  0  0  0  0  0  0 30  0  0
  1 23  1  0
  2 24  1  0
  3  5  1  0
  3  6  1  0
  7  3  1  6
  4  8  1  0
  4  9  1  0
  4 10  1  0
  5  8  1  0
  6  9  1  0
  7 11  1  0
  7 12  1  0
 10 13  1  0
 11 14  2  0
 11 16  1  0
 12 15  2  0
 12 17  1  0
 13 22  2  0
 14 18  1  0
 15 19  1  0
 16 20  2  0
 17 21  2  0
 18 23  2  0
 19 24  2  0
 20 23  1  0
 21 24  1  0
 22 25  1  0
 25 26  2  0
 25 27  1  0
 26 28  1  0
 27 29  2  0
 28 30  2  0
 29 30  1  0
M  END
>  <InChIKey>  (82) 
SMANXXCATUTDDT-QPJJXVBHSA-N

>  <PubChem_CID>  (82) 
941361

>  <BOM_1A2>  (82) 
<3,7;Dealkylation;R1>
<7,H;Dealkylation;R1>
<10,4;Dealkylation;R2>
<10,H;Dealkylation;R2>

>  <BOM_2A6>  (82) 
<3,7;Dealkylation;R1>
<7,H;Dealkylation;R1>
<10,4;Dealkylation;R2>
<10,H;Dealkylation;R2>

>  <BOM_2B6>  (82) 


>  <BOM_2C8>  (82) 


>  <BOM_2C9>  (82) 
<3,7;Dealkylation;R1>
<7,H;Dealkylation;R1>
<10,4;Dealkylation;R2>
<10,H;Dealkylation;R2>

>  <BOM_2C19>  (82) 


>  <BOM_2D6>  (82) 
<30,H;Hydroxylation;R3>

>  <BOM_2E1>  (82) 


>  <BOM_3A4>  (82) 


>  <References>  (82) 
Rendic, Slobodan. "Summary of information on human CYP enzymes: human P450 metabolism data." Drug metabolism reviews 34.1-2 (2002): 83-448.
Zhou, S-F., et al. "Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development." Current medicinal chemistry 16.27 (2009): 3480-3675.

>  <FLAG_COMMENTS>  (82) 


>  <Name>  (82) 
Flunarizine

>  <ID>  (82) 
941361

$$$$
3083544
     RDKit          3D

 25 26  0  0  1  0  0  0  0  0999 V2000
   -2.8151    3.3368    0.9059 O   0  0  0  0  0  0  0  0  0  1  0  0
    2.8156   -3.3889    0.5834 O   0  0  0  0  0  0  0  0  0  2  0  0
   -2.2576   -2.8257    1.6873 O   0  0  0  0  0  0  0  0  0  3  0  0
   -3.2315   -0.8373   -2.9284 O   0  0  0  0  0  0  0  0  0  4  0  0
    0.5285    2.3873   -0.3861 N   0  0  0  0  0  0  0  0  0  5  0  0
   -2.8740   -2.0869   -0.9507 N   0  0  0  0  0  0  0  0  0  6  0  0
    1.8773    2.9144   -0.1591 C   0  0  1  0  0  0  0  0  0  7  0  0
    2.9019    2.0496   -0.9159 C   0  0  0  0  0  0  0  0  0  8  0  0
   -0.4502    3.1363    0.3842 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.8637    2.5902    0.1485 C   0  0  1  0  0  0  0  0  0 10  0  0
    1.9033    4.3769   -0.6037 C   0  0  0  0  0  0  0  0  0 11  0  0
    2.8784    0.5942   -0.5143 C   0  0  0  0  0  0  0  0  0 12  0  0
   -1.9713    1.1369    0.5551 C   0  0  0  0  0  0  0  0  0 13  0  0
   -2.3713    0.2002   -0.3822 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.0464   -0.2830   -1.1911 C   0  0  0  0  0  0  0  0  0 15  0  0
    3.6899    0.1629    0.5226 C   0  0  0  0  0  0  0  0  0 16  0  0
   -1.6666    0.7753    1.8560 C   0  0  0  0  0  0  0  0  0 17  0  0
   -2.4699   -1.1396   -0.0069 C   0  0  0  0  0  0  0  0  0 18  0  0
   -1.7649   -0.5646    2.2312 C   0  0  0  0  0  0  0  0  0 19  0  0
    2.0251   -1.6276   -0.8209 C   0  0  0  0  0  0  0  0  0 20  0  0
    3.6688   -1.1819    0.8927 C   0  0  0  0  0  0  0  0  0 21  0  0
   -2.1667   -1.5220    1.2998 C   0  0  0  0  0  0  0  0  0 22  0  0
    2.8363   -2.0772    0.2209 C   0  0  0  0  0  0  0  0  0 23  0  0
   -3.2104   -1.8761   -2.2834 C   0  0  0  0  0  0  0  0  0 24  0  0
    1.9417   -4.2501   -0.1448 C   0  0  0  0  0  0  0  0  0 25  0  0
 10  1  1  1
  2 23  1  0
  2 25  1  0
  3 22  1  0
  4 24  2  0
  5  7  1  0
  5  9  1  0
  6 18  1  0
  6 24  1  0
  7  8  1  0
  7 11  1  6
  8 12  1  0
  9 10  1  0
 10 13  1  0
 12 15  2  0
 12 16  1  0
 13 14  2  0
 13 17  1  0
 14 18  1  0
 15 20  1  0
 16 21  2  0
 17 19  2  0
 18 22  2  0
 19 22  1  0
 20 23  2  0
 21 23  1  0
M  END
>  <InChIKey>  (83) 
BPZSYCZIITTYBL-YJYMSZOUSA-N

>  <PubChem_CID>  (83) 
3083544

>  <BOM_1A2>  (83) 


>  <BOM_2A6>  (83) 
<2,25;Dealkylation;R1>
<25,H;Dealkylation;R1>

>  <BOM_2B6>  (83) 


>  <BOM_2C8>  (83) 


>  <BOM_2C9>  (83) 
<2,25;Dealkylation;R1>
<25,H;Dealkylation;R1>

>  <BOM_2C19>  (83) 
<2,25;Dealkylation;R1>
<25,H;Dealkylation;R1>

>  <BOM_2D6>  (83) 
<2,25;Dealkylation;R1>
<25,H;Dealkylation;R1>

>  <BOM_2E1>  (83) 


>  <BOM_3A4>  (83) 


>  <References>  (83) 
Rosenborg, Johan, et al. "Mass balance and metabolism of [3H] formoterol in healthy men after combined iv and oral administration–mimicking inhalation." Drug metabolism and disposition 27.10 (1999): 1104-1116.
PDR; Physicians' Desk Reference 57th ed 2003. Montvale,NJ: Medical Economics Co. p. 2275 (2003)
"PERFOROMIST (Formoterol Fumarate) Inhalation Solution." U.S. Food and Drug Administration, 29 May 2019, www.accessdata.fda.gov/drugsatfda_docs/label/2019/022007s015lbl.pdf. Accessed 8 Mar. 2024.

>  <FLAG_COMMENTS>  (83) 


>  <Name>  (83) 
Formoterol

>  <ID>  (83) 
3083544

$$$$
3902
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0488    2.1750   -0.1529 N   0  0  0  0  0  0  0  0  0  1  0  0
    0.5991    2.3578    1.0251 N   0  0  0  0  0  0  0  0  0  2  0  0
   -0.1817    4.2817    0.0652 N   0  0  0  0  0  0  0  0  0  3  0  0
   -5.9267   -2.4767    0.5053 N   0  0  0  0  0  0  0  0  0  4  0  0
    5.8144   -2.6423    0.5551 N   0  0  0  0  0  0  0  0  0  5  0  0
   -0.0037    0.7872   -0.7151 C   0  0  2  0  0  0  0  0  0  6  0  0
   -1.2897    0.0797   -0.4508 C   0  0  0  0  0  0  0  0  0  7  0  0
    1.2989    0.0185   -0.4316 C   0  0  0  0  0  0  0  0  0  8  0  0
   -1.8452   -0.7463   -1.4280 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.3901    0.2736   -1.2228 C   0  0  0  0  0  0  0  0  0 10  0  0
   -1.9366    0.2435    0.7741 C   0  0  0  0  0  0  0  0  0 11  0  0
    1.3083   -0.8858    0.6000 C   0  0  0  0  0  0  0  0  0 12  0  0
   -0.4151    3.2701   -0.7383 C   0  0  0  0  0  0  0  0  0 13  0  0
   -3.0478   -1.4084   -1.1804 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.5708   -0.4229   -0.9653 C   0  0  0  0  0  0  0  0  0 15  0  0
   -3.1391   -0.4188    1.0216 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.4891   -1.5821    0.8576 C   0  0  0  0  0  0  0  0  0 17  0  0
   -3.6946   -1.2447    0.0444 C   0  0  0  0  0  0  0  0  0 18  0  0
    3.6203   -1.3506    0.0749 C   0  0  0  0  0  0  0  0  0 19  0  0
    0.4354    3.6787    1.1236 C   0  0  0  0  0  0  0  0  0 20  0  0
   -4.9257   -1.9243    0.2986 C   0  0  0  0  0  0  0  0  0 21  0  0
    4.8305   -2.0630    0.3397 C   0  0  0  0  0  0  0  0  0 22  0  0
  1  2  1  0
  6  1  1  1
  1 13  1  0
  2 20  2  0
  3 13  2  0
  3 20  1  0
  4 21  3  0
  5 22  3  0
  6  7  1  0
  6  8  1  0
  7  9  2  0
  7 11  1  0
  8 10  2  0
  8 12  1  0
  9 14  1  0
 10 15  1  0
 11 16  2  0
 12 17  2  0
 14 18  2  0
 15 19  2  0
 16 18  1  0
 17 19  1  0
 18 21  1  0
 19 22  1  0
M  END
>  <InChIKey>  (84) 
HPJKCIUCZWXJDR-UHFFFAOYSA-N

>  <PubChem_CID>  (84) 
3902

>  <BOM_1A2>  (84) 


>  <BOM_2A6>  (84) 
<1,6;Dealkylation;R1>
<6,H;Dealkylation;R1>

>  <BOM_2B6>  (84) 


>  <BOM_2C8>  (84) 


>  <BOM_2C9>  (84) 


>  <BOM_2C19>  (84) 


>  <BOM_2D6>  (84) 


>  <BOM_2E1>  (84) 


>  <BOM_3A4>  (84) 
<1,6;Dealkylation;R1>
<6,H;Dealkylation;R1>

>  <References>  (84) 
Jeong, Seongwook, et al. "Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4, 4  -methanol-bisbenzonitrile in vitro." Cancer chemotherapy and pharmacology 64.5 (2009): 867-875.
Desta, Z., B. A. Ward, and D. A. Flockhart. "In vitro letrozole N‐dealkylation is mainly catalyzed by human cytochrome P450 (CYP) 3A." Clinical Pharmacology & Therapeutics 77.2 (2005): P79-P79.

>  <FLAG_COMMENTS>  (84) 


>  <Name>  (84) 
Letrozole

>  <ID>  (84) 
3902

$$$$
5206
     RDKit          3D

 12 11  0  0  0  0  0  0  0  0999 V2000
    1.2852   -1.7729   -0.3891 F   0  0  0  0  0  0  0  0  0  1  0  0
    0.0143   -1.3472    1.3282 F   0  0  0  0  0  0  0  0  0  2  0  0
   -0.8714   -2.0796   -0.5270 F   0  0  0  0  0  0  0  0  0  3  0  0
   -2.4368    0.0880   -0.5846 F   0  0  0  0  0  0  0  0  0  4  0  0
   -1.5027    2.0543   -0.4320 F   0  0  0  0  0  0  0  0  0  5  0  0
   -1.5295    0.7172    1.2925 F   0  0  0  0  0  0  0  0  0  6  0  0
    3.2025    1.2778    0.1765 F   0  0  0  0  0  0  0  0  0  7  0  0
    0.9768    0.9476    0.0483 O   0  0  0  0  0  0  0  0  0  8  0  0
   -0.0791    0.1569   -0.4888 C   0  0  1  0  0  0  0  0  0  9  0  0
    0.0855   -1.2739   -0.0197 C   0  0  2  0  0  0  0  0  0 10  0  0
   -1.3951    0.7639   -0.0508 C   0  0  1  0  0  0  0  0  0 11  0  0
    2.2503    0.4680   -0.3535 C   0  0  0  0  0  0  0  0  0 12  0  0
 10  1  1  6
  2 10  1  0
  3 10  1  0
 11  4  1  6
  5 11  1  0
  6 11  1  0
  7 12  1  0
  9  8  1  1
  8 12  1  0
  9 10  1  0
  9 11  1  0
M  END
>  <InChIKey>  (85) 
DFEYYRMXOJXZRJ-UHFFFAOYSA-N

>  <PubChem_CID>  (85) 
5206

>  <BOM_1A2>  (85) 


>  <BOM_2A6>  (85) 
<12,8;Dealkylation;R1>
<12,H;Dealkylation;R1>

>  <BOM_2B6>  (85) 
<12,8;Dealkylation;R1>
<12,H;Dealkylation;R1>

>  <BOM_2C8>  (85) 


>  <BOM_2C9>  (85) 


>  <BOM_2C19>  (85) 


>  <BOM_2D6>  (85) 


>  <BOM_2E1>  (85) 
<12,8;Dealkylation;R1>
<12,H;Dealkylation;R1>

>  <BOM_3A4>  (85) 
<12,8;Dealkylation;R1>
<12,H;Dealkylation;R1>

>  <References>  (85) 
Kharasch, Evan D., Douglas C. Hankins, and Kenneth E. Thummel. "Human kidney methoxyflurane and sevoflurane metabolism: intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity." The Journal of the American Society of Anesthesiologists 82.3 (1995): 689-699.
Chang, G. W. M., and P. C. A. Kam. "The physiological and pharmacological roles of cytochrome P450 isoenzymes." Anaesthesia 54.1 (1999): 42-50.

>  <FLAG_COMMENTS>  (85) 


>  <Name>  (85) 
Sevoflurane

>  <ID>  (85) 
5206

$$$$
42586
     RDKit          3D

 20 20  0  0  1  0  0  0  0  0999 V2000
    3.8417    0.6531   -0.4189 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2738   -3.4391    0.1024 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9752   -2.3805   -0.5609 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5539   -0.5969    1.0177 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2662   -0.1176   -0.4130 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4866    0.5178   -0.8399 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.8745    0.7298   -0.0687 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9912    1.1412    1.2271 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7483    1.0533   -1.0656 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3135    2.0286   -0.8456 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1155   -1.5308   -0.3095 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6697    0.1237    0.0316 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0801    1.9487    1.5558 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8371    1.8609   -0.7368 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200    0.7720    2.3014 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5980    0.5895   -2.4783 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0029    2.3086    0.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2587   -2.0274    0.1019 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0078    0.3215    0.3423 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5455   -3.9565    0.4829 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  1 19  1  0
  2 18  1  0
  2 20  1  0
  3 11  2  0
  4 12  2  0
  5  6  1  0
  5  7  1  0
  5 11  1  0
  6 10  1  1
  6 12  1  0
  7  8  2  0
  7  9  1  0
  8 13  1  0
  8 15  1  0
  9 14  2  0
  9 16  1  0
 11 18  1  0
 13 17  2  0
 14 17  1  0
M  END
>  <InChIKey>  (86) 
ZQEIXNIJLIKNTD-UHFFFAOYSA-N

>  <PubChem_CID>  (86) 
42586

>  <BOM_1A2>  (86) 


>  <BOM_2A6>  (86) 


>  <BOM_2B6>  (86) 
<20,2;Dealkylation;R1>
<20,H;Dealkylation;R1>
<19,1;Dealkylation;R2>
<19,H;Dealkylation;R2>

>  <BOM_2C8>  (86) 


>  <BOM_2C9>  (86) 


>  <BOM_2C19>  (86) 


>  <BOM_2D6>  (86) 


>  <BOM_2E1>  (86) 


>  <BOM_3A4>  (86) 
<20,2;Dealkylation;R1>
<20,H;Dealkylation;R1>
<19,1;Dealkylation;R2>
<19,H;Dealkylation;R2>
<16,H;Hydroxylation;R3>
<15,H;Hydroxylation;R3>
<14,H;Hydroxylation;R4>
<13,H;Hydroxylation;R4>

>  <References>  (86) 
Abass, Khaled, et al. "In vitro metabolism and interactions of the fungicide metalaxyl in human liver preparations." Environmental Toxicology and Pharmacology 23.1 (2007): 39-47.

>  <FLAG_COMMENTS>  (86) 


>  <Name>  (86) 
Metalaxyl

>  <ID>  (86) 
42586

$$$$
6557
     RDKit          3D

  5  4  0  0  0  0  0  0  0  0999 V2000
   -0.5185    0.0447   -0.0001 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.6822   -1.4501    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.8202    0.6168    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.5949    0.8486    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    1.9754   -0.0600    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  3  5  2  0
M  END
>  <InChIKey>  (87) 
RRHGJUQNOFWUDK-UHFFFAOYSA-N

>  <PubChem_CID>  (87) 
6557

>  <BOM_1A2>  (87) 


>  <BOM_2A6>  (87) 


>  <BOM_2B6>  (87) 
<3,5;Epoxidation;R1>
<1,4;Epoxidation;R2>

>  <BOM_2C8>  (87) 


>  <BOM_2C9>  (87) 


>  <BOM_2C19>  (87) 


>  <BOM_2D6>  (87) 


>  <BOM_2E1>  (87) 
<3,5;Epoxidation;R1>
<1,4;Epoxidation;R2>

>  <BOM_3A4>  (87) 


>  <References>  (87) 
Bogaards, Jan JP, Joke C. Venekamp, and Peter J. van Bladeren. "The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes." Chemico-biological interactions 102.3 (1996): 169-182.

>  <FLAG_COMMENTS>  (87) 


>  <Name>  (87) 
Isoprene

>  <ID>  (87) 
6557

$$$$
6426760
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   -5.7848   -6.4892    0.0000 F   0  0  0  0  0  0  0  0  0  1  0  0
   -5.5298   -5.7046    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.0819   -5.0915    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -5.8269   -4.3068    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.0200   -4.1353    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -4.4679   -4.7484    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -3.6610   -4.5769    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -3.4060   -3.7923    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -2.5990   -3.6207    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
   -2.3441   -2.8361    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -1.5371   -2.6646    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.9851   -3.2777    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
   -0.1781   -3.1062    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.0768   -2.3215    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.8838   -2.1500    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.1387   -1.3654    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    0.6538   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.1387   -0.0305    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
    1.9233   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    2.6378    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    3.3523   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    3.3523   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    2.6378   -1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    1.9233   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    4.0668   -1.5229    0.0000 N   0  0  0  0  0  0  0  0  0 25  0  0
    4.8204   -1.1874    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    5.3725   -1.8005    0.0000 N   0  0  0  0  0  0  0  0  0 27  0  0
    4.9600   -2.5150    0.0000 N   0  0  0  0  0  0  0  0  0 28  0  0
    4.1530   -2.3434    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
   -1.2400   -4.0623    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
   -2.0470   -4.2338    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
   -4.7229   -5.5330    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 16 24  1  0
 19 24  1  0
 22 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 25 29  1  0
 12 30  1  0
 30 31  1  0
  9 31  1  0
  6 32  2  0
  2 32  1  0
M  END
>  <InChIKey>  (88) 
ZUTQCPBDRJBADG-UHFFFAOYSA-N 

>  <PubChem_CID>  (88) 
6426760

>  <BOM_1A2>  (88) 


>  <BOM_2A6>  (88) 


>  <BOM_2B6>  (88) 


>  <BOM_2C8>  (88) 
<8,9;Dealkylation;R1>
<8,H;Dealkylation;R1>
<7,H;Hydroxylation;R2>

>  <BOM_2C9>  (88) 


>  <BOM_2C19>  (88) 


>  <BOM_2D6>  (88) 


>  <BOM_2E1>  (88) 


>  <BOM_3A4>  (88) 
<8,9;Dealkylation;R1>
<8,H;Dealkylation;R1>
<7,H;Hydroxylation;R2>

>  <References>  (88) 
Prueksaritanont, T., et al. "Interspecies comparison and role of human cytochrome P450 and flavin-containing monooxygenase in hepatic metabolism of L-775,606, a potent 5-HT1D receptor agonist." Xenobiotica 30.1 (2000): 47-59.

>  <FLAG_COMMENTS>  (88) 


>  <Name>  (88) 
L-775606

>  <ID>  (88) 
6426760

$$$$
115368
     RDKit          2D

 30 34  0  0  1  0  0  0  0  0999 V2000
    0.2716   -9.9932    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.5130   -9.7382    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -0.6846   -8.9313    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -0.0715   -8.3792    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.7132   -8.6342    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.8847   -9.4412    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    1.1981   -7.9667    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    2.0231   -7.9667    0.0000 O   0  0  0  0  0  0  0  0  0  8  0  0
    0.7132   -7.2993    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
   -0.0715   -7.5542    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.7389   -7.0693    0.0000 O   0  0  0  0  0  0  0  0  0 11  0  0
    0.9681   -6.5147    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.4161   -5.9016    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.6710   -5.1170    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.1190   -4.5039    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.3739   -3.7192    0.0000 N   0  0  0  0  0  0  0  0  0 16  0  0
   -0.1781   -3.1062    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    0.0768   -2.3215    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.8838   -2.1500    0.0000 N   0  0  0  0  0  0  0  0  0 19  0  0
    1.4358   -2.7631    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    1.1809   -3.5477    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    1.1387   -1.3654    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    0.6538   -0.6979    0.0000 N   0  0  0  0  0  0  0  0  0 23  0  0
    1.1387   -0.0305    0.0000 S   0  0  0  0  0  0  0  0  0 24  0  0
    1.9233   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    2.6378    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    3.3523   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    3.3523   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    2.6378   -1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    1.9233   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
  1  2  1  0
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  6
  1  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  4 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 16 21  1  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 25 30  1  0
 22 30  1  0
M  END
>  <InChIKey>  (89) 
FBVFZWUMDDXLLG-HDICACEKSA-N

>  <PubChem_CID>  (89) 
115368

>  <BOM_1A2>  (89) 


>  <BOM_2A6>  (89) 


>  <BOM_2B6>  (89) 


>  <BOM_2C8>  (89) 
<15,16;Dealkylation;R2>
<15,H;Dealkylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R3>
<1,H;Hydroxylation;R4>
<2,H;Hydroxylation;R4>

>  <BOM_2C9>  (89) 


>  <BOM_2C19>  (89) 


>  <BOM_2D6>  (89) 
<1,H;Hydroxylation;R4>
<2,H;Hydroxylation;R4>

>  <BOM_2E1>  (89) 


>  <BOM_3A4>  (89) 
<4,5;Dehydrogenation;R1>
<15,16;Dealkylation;R2>
<15,H;Dealkylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R3>

>  <References>  (89) 
Suzuki, Yutaro, et al. "The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients." Progress in Neuro-Psychopharmacology and Biological Psychiatry 34.6 (2010): 830-833.
Mizuno, Y., Tani, N., Komuro, S. et al. In vitro metabolism of perospirone in rat, monkey and human liver microsomes. Eur. J. Drug Metab. Pharmacokinet. 28, 59–65 (2003). https://doi.org/10.1007/BF03190868

>  <FLAG_COMMENTS>  (89) 


>  <Name>  (89) 
Perospirone

>  <ID>  (89) 
115368

$$$$
15951529
     RDKit          3D

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.1657    1.1150    1.4113 S   0  0  0  0  0  0  0  0  0  1  0  0
   -5.8995   -1.4283    0.5251 F   0  0  0  0  0  0  0  0  0  2  0  0
    3.6195    3.1488   -0.3259 F   0  0  0  0  0  0  0  0  0  3  0  0
    5.4054    2.7851    0.8497 F   0  0  0  0  0  0  0  0  0  4  0  0
    5.4545    2.5188   -1.3079 F   0  0  0  0  0  0  0  0  0  5  0  0
    1.3282   -3.2530   -0.8529 O   0  0  0  0  0  0  0  0  0  6  0  0
   -7.2932    0.5451   -0.4942 O   0  0  0  0  0  0  0  0  0  7  0  0
   -1.1211   -1.0095    0.1636 N   0  0  0  0  0  0  0  0  0  8  0  0
    1.1445   -1.1134    0.0966 N   0  0  0  0  0  0  0  0  0  9  0  0
   -6.4271    2.6213    0.0680 N   0  0  0  0  0  0  0  0  0 10  0  0
    7.7793    0.4166    0.0864 N   0  0  0  0  0  0  0  0  0 11  0  0
   -0.8343   -2.4126   -0.1432 C   0  0  1  0  0  0  0  0  0 12  0  0
    0.6786   -2.3323   -0.3672 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.0280   -3.3515    1.0563 C   0  0  0  0  0  0  0  0  0 14  0  0
   -1.4871   -2.9445   -1.4218 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.0764   -0.3061    0.5093 C   0  0  0  0  0  0  0  0  0 16  0  0
   -2.4336   -0.4389    0.0707 C   0  0  0  0  0  0  0  0  0 17  0  0
    2.5338   -0.7823    0.0933 C   0  0  0  0  0  0  0  0  0 18  0  0
   -3.5521   -1.2222    0.3468 C   0  0  0  0  0  0  0  0  0 19  0  0
   -2.5854    0.8970   -0.2947 C   0  0  0  0  0  0  0  0  0 20  0  0
    2.9347    0.5465   -0.0476 C   0  0  0  0  0  0  0  0  0 21  0  0
    3.4906   -1.7880    0.2314 C   0  0  0  0  0  0  0  0  0 22  0  0
   -4.8287   -0.6672    0.2571 C   0  0  0  0  0  0  0  0  0 23  0  0
   -3.8620    1.4519   -0.3847 C   0  0  0  0  0  0  0  0  0 24  0  0
    4.2917    0.8694   -0.0506 C   0  0  0  0  0  0  0  0  0 25  0  0
   -4.9835    0.6700   -0.1087 C   0  0  0  0  0  0  0  0  0 26  0  0
    4.8476   -1.4651    0.2286 C   0  0  0  0  0  0  0  0  0 27  0  0
    5.2482   -0.1364    0.0874 C   0  0  0  0  0  0  0  0  0 28  0  0
    4.6841    2.3041   -0.2038 C   0  0  2  0  0  0  0  0  0 29  0  0
   -6.3128    1.2531   -0.2036 C   0  0  0  0  0  0  0  0  0 30  0  0
    6.6466    0.1690    0.0869 C   0  0  0  0  0  0  0  0  0 31  0  0
   -7.6809    3.3396    0.0382 C   0  0  0  0  0  0  0  0  0 32  0  0
  1 16  2  0
  2 23  1  0
 29  3  1  6
  4 29  1  0
  5 29  1  0
  6 13  2  0
  7 30  2  0
  8 12  1  0
  8 16  1  0
  8 17  1  0
  9 13  1  0
  9 16  1  0
  9 18  1  0
 10 30  1  0
 10 32  1  0
 11 31  3  0
 12 13  1  0
 12 14  1  1
 12 15  1  0
 17 19  2  0
 17 20  1  0
 18 21  2  0
 18 22  1  0
 19 23  1  0
 20 24  2  0
 21 25  1  0
 22 27  2  0
 23 26  2  0
 24 26  1  0
 25 28  2  0
 25 29  1  0
 26 30  1  0
 27 28  1  0
 28 31  1  0
M  END
>  <InChIKey>  (90) 
WXCXUHSOUPDCQV-UHFFFAOYSA-N

>  <PubChem_CID>  (90) 
15951529

>  <BOM_1A2>  (90) 


>  <BOM_2A6>  (90) 


>  <BOM_2B6>  (90) 


>  <BOM_2C8>  (90) 
<10,32;Dealkylation;R1>
<32,H;Dealkylation;R1>

>  <BOM_2C9>  (90) 


>  <BOM_2C19>  (90) 


>  <BOM_2D6>  (90) 


>  <BOM_2E1>  (90) 


>  <BOM_3A4>  (90) 
<10,32;Dealkylation;R1>
<32,H;Dealkylation;R1>

>  <References>  (90) 
Benoist, Guillemette E., et al. "Pharmacokinetic aspects of the two novel oral drugs used for metastatic castration-resistant prostate cancer: abiraterone acetate and enzalutamide." Clinical pharmacokinetics 55.11 (2016): 1369-1380.

>  <FLAG_COMMENTS>  (90) 


>  <Name>  (90) 
Enzalutamide

>  <ID>  (90) 
15951529

$$$$
3152
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -0.5837   -5.6992    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -1.4087   -5.6992    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -1.8212   -4.9848    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -1.4087   -4.2703    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -0.5837   -4.2703    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -0.1712   -4.9848    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -1.8212   -3.5558    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -1.4087   -2.8414    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
   -1.8212   -2.1269    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -1.4087   -1.4124    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -0.5837   -1.4124    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -0.1712   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.6538   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    1.1387   -0.0305    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.8838    0.7541    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
    1.9233   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.6378    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    3.3523   -0.2854    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    4.0668    0.1271    0.0000 O   0  0  0  0  0  0  0  0  0 19  0  0
    4.0668    0.9521    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    3.3523   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    4.0668   -1.5229    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
    4.0668   -2.3479    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.6378   -1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    1.9233   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    1.1387   -1.3654    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -0.1712   -2.1269    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -0.5837   -2.8414    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  2  0
 21 22  1  0
 22 23  1  0
 21 24  1  0
 24 25  2  0
 16 25  1  0
 25 26  1  0
 13 26  1  0
 11 27  1  0
 27 28  1  0
  8 28  1  0
M  END
>  <InChIKey>  (91) 
ADEBPBSSDYVVLD-UHFFFAOYNA-N

>  <PubChem_CID>  (91) 
3152

>  <BOM_1A2>  (91) 


>  <BOM_2A6>  (91) 


>  <BOM_2B6>  (91) 


>  <BOM_2C8>  (91) 


>  <BOM_2C9>  (91) 
<22,23;Dealkylation;R1>
<23,H;Dealkylation;R1>
<7,8;Dealkylation;R2>
<7,H;Dealkylation;R2>
<19,20;Dealkylation;R3>
<20,H;Dealkylation;R3>

>  <BOM_2C19>  (91) 


>  <BOM_2D6>  (91) 
<22,23;Dealkylation;R1>
<23,H;Dealkylation;R1>
<8,N;N-Oxidation;R4>

>  <BOM_2E1>  (91) 


>  <BOM_3A4>  (91) 
<22,23;Dealkylation;R1>
<23,H;Dealkylation;R1>
<7,8;Dealkylation;R2>
<7,H;Dealkylation;R2>
<19,20;Dealkylation;R3>
<20,H;Dealkylation;R3>
<8,N;N-Oxidation;R4>

>  <References>  (91) 
Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677
Seltzer B: Donepezil: a review. Expert Opin Drug Metab Toxicol. 2005 Oct;1(3):527-36. doi: 10.1517/17425255.1.3.527 .

>  <FLAG_COMMENTS>  (91) 


>  <Name>  (91) 
Donepezil

>  <ID>  (91) 
3152

$$$$
6291
     RDKit          2D

 23 26  0  0  1  0  0  0  0  0999 V2000
   -2.8207   -0.5585    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
   -2.5008   -1.3814    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -3.3129   -1.2362    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -4.1250   -1.0910    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -2.7301   -2.1739    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -2.0473   -2.6369    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -1.3959   -2.1305    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -0.5838   -2.2757    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -0.3035   -3.0516    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    0.5086   -3.1969    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    1.0404   -2.5662    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
    0.7601   -1.7902    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    1.2920   -1.1595    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    2.1041   -1.3047    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.3844   -2.0807    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    3.1965   -2.2259    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
    3.7283   -1.5952    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.8526   -2.7114    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -0.0520   -1.6450    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -0.3323   -0.8691    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -1.1444   -0.7239    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -1.6762   -1.3546    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -1.8575   -0.6122    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
  2  1  1  6
  2  3  1  0
  3  4  3  0
  2  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  2  0
 11 18  1  0
 12 19  1  0
  8 19  1  0
 19 20  1  6
 20 21  1  0
 21 22  1  0
  2 22  1  0
  7 22  1  0
 22 23  1  6
M  END
>  <InChIKey>  (92) 
IMSSROKUHAOUJS-MJCUULBUSA-N

>  <PubChem_CID>  (92) 
6291

>  <BOM_1A2>  (92) 


>  <BOM_2A6>  (92) 


>  <BOM_2B6>  (92) 


>  <BOM_2C8>  (92) 


>  <BOM_2C9>  (92) 
<16,17;Dealkylation;R1>
<17,H;Dealkylation;R1>

>  <BOM_2C19>  (92) 


>  <BOM_2D6>  (92) 


>  <BOM_2E1>  (92) 


>  <BOM_3A4>  (92) 


>  <References>  (92) 
(R1) Zhou, S-F., et al. "Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development." Current medicinal chemistry 16.27 (2009): 3480-3675.

>  <FLAG_COMMENTS>  (92) 


>  <Name>  (92) 
Mestranol

>  <ID>  (92) 
6291

$$$$
4927
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.7145    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
    1.4289    2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.1434    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    2.1434    1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  4  0  0
    2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    3.5724    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.2868    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    4.2868    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    3.5724   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.8579    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    2.1434   -0.4125    0.0000 S   0  0  0  0  0  0  0  0  0 11  0  0
    1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    0.7145   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    1.4289    3.3000    0.0000 N   0  0  0  0  0  0  0  0  0 18  0  0
    0.7145    3.7125    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    2.1434    3.7125    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  5 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  4 17  1  0
 12 17  1  0
  2 18  1  0
 18 19  1  0
 18 20  1  0
M  END
>  <InChIKey>  (93) 
PWWVAXIEGOYWEE-UHFFFAOYSA-N

>  <PubChem_CID>  (93) 
4927

>  <BOM_1A2>  (93) 


>  <BOM_2A6>  (93) 


>  <BOM_2B6>  (93) 


>  <BOM_2C8>  (93) 


>  <BOM_2C9>  (93) 


>  <BOM_2C19>  (93) 


>  <BOM_2D6>  (93) 
<18,19;Dealkylation;R1>
<19,H;Dealkylation;R1>
<18,20;Dealkylation;R1>
<20,H;Dealkylation;R1>
<11,S;S-Oxidation;R2>
<14,H;Hydroxylation;R3>
<8,H;Hydroxylation;R3>
<18,N;N-Oxidation;R4>

>  <BOM_2E1>  (93) 


>  <BOM_3A4>  (93) 


>  <References>  (93) 
Rudik, Anastasia V., et al. "Prediction of reacting atoms for the major biotransformation reactions of organic xenobiotics." Journal of cheminformatics 8 (2016): 1-9.
Nakamura, Katsunori, et al. "CYP2D6 is the principal cytochrome P450 responsible for metabolism of the histamine 111 antagonist promethazine in human liver microsomes." Pharmacogenetics and Genomics 6.5 (1996): 449-457.
CYP-MAP:  Eh-Haj, Babiker M. "Metabolic N-dealkylation and N-oxidation as elucidators of the role of alkylamino moieties in drugs acting at various receptors." Molecules 26.7 (2021): 1917.

>  <FLAG_COMMENTS>  (93) 


>  <Name>  (93) 
Promethazine

>  <ID>  (93) 
4927

$$$$
3033767
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -7.1447   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -7.1447   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -6.4302   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
   -6.4302   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -5.7158    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -5.7158    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -5.0013    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
   -4.2868    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -3.5724    1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  9  0  0
   -2.8579    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
   -2.1434    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 11  0  0
   -1.4289    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
   -0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -4.2868    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -5.0013   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
   -7.1447    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
   -7.8592   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -8.5737    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -8.5737    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
   -7.8592    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -7.8592    2.0625    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
   -7.1447    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -5.7158   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
   -5.0013   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -4.2868   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -4.2868   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -5.0013   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
   -5.7158   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
  8 15  1  0
 15 16  2  0
  5 16  1  0
  4 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 17 23  1  0
  3 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 24 29  1  0
M  END
>  <InChIKey>  (94) 
ZQZFYGIXNQKOAV-OCEACIFDSA-N

>  <PubChem_CID>  (94) 
3033767

>  <BOM_1A2>  (94) 


>  <BOM_2A6>  (94) 


>  <BOM_2B6>  (94) 


>  <BOM_2C8>  (94) 


>  <BOM_2C9>  (94) 


>  <BOM_2C19>  (94) 


>  <BOM_2D6>  (94) 
<12,14;Dealkylation;R1>
<14,H;Dealkylation;R1>
<12,13;Dealkylation;R1>
<13,H;Dealkylation;R1>
<20,H;Hydroxylation;R2>

>  <BOM_2E1>  (94) 


>  <BOM_3A4>  (94) 
<12,14;Dealkylation;R1>
<14,H;Dealkylation;R1>
<12,13;Dealkylation;R1>
<13,H;Dealkylation;R1>
<20,H;Hydroxylation;R2>

>  <References>  (94) 
Zhou, Shu-Feng. "Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II." Clinical pharmacokinetics 48 (2009): 761-804.
Dehal, Shangara S., and David Kupfer. "Cytochrome P-450 3A and 2D6 catalyze orthohydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins." Drug metabolism and disposition 27.6 (1999): 681-688.

>  <FLAG_COMMENTS>  (94) 


>  <Name>  (94) 
Droloxifene

>  <ID>  (94) 
3033767

$$$$
43815
     RDKit          2D

 24 27  0  0  1  0  0  0  0  0999 V2000
    4.9279    4.4104    0.0000 F   0  0  0  0  0  0  0  0  0  1  0  0
    4.9279    3.5854    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    5.6424    3.1729    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    5.6424    2.3479    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    4.9279    1.9354    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    4.2135    2.3479    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    4.2135    3.1729    0.0000 C   0  0  0  0  0  0  0  0  0  7  0  0
    4.9279    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    5.6424    0.6979    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    5.6424   -0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    4.9279   -0.5396    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
    4.2135   -0.1271    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    4.2135    0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    3.4990    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    2.7845    0.6979    0.0000 O   0  0  0  0  0  0  0  0  0 15  0  0
    2.0701    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    1.3556    0.6979    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    0.6411    1.1104    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    0.6411    1.9354    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
   -0.1435    2.1904    0.0000 O   0  0  0  0  0  0  0  0  0 20  0  0
   -0.6284    1.5229    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
   -0.1435    0.8555    0.0000 O   0  0  0  0  0  0  0  0  0 22  0  0
    1.3556    2.3479    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.0701    1.9354    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  2  7  1  0
  8  5  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  8 13  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 18 22  1  0
 19 23  1  0
 23 24  2  0
 16 24  1  0
M  END
>  <InChIKey>  (95) 
AHOUBRCZNHFOSL-YOEHRIQHSA-N

>  <PubChem_CID>  (95) 
43815

>  <BOM_1A2>  (95) 
<20,21;Dealkylation;R1>
<21,22;Dealkylation;R1>
<21,H;Dealkylation;R1>

>  <BOM_2A6>  (95) 


>  <BOM_2B6>  (95) 


>  <BOM_2C8>  (95) 


>  <BOM_2C9>  (95) 


>  <BOM_2C19>  (95) 
<20,21;Dealkylation;R1>
<21,22;Dealkylation;R1>
<21,H;Dealkylation;R1>

>  <BOM_2D6>  (95) 
<20,21;Dealkylation;R1>
<21,22;Dealkylation;R1>
<21,H;Dealkylation;R1>

>  <BOM_2E1>  (95) 


>  <BOM_3A4>  (95) 
<20,21;Dealkylation;R1>
<21,22;Dealkylation;R1>
<21,H;Dealkylation;R1>

>  <References>  (95) 
Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. PMID: 19817501.
Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. PMID: 19902987.
Jornil, Jakob, et al. "Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator." Drug Metabolism and Disposition 38.3 (2010): 376-385.

>  <FLAG_COMMENTS>  (95) 
CYP-MAP: Based on Jornil, Jakob, et al., a subtype involving metabolism was added.

>  <Name>  (95) 
Paroxetine

>  <ID>  (95) 
43815

$$$$
2218
     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -1.1810   -3.4491    0.0000 C   0  0  0  0  0  0  0  0  0  1  0  0
   -0.7685   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    0.0565   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    0.4690   -3.4491    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
    0.0565   -4.1636    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -0.7685   -4.1636    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
    1.2940   -3.4491    0.0000 N   0  0  0  0  0  0  0  0  0  7  0  0
    1.7065   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
    2.5315   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
    2.9440   -2.0202    0.0000 C   0  0  0  0  0  0  0  0  0 10  0  0
    3.7690   -2.0202    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
    4.1815   -1.3057    0.0000 C   0  0  0  0  0  0  0  0  0 12  0  0
    5.0065   -1.3057    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
    4.1815   -2.7346    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.7690   -3.4491    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    1.7065   -4.1636    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    2.5270   -4.2498    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    2.6985   -5.0568    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    3.4130   -5.4693    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    3.4130   -6.2943    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    2.6985   -6.7068    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    1.9840   -6.2943    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    1.9840   -5.4693    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    1.3709   -4.9173    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 18 23  1  0
 23 24  1  0
 16 24  1  0
M  END
>  <InChIKey>  (96) 
NZLBHDRPUJLHCE-UHFFFAOYSA-N

>  <PubChem_CID>  (96) 
2218

>  <BOM_1A2>  (96) 


>  <BOM_2A6>  (96) 


>  <BOM_2B6>  (96) 


>  <BOM_2C8>  (96) 


>  <BOM_2C9>  (96) 


>  <BOM_2C19>  (96) 


>  <BOM_2D6>  (96) 
<11,12;Dealkylation;R1>
<12,H;Dealkylation;R1>
<11,14;Dealkylation;R1>
<14,H;Dealkylation;R1>
<21,H;Hydroxylation;R2>
<20,H;Hydroxylation;R2>
<1,H;Hydroxylation;R3>

>  <BOM_2E1>  (96) 


>  <BOM_3A4>  (96) 


>  <References>  (96) 
(R1) Brown, Caitlin M., Brad Reisfeld, and Arthur N. Mayeno. "Cytochromes P450: a structure-based summary of biotransformations using representative substrates." Drug metabolism reviews 40.1 (2008): 1-100.
Ebner, T., and M. Eichelbaum. "The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism." British journal of clinical pharmacology 35.4 (1993): 426-430.

>  <FLAG_COMMENTS>  (96) 


>  <Name>  (96) 
Aprindine

>  <ID>  (96) 
2218

$$$$
6604414
     RDKit          2D

 28 29  0  0  1  0  0  0  0  0999 V2000
   -7.2995    1.5848    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
   -8.0139    1.1723    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -8.7284    1.5848    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
   -8.0139    0.3473    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -7.2995   -0.0652    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
   -7.2995   -0.8902    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
   -6.5850   -1.3027    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
   -6.5850   -2.1277    0.0000 C   0  0  0  0  0  0  0  0  0  8  0  0
   -5.8705   -2.5402    0.0000 C   0  0  0  0  0  0  0  0  0  9  0  0
   -5.1561   -2.9527    0.0000 F   0  0  0  0  0  0  0  0  0 10  0  0
   -5.4580   -1.8257    0.0000 F   0  0  0  0  0  0  0  0  0 11  0  0
   -6.2830   -3.2546    0.0000 F   0  0  0  0  0  0  0  0  0 12  0  0
   -8.0139   -1.3027    0.0000 C   0  0  0  0  0  0  0  0  0 13  0  0
   -8.7284   -0.8902    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
   -8.7284   -0.0652    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
   -9.4429    0.3473    0.0000 O   0  0  0  0  0  0  0  0  0 16  0  0
   -9.4429    1.1723    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
  -10.1574    1.5848    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
   -9.7449    2.2993    0.0000 F   0  0  0  0  0  0  0  0  0 19  0  0
  -10.5699    0.8704    0.0000 F   0  0  0  0  0  0  0  0  0 20  0  0
  -10.8718    1.9973    0.0000 F   0  0  0  0  0  0  0  0  0 21  0  0
   -7.2995    2.4098    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
   -8.0139    2.8223    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
   -8.7284    2.4098    0.0000 N   0  0  0  0  0  0  0  0  0 24  0  0
   -9.4429    2.8223    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
   -9.4429    3.6473    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
   -8.7284    4.0598    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
   -8.0139    3.6473    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
  6 13  2  0
 13 14  1  0
 14 15  2  0
  4 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
  1 22  1  0
 23 22  1  1
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 23 28  1  0
M  END
>  <InChIKey>  (97) 
DJBNUMBKLMJRSA-LDGXTIHJNA-N

>  <PubChem_CID>  (97) 
6604414

>  <BOM_1A2>  (97) 
<7,8;Dealkylation;R1>
<8,H;Dealkylation;R1>

>  <BOM_2A6>  (97) 


>  <BOM_2B6>  (97) 


>  <BOM_2C8>  (97) 


>  <BOM_2C9>  (97) 


>  <BOM_2C19>  (97) 


>  <BOM_2D6>  (97) 
<7,8;Dealkylation;R1>
<8,H;Dealkylation;R1>

>  <BOM_2E1>  (97) 


>  <BOM_3A4>  (97) 


>  <References>  (97) 
(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693
Doki, Kosuke, et al. "Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity." Drug Metabolism and Pharmacokinetics 30.4 (2015): 257-262.

>  <FLAG_COMMENTS>  (97) 
CYP-MAP:  1A2 subtype added

>  <Name>  (97) 
Flecainide

>  <ID>  (97) 
6604414

$$$$
392622
     RDKit          2D

 50 53  0  0  1  0  0  0  0  0999 V2000
   10.4027    0.0393    0.0000 S   0  0  0  0  0  0  0  0  0  1  0  0
    7.4051   -1.1082    0.0000 S   0  0  0  0  0  0  0  0  0  2  0  0
    2.3645    0.2063    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    5.2224    0.2063    0.0000 O   0  0  0  0  0  0  0  0  0  4  0  0
    5.2224   -1.4438    0.0000 O   0  0  0  0  0  0  0  0  0  5  0  0
    4.5080   -0.2063    0.0000 O   0  0  0  0  0  0  0  0  0  6  0  0
    7.3659    2.2688    0.0000 O   0  0  0  0  0  0  0  0  0  7  0  0
    4.5080    1.4438    0.0000 N   0  0  0  0  0  0  0  0  0  8  0  0
    3.7935   -1.4438    0.0000 N   0  0  0  0  0  0  0  0  0  9  0  0
    6.6515    1.0313    0.0000 N   0  0  0  0  0  0  0  0  0 10  0  0
    8.0804    1.0313    0.0000 N   0  0  0  0  0  0  0  0  0 11  0  0
   10.2631    1.3668    0.0000 N   0  0  0  0  0  0  0  0  0 12  0  0
    7.5446   -2.4358    0.0000 N   0  0  0  0  0  0  0  0  0 13  0  0
    3.7935    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 14  0  0
    3.7935    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0 15  0  0
    3.0790   -0.2063    0.0000 C   0  0  0  0  0  0  0  0  0 16  0  0
    3.0790   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 17  0  0
    3.0790    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 18  0  0
    2.3645   -1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 19  0  0
    5.9370    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 20  0  0
    5.9370    2.2688    0.0000 C   0  0  0  0  0  0  0  0  0 21  0  0
    5.2224    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 22  0  0
    3.0790    2.2688    0.0000 C   0  0  0  0  0  0  0  0  0 23  0  0
    2.3645   -2.2688    0.0000 C   0  0  0  0  0  0  0  0  0 24  0  0
    6.6515    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 25  0  0
    5.2224    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 26  0  0
    2.3645    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 27  0  0
    3.7935    2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 28  0  0
    4.5080   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 29  0  0
    3.0790   -2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 30  0  0
    1.6500   -2.6813    0.0000 C   0  0  0  0  0  0  0  0  0 31  0  0
    7.3659    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 32  0  0
    2.3645    3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 33  0  0
    3.7935    3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 34  0  0
    3.0790   -3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 35  0  0
    1.6500   -3.5063    0.0000 C   0  0  0  0  0  0  0  0  0 36  0  0
    3.0790    3.9188    0.0000 C   0  0  0  0  0  0  0  0  0 37  0  0
    2.3645   -3.9188    0.0000 C   0  0  0  0  0  0  0  0  0 38  0  0
    8.7949    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 39  0  0
    8.0804    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0 40  0  0
    5.9370   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 41  0  0
    9.5094    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0 42  0  0
    6.6515   -1.4438    0.0000 C   0  0  0  0  0  0  0  0  0 43  0  0
   10.8152    0.7537    0.0000 C   0  0  0  0  0  0  0  0  0 44  0  0
    9.5956    0.2108    0.0000 C   0  0  0  0  0  0  0  0  0 45  0  0
   11.6356    0.8400    0.0000 C   0  0  0  0  0  0  0  0  0 46  0  0
   12.1206    0.1725    0.0000 C   0  0  0  0  0  0  0  0  0 47  0  0
   11.9712    1.5937    0.0000 C   0  0  0  0  0  0  0  0  0 48  0  0
    6.7377   -2.2643    0.0000 C   0  0  0  0  0  0  0  0  0 49  0  0
    7.9571   -1.7213    0.0000 C   0  0  0  0  0  0  0  0  0 50  0  0
  1 44  1  0
  1 45  1  0
  2 43  1  0
  2 50  1  0
 16  3  1  1
  4 22  2  0
  5 29  1  0
  5 41  1  0
  6 29  2  0
  7 32  2  0
 14  8  1  0
  8 22  1  0
 17  9  1  0
  9 29  1  0
 20 10  1  6
 10 32  1  0
 11 32  1  0
 11 39  1  0
 11 40  1  0
 12 42  1  0
 12 44  2  0
 13 49  1  0
 13 50  2  0
 14 15  1  6
 14 18  1  0
 15 16  1  0
 16 17  1  0
 17 19  1  1
 18 23  1  0
 19 24  1  0
 20 21  1  0
 20 22  1  0
 21 25  1  0
 21 26  1  0
 23 27  2  0
 23 28  1  0
 24 30  2  0
 24 31  1  0
 27 33  1  0
 28 34  2  0
 30 35  1  0
 31 36  2  0
 33 37  2  0
 34 37  1  0
 35 38  2  0
 36 38  1  0
 39 42  1  0
 41 43  1  0
 42 45  2  0
 43 49  2  0
 44 46  1  0
 46 47  1  0
 46 48  1  0
M  END
>  <InChIKey>  (98) 
NCDNCNXCDXHOMX-XGKFQTDJSA-N

>  <PubChem_CID>  (98) 
392622

>  <BOM_1A2>  (98) 


>  <BOM_2A6>  (98) 


>  <BOM_2B6>  (98) 


>  <BOM_2C8>  (98) 


>  <BOM_2C9>  (98) 


>  <BOM_2C19>  (98) 


>  <BOM_2D6>  (98) 
<11,40;Dealkylation;R1>
<40,H;Dealkylation;R1>
<46,H;Hydroxylation;R3>

>  <BOM_2E1>  (98) 


>  <BOM_3A4>  (98) 
<11,40;Dealkylation;R1>
<40,H;Dealkylation;R1>
<29,9;Hydrolysis;R2>
<46,H;Hydroxylation;R3>
<11,39;Dealkylation;R4>
<39,H;Dealkylation;R4>

>  <References>  (98) 
Zhou, S-F., et al. "Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development." Current medicinal chemistry 16.27 (2009): 3480-3675.
Rendic, Slobodan. "Summary of information on human CYP enzymes: human P450 metabolism data." Drug metabolism reviews 34.1-2 (2002): 83-448.

>  <FLAG_COMMENTS>  (98) 


>  <Name>  (98) 
Ritonavir

>  <ID>  (98) 
392622

$$$$
6338
     RDKit          2D

  3  2  0  0  0  0  0  0  0  0999 V2000
    1.2375   -0.7145    0.0000 Cl  0  0  0  0  0  0  0  0  0  1  0  0
    1.9520   -1.1270    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.6664   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
  1  2  1  0
  2  3  2  0
M  END
>  <InChIKey>  (99) 
BZHJMEDXRYGGRV-UHFFFAOYSA-N

>  <PubChem_CID>  (99) 
6338

>  <BOM_1A2>  (99) 


>  <BOM_2A6>  (99) 


>  <BOM_2B6>  (99) 


>  <BOM_2C8>  (99) 


>  <BOM_2C9>  (99) 


>  <BOM_2C19>  (99) 


>  <BOM_2D6>  (99) 


>  <BOM_2E1>  (99) 
<2,3;Epoxidation;R1>

>  <BOM_3A4>  (99) 


>  <References>  (99) 
Brown, Caitlin M., Brad Reisfeld, and Arthur N. Mayeno. "Cytochromes P450: a structure-based summary of biotransformations using representative substrates." Drug metabolism reviews 40.1 (2008): 1-100.

>  <FLAG_COMMENTS>  (99) 


>  <Name>  (99) 
VINYL_CHLORIDE

>  <ID>  (99) 
6338

$$$$
27492
     RDKit          2D

  6  5  0  0  0  0  0  0  0  0999 V2000
    2.4750   -1.4289    0.0000 N   0  0  0  0  0  0  0  0  0  1  0  0
    2.0625   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
    2.4750    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  3  0  0
    1.2375   -0.7145    0.0000 O   0  0  0  0  0  0  0  0  0  4  0  0
    0.8250    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  6  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
M  END
>  <InChIKey>  (100) 
LVLANIHJQRZTPY-UHFFFAOYSA-N

>  <PubChem_CID>  (100) 
27492

>  <BOM_1A2>  (100) 


>  <BOM_2A6>  (100) 


>  <BOM_2B6>  (100) 


>  <BOM_2C8>  (100) 


>  <BOM_2C9>  (100) 


>  <BOM_2C19>  (100) 


>  <BOM_2D6>  (100) 


>  <BOM_2E1>  (100) 
<5,6;Epoxidation;R1>

>  <BOM_3A4>  (100) 


>  <References>  (100) 
Forkert, Poh-Gek, Raymond P. Lee, and Ken Reid. "Involvement of CYP2E1 and carboxylesterase enzymes in vinyl carbamate metabolism in human lung microsomes." Drug metabolism and disposition 29.3 (2001): 258-263.

>  <FLAG_COMMENTS>  (100) 


>  <Name>  (100) 
Vinyl_carbamate

>  <ID>  (100) 
27492

$$$$
11
     RDKit          3D

  4  3  0  0  0  0  0  0  0  0999 V2000
    1.6464   -0.7110    0.1375 Cl  0  0  0  0  0  0  0  0  0  1  0  0
   -1.6463   -0.7111   -0.1375 Cl  0  0  0  0  0  0  0  0  0  2  0  0
    0.6836    0.7111   -0.3310 C   0  0  0  0  0  0  0  0  0  3  0  0
   -0.6837    0.7111    0.3310 C   0  0  0  0  0  0  0  0  0  4  0  0
  1  3  1  0
  2  4  1  0
  3  4  1  0
M  END
>  <InChIKey>  (101) 
WSLDOOZREJYCGB-UHFFFAOYSA-N

>  <PubChem_CID>  (101) 
11

>  <BOM_1A2>  (101) 


>  <BOM_2A6>  (101) 


>  <BOM_2B6>  (101) 


>  <BOM_2C8>  (101) 


>  <BOM_2C9>  (101) 


>  <BOM_2C19>  (101) 


>  <BOM_2D6>  (101) 


>  <BOM_2E1>  (101) 
<2,4;Dehalogenation;R1>
<1,3;Dehalogenation;R2>

>  <BOM_3A4>  (101) 


>  <References>  (101) 
Guengerich, F. Peter, Dong Hyun Kim, and Masahiko Iwasaki. "Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects." Chemical research in toxicology 4.2 (1991): 168-179.
Bolt, H. M., et al. "SCOEL/REC/302 1, 2-Dichloroethane (Ethylene dichloride)." (2016).

>  <FLAG_COMMENTS>  (101) 


>  <Name>  (101) 
1_2-dichloroethane

>  <ID>  (101) 
11

$$$$
3283
     RDKit          2D

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0008   -0.2762    0.0000 O   0  0  0  0  0  0  0  0  0  1  0  0
    1.1747    0.5222    0.0000 C   0  0  0  0  0  0  0  0  0  2  0  0
   -1.1754    0.5226    0.0000 C   0  0  0  0  0  0  0  0  0  3  0  0
    2.3873   -0.3840    0.0000 C   0  0  0  0  0  0  0  0  0  4  0  0
   -2.3874   -0.3844    0.0000 C   0  0  0  0  0  0  0  0  0  5  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
M  END
>  <InChIKey>  (102) 
RTZKZFJDLAIYFH-UHFFFAOYSA-N

>  <PubChem_CID>  (102) 
3283

>  <BOM_1A2>  (102) 


>  <BOM_2A6>  (102) 


>  <BOM_2B6>  (102) 


>  <BOM_2C8>  (102) 


>  <BOM_2C9>  (102) 


>  <BOM_2C19>  (102) 


>  <BOM_2D6>  (102) 


>  <BOM_2E1>  (102) 
<1,3;Dealkylation;R1>
<3,H;Dealkylation;R1>
<1,2;Dealkylation;R1>
<2,H;Dealkylation;R1>

>  <BOM_3A4>  (102) 


>  <References>  (102) 
(2012). Diethyl ether [MAK Value Documentation, 1999]. In The MAK \Collection for Occupational Health and Safety (eds and ). doi:10.1002/3527600418.mb6029e0013

>  <FLAG_COMMENTS>  (102) 
CYP-MAP: followed EBoMD

>  <Name>  (102) 
Diethyl_Ether

>  <ID>  (102) 
3283

$$$$
